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Sum m ary
Following the work of Pocock (1977) and O’Brien &; Fleming (1979), group sequential 
methods have become commonly used in the monitoring of clinical trials. An appealing 
property of these methods is the possibility of terminating the trial once there is 
sufficient evidence in favour of one of the treatments being studied. This can lead 
to great savings in time and resources and, more importantly, reduce the number of 
patients who receive the inferior treatment. Work by Eales &: Jennison (1992), based on 
earlier research by Lai (1973), has shown tha t group sequential designs which minimise 
the expected sample size can be found when the type I and type II error rates are equal. 
However, these optimal tests lack flexibility in that the precise schedule of analyses must 
be fixed before the commencement of the trial.
We generalise the method of Eales & Jennison to cope with unequal error rates and 
show tha t commonly used and popular existing methods can be reasonably efficient in 
the sense of the expected sample size. However, there are significant improvements in 
expected sample size to be gained from using the optimal tests.
A popular existing method is the error spending approach, proposed by Lan & DeMets 
(1983). Not only can this method be reasonably efficient in terms of expected sample 
size, but it has great flexibility in dealing with trials where the observations accrue at an 
unanticipated rate. We develop optimal designs which do not require a fixed schedule 
of analyses and use these optimal design to assess the strengths and weaknesses of the 
error spending approach.
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1.1 O u tlin e
Sequential methods are of great potential use in clinical trials. By allowing the 
possibility of stopping the trial at an early stage if there is sufficient evidence in favour 
of one of the treatm ents on trial, significant saving in time and resources can be made. 
Moreover, it is possible to greatly reduce the expected number of patients involved 
in the trial and thus minimise the number of patients who will be given an inferior 
treatment. We shall discuss a means of maximising the benefits of sequential clinical 
trials in a number of settings.
In this chapter we discuss the clinical trials setting and the development of sequential 
methods, with some comments on the practical implementation of sequential clinical 
trials. Chapter 2 introduces two rich families of sequential designs which are commonly 
used. Chapters 3 to 6  discuss the optimisation of sequential designs in several settings 
and use the optimal designs to assess the performance of the existing designs introduced 
in chapter 2. We conclude with some conclusions and recommendations for designing 
sequential trials in chapter 7, along with some possible avenues for future research.
1
1.2 W h y  sequ en tia l clin ical trials?
In this section, the background to sequential clinical trials is discussed, with the 
motivation for such trials and the practical considerations tha t lead to the use of 
group sequential trials described in §1.2.2. One criterion for optimality of such trials, 
minimising the expected number of patients on trial, is defined in §1.2.3. Our goal 
is to find optimal group sequential tests with respect to this criterion in a number 
of circumstances and to use these optimal tests to evaluate the performance of some 
existing and commonly used designs. Two such existing methods are described in 
chapter 2  and their performance with respect to our optimality criteria is assessed 
in chapters 3 to 6 . Some practical aspects of implementing group sequential clinical 
trials are also discussed in §1.3. Firstly, a brief description of clinical trials is given 
in §1.2.1. More details regarding the design and statistical analysis of non-sequential 
clinical trials are given in numerous books including Pocock (1983), while the use of 
sequential designs in clinical trials is discussed by Whitehead (1992) and Jennison & 
Turnbull (2000).
1 .2 .1  C lin ic a l tr ia ls
The goal of a clinical trial is to determine the efficacy of one or more treatm ents for some 
medical condition, relative to a control or each other. Pocock defines a clinical trial as 
“any form of planned experiment which involves patients and is designed to elucidate 
the most appropriate treatm ent of future patients with a given medical condition” 
(Pocock, 1983, chapter 1). In clinical trials involving human subjects the ethics and 
conduct of the trial must be more closely scrutinised and regulated than, for example, 
early-stage pharmaceutical trials on laboratory animals.
We assume tha t a new treatm ent is being compared to a control, which could be either 
a placebo or an established treatment. We shall assume that the difference between
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the treatm ent on trial and the control can be measured in some numerical fashion, 
and shall call the treatment difference //, with positive treatm ent difference (fi > 0 ) 
implying superiority of the new treatment. The available data consist of observations 
X i,  X 2 , . . where each X i ~  N (fi, a2) independently with a2 known. For example, 
these observations could be the differences between matched pairs of individuals, or 
the difference in response to the treatments for one individual.
In order to address the question “is the new treatm ent superior to the control?” , we shall 
wish to test the null hypothesis < 0  against the one-sided alternative Hi'.fi > 0  
with some chosen size a  at \l = 0 and with power I — (3 fixed at fi = 8. Both one- and 
two-sided tests are justified in different situations; a brief discussion of this is given in 
Pampallona Sz Tsiatis (1994), and the methods tha t we shall discuss are easily adapted 
to the two-sided case. In the trial design stage, 6  would be chosen to be some clinically 
significant and plausible treatm ent effect. The null hypothesis represents the situation 
where the new treatm ent is not superior to the control and the alternative corresponds 
to the situation where the new treatment is sufficiently superior to the control to make 
its use desirable. Note tha t the null hypothesis incorporates two situations; where the 
new treatm ent is equivalent to the control and when it is inferior. If the control is an 
existing treatm ent, it is irrelevant whether a new treatment is equivalent or inferior 
to it as in either case the new treatment will not be used. Similarly, if the control is 
a placebo, finding the new treatm ent to be equivalent to the control implies tha t the 
only benefit gained from the new treatm ent is simply a psychological placebo effect, so 
again the new treatm ent will not be put into use.
Initially, the assumption of independent and identically distributed normal data 
appears to pose an unrealistically simple problem of little interest. However, in the 
group sequential setting, there are many applications where the statistical formulation 
has, at least asymptotically, the same distribution as in this case. For examples of 
the wide applicability of this distribution see Jennison Sz Turnbull (1997). Jennison
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& Turnbull show tha t this asymptotic distribution occurs for sequences of maximum 
likelihood estimators of parameters in statistical models. They specifically discuss 
parameters of a generalised linear model and a Cox proportional hazards model. 
W hitehead (1992) discusses a framework which can be used for problems involving 
binary, Poisson and ordinal responses and with censored survival data, although 
without explicitly considering the joint distribution of the summary statistics involved. 
More generally, Scharfstein, Tsiatis & Robins (1997) show tha t the relevant joint 
distribution occurs when a single parameter of a parametric or semi-parametric model 
is efficiently estimated in a sequential fashion.
In more complicated examples than tha t of simple independent and identically 
distributed normal observations, the sample size n  is no longer directly interpreted 
as the number of observations, but as the information level; in most cases this will be 
Fisher’s information. This implies a “time” scale where we start the trial with zero 
information and accumulate data until a conclusion is reached; this approach is often 
referred to as a maximum information design. This information level is distinct from 
calendar time as the two may proceed at different rates. For example, if the trial is 
examining the survival rates of patients with some terminal condition, there may be an 
initial period of recruitment to the trial after which a lengthy follow-up period will take 
place. The information available is directly proportional to the number of deaths which 
have occurred; the rate of deaths will not be constant over time. Thus, the information 
level will have accrued at a rate which will not be proportional to calendar time. A 
more detailed discussion of the differences and links between the passing of calendar 
time and accrual of information is given by Lan, Reboussin & DeMets (1994).
1 .2 .2  S eq u en tia l and  grou p  seq u en tia l t e s ts
In large clinical trials, which may involve thousands of patients, it is usual to monitor 
accumulating data for a number of reasons. For example, there is always the
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possibility of unanticipated toxicity of a treatment, or of other undesirable side-effects, 
necessitating the early termination of the trial. Many regulatory bodies now require 
the monitoring of data as the trial progresses. One example is found in the Food and 
Drug Administration’s guidelines for clinical trials, which states that “it is recognized 
that safety must be monitored in all trials; therefore, the need for formal procedures 
to cover early stopping for safety reasons should always be considered” (FDA, 1998).
A natural consequence of this monitoring is a desire to stop the trial before the planned 
number of observations have been seen if a clear difference in efficacy between the two 
treatm ents is observed earlier in the trial. To this end, sequential and group sequential 
methods have been developed.
Initial work on sequential schemes was based on industrial quality control problems. 
Wald (1945) proposed the sequential probability ratio test, which assumes tha t there 
is no maximum to the number of observations tha t can be taken. Later work by 
Anderson (1960) looked at the sequential analysis of data when a fixed maximum 
number of observations can be taken. All these proposals were based on analysing the 
data after each observation was made. A more practical proposal for use in the medical 
setting was made by Pocock (1977), where data axe analysed in groups, referred to as 
group sequential analysis. This made the logistics of interim analyses practical in a 
medical context. We shall refer to methods requiring analysis of the data after every 
observation as fully sequential methods. The term sequential analysis will refer to 
both fully sequential and group sequential methods. A more detailed discussion of the 
history of sequential analysis is given by Ghosh (1991).
In order to carry out the hypothesis test described in §1.2.1, we assume tha t there will 
be a maximum of K  interim analyses of the data, with the trial terminating at analysis 
K  if it has not done so at an earlier analysis. Note that we refer to all analyses of the 
data, including the final possible analysis, as interim analyses to distinguish them from 
the analysis taken at the conclusion of a non-sequential trial. Define rii to be the total
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number of observations taken by analysis i. We note that the maximum sample size 
riK will be larger than the sample size required for a fixed sample size test allowing 
no interim analyses of the same hypotheses with equal size and power. Initially, in 
chapters 3 and 4, we only consider problems where K  and the sample sizes n i , . . . ,  tik 
are fixed as part of the trial design. In chapter 5, we shall go on to consider what 
happens when the sequence of sample sizes is not fixed in advance and in chapter 6  we 
relax the requirement of fixing the maximum number of analyses.
Commonly, sequential methods are represented by the plotting of an information 
statistic (in the case of independent and identically distributed normal data we have 
discussed above the information statistic is simply the cumulative sample size) against 
a summary statistic of the observed data (such as the sum of the data observed to date). 
At each analysis there will be a continuation region, and the trial will be term inated 
with either the rejection or acceptance of Ho if the observed summary statistic is outside 
the continuation region. The bounds of the continuation regions at each analysis are 
said to form the sequential boundary and the test will be terminated once the test 
boundary is crossed. Many different rules exist to  determine the continuation region 
at each analysis, and hence the sequential boundary; two popular and commonly used 
rules are described in chapter 2. In chapters 3 to 6 , we describe methods for finding 
optimal group sequential boundaries, but first we must define our optimality criteria, 
which we discuss in the next section.
1 .2 .3  O p tim a l grou p  seq u en tia l te s t s
One of the main motivations for group sequential tests is the ethical imperative to 
stop the trial with a recommendation as to the superior treatm ent as early as possible; 
the aim being to reduce the number of patients randomised to the inferior treatm ent. 
Work has been done on adapting the allocation of new patients to treatm ents in light 
of the data so far seen in a trial, but that is beyond the scope of our current work; for
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a review of this subject, see Basu, Box & Ghosh (1991) and for more recent work see 
Coad &: Rosenberger (1999) or Jennison & Turnbull (2000, chapter 17). Stopping the 
trial as early as possible also reduces the cost of the trial, in terms of both financial 
and other resources which is an attraction to pharmaceutical companies. We shall take 
the desire to minimise the expected number of observations as our prime motivation in 
designing group sequential tests.
Note tha t the sample size of the test (i.e. the number of observations taken) is a random 
variable, as opposed to the fixed sample size tests used when there are no interim 
analyses. Define N  to be the total number of observations taken and 7i; to be the 
cumulative sample size at analysis i. Then N  takes values in the set { n i . . . ,  n x }  and 
Ffj,{N = n;} =  {trial terminates at analysis i}. We shall describe a test as optimal 
if it minimises E^liV} for a particular value or set of values of /i; these expectations 
are referred to as objective functions. For example, one such objective function would 
be Eo{iV}, the expected sample size if, in tru th , the new treatm ent is equal in efficacy 
to the control. In §3.1.1 we define several objective functions, for different values of (i 
or averaged over several values of fi.
Having defined objective functions and set our initial goal to be the minimising of 
these, we note that in some cases it will not be appropriate to seek the minimising of 
expected sample size as the primary criterion for test design. For example, in a clinical 
trial where the treatm ents are of similar cost, toxicity and efficacy, information on long­
term  effects may be desired. Alternatively, it is possible to imagine a situation where 
there is initial superiority for one treatment, but where survival for the two treatm ent 
arms converges or even crosses as follow-up increases. Also, as we shall see, some 
tests which have extremely low expected sample sizes have the undesirable property 
of having a very large maximum sample size. Even if the probability of reaching the 
maximum sample size is small, a design which allows the possibility of taking twice as 
many observations as the equivalent fixed sample size design will be unattractive.
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1.3 Im p lem en tin g  group sequ en tia l clin ica l tria ls
Having briefly discussed the motivation for and background to group sequential tests, 
it is im portant to remember that any group sequential design must be practical to 
implement if it is to be used in a clinical trial. It is this criterion which has lead to 
the development of group sequential designs in place of fully sequential methods; the 
logistics of analysing the accumulating data after each observation are prohibitive.
Commonly, information collected in the course of a large scale clinical trial will be 
periodically reviewed by a data monitoring committee which will have the responsibility 
of recommending the continuation or termination of the trial to the investigators. In 
§1.3.2, the role of the data monitoring committee is considered, but first we discuss 
several design criteria for group sequential trials.
1 .3 .1  D e s ig n  cr iter ia
Many possible schemes have been proposed for designing and carrying out a group 
sequential clinical trial. By “scheme” , we refer to the rules used to determine when the 
interim analyses will occur and what action will be taken as a result of the observed data 
at these analyses. Before selecting a scheme, it is im portant to consider the reason for 
using a group sequential design and to note certain points which are valid irrespective 
of the scheme used.
As with any statistical analysis, the endpoint(s) of interest must be identified. While 
the vast majority of work on group sequential tests has been devoted to trials with a 
single endpoint, the question of multivariate endpoints has been addressed. Jennison &; 
Turnbull (1993) considered bivariate responses, monitoring both the efficacy and safety 
of a new treatment. Cook & Farewell (1996) consider combining the clinical endpoint 
of a trial and a surrogate endpoint to form a single test statistic. There have also 
been ad-hoc treatments of this problem, such as example 2 of Geller & Pocock (1987).
Geller & Pocock go on to discuss this problem briefly, making three suggestions. One 
is to combine endpoints of interest, so for example recurrence of a condition or death 
could be combined into one event. A second is to test each endpoint separately at each 
interim analysis, making suitable modifications to avoid error inflation. Thirdly, it may 
be possible to combine multiple endpoints into a global test statistic.
The number and timing of interim analyses planned must be considered. In part, 
the selection of a group sequential scheme will influence this choice. However, for all 
schemes the increase in efficiency possible through group sequential testing is mostly 
gained with a small number of analyses, as shown by Pocock (1982), Jennison (1987), 
Eales & Jennison (1992) and §3.2.1 of this thesis, amongst others.
Moreover, while some schemes such as the error-spending approach proposed by Lan k  
DeMets (1983) (see §2.3) or W hitehead’s triangular test (Whitehead, 1992, chapter 4), 
have the advantage of flexibility of the timing of analyses, this flexibility must not 
be abused. The choice of analysis times should not be response-dependent, although 
altering the times of analysis on the basis of unanticipated accrual rates is acceptable. 
By fixing the analysis times as part of the trial design, accusations of such manipulation 
of the trial can be avoided. Another reason for planning analysis times in advance is 
the purely practical point that members of the data monitoring committee will be able 
to schedule meetings to discuss the trial.
It is also im portant to note that the analyses do not need to occur at equally spaced 
intervals of calendar time or after equal increments in information level, although some 
group sequential schemes do stipulate analyses at equally spaced intervals, usually equal 
information level increments. If the trial is investigating treatm ents for a condition 
with a delay between treatment and onset of effect, or with long follow-up, it may be 
desirable to delay the initial analyses until the treatment has had time to take effect.
Potentially the most important choice to be made in group sequential trial design is the
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choice of which scheme to use. This question should be approached by first considering 
the reasons for monitoring the data. If the data are only subjected to interim analysis 
for safety reasons and to comply with regulatory body guidelines, with little or no 
expectation of early termination, a scheme which is conservative at early analyses will 
be appropriate. The final analysis of such a scheme will be similar to an equivalent 
non-sequential design, and as such will be easier to interpret. Conversely, a trial where 
there is believed to be the possibility for a large treatm ent effect has greater potential 
for early termination and in such cases a scheme which is less conservative at early 
analyses will be more appropriate.
Another question which will influence the choice of scheme is the rate of arrival of the 
data. Many schemes assume that the number of observations available at each analysis 
will be fixed in advance. While such schemes are usually robust to small departures 
from this assumption, as shown by Pocock (1977), gross departures can lead to problems 
as described by Proschan, Follman & Waclawiw (1992). In a trial where fears exist 
tha t the rate of data  arrival might be unpredictable or erratic, a flexible approach such 
as error spending (Lan &; DeMets, 1983) or W hitehead’s triangular test (Whitehead, 
1992, chapter 4) might be considered.
1 .3 .2  T h e  ro le  o f  th e  d a ta  m o n ito r in g  c o m m itte e
It is now common practice for the progress of a large scale clinical trial to be monitored 
by a data monitoring committee (also sometimes referred to as a data  and safety 
monitoring board, or other equivalent terms). The data monitoring committee will 
either be internal to the institution carrying out the trial or an independent body. In 
either case, the committee has several duties. One of these is to ensure the trial protocol 
is adhered to. The committee may also find it appropriate to recommend alterations 
to the protocol; for example, if practical circumstances dictate a change in treatm ent 
regime or inclusion criteria, or if new information becomes available from other trials.
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Whenever feasible, a clinical trial will be blinded; that is the patients and clinicians 
will not know which treatm ent is being given to each individual. The goal of this is to 
ensure that there is no conscious or unconscious bias and to make the placebo effect 
apply equally to both control and treatment groups. Frequently, the interim analyses 
involved in a sequential scheme will require the breaking of this blind, at least by the 
statistician analysing the data, but this is not always the case. In some situations 
it would be possible to report that the trial was nearing the boundary indicating 
superiority of treatm ent A without saying whether treatm ent A was the new or control 
treatm ent. Even if the blind is not broken, the data monitoring committee should 
ideally be comprised of individuals not directly involved with the trial and with no 
possible conflict of interest.
A potential reason for the termination of the trial is that sufficient evidence has been 
accrued to support the superiority of one of the treatments (or to support the hypothesis 
tha t there is no treatm ent difference). This is precisely the function of sequential 
monitoring schemes, and hence one role of the committee is to act as custodians of 
the scheme. The data  monitoring committee may also recommend the termination 
of the trial under circumstances other than the crossing of the sequential boundary. 
For example, if there is unanticipated mortality or other negative side effects on one 
treatm ent it may be appropriate to terminate the trial.
As previously stated, there may be alternative reasons for terminating the trial before 
the planned end other than the sequential boundary being crossed. Conversely, there 
may also be a desire to continue the trial after the sequential boundary has been 
crossed. For example, in an equivalence trial the test may have concluded tha t there 
are no differences between the two treatments. If there are no known side effects 
and the costs of the treatments are similar, then the data monitoring committee may 
recommend the continuation of the trial to obtain further information on the long-term 
effects of the new treatment.
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Thus, the stopping rule determined by the group sequential scheme may be interpreted 
as a somewhat flexible guideline rather than a rigid rule. While this may be statistically 
and even ethically dubious, given the complexity of the decision process involved in 
monitoring the trial, it is im portant that the data monitoring committee retains the 
ability to recommend actions contrary to those dictated by the stopping rule. However, 
it must be noted tha t continuing the trial when the scheme dictates the term ination 
of the trial invalidates much of the existing methodology for post-trial analysis. More 
details of this are given in the next section.
Further discussion of the role and responsibilities of the data monitoring committee 
can be found in Korn &; Simon (1996) or Fleming & DeMets (1993).
1 .3 .3  P o s t- tr ia l e s t im a tio n  and  a n a ly sis
On conclusion of a clinical trial, whether or not the trial is sequential in nature, more 
detailed statistical analysis will be required than a simple statem ent tha t the new 
treatm ent studied is or is not superior in efficacy to the control at some pre-specified 
level of significance. The treatm ent effect must be estimated, either as a point estimate 
or preferably a confidence interval; p-values will frequently be required as a measure 
of evidence by regulatory bodies and clinicians who must decide whether or not to use 
the new treatment.
Conventional fixed-sample methods for carrying out statistical analyses are invalid 
after completion of a sequential trial and alternatives must be used. Most frequentist 
methods are based on an ordering of the possible sample space of observed data and 
at what point the trial was terminated (earlier termination of the trial often being 
taken as more conclusive evidence of treatm ent difference), such as tha t described by 
Jennison & Turnbull (1991). Post trial analysis is discussed in depth by W hitehead 
(1992, chapter 5) and by Jennison & Turnbull (2000, chapter 8 ).
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Chapter 2
Two existing group sequential 
test designs
2.1 In trod u ction
In this chapter, two existing designs for group sequential tests are introduced and 
discussed. These designs produce rich families of tests, allowing a wide choice of tests 
in each family. The first of these two designs is the A-family of one-sided tests due to 
Pampallona &; Tsiatis (1994), following work by Emerson & Fleming (1989), discussed 
in §2 .2 . In §2.3 we introduce the error-spending method of Lan &: DeMets (1983), first 
in the two-sided context where this method was initially proposed and then in the case 
of one-sided tests. These methods are assessed in terms of maximum and expected 
sample size in various situations in the following chapters.
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2.2 T h e A -fam ily
Many authors have proposed group sequential schemes based on a fixed series of analysis 
times. The first group sequential designs, by Pocock (1977) and O’Brien Sz Fleming 
(1979), were two-sided test designs of this form. Wang & Tsiatis (1987) proposed a 
family of two-sided tests which included the Pocock and O’Brien & Fleming tests as 
special cases. This rich family of tests was extended by Emerson & Fleming (1989) 
and by Pampallona & Tsiatis (1994) to include two-sided tests with the possibility 
of stopping in favour of the null hypothesis and to include one-sided tests. We now 
describe this family of tests, which we index by the parameter A. We shall refer to this 
family of tests as the A-family.
Suppose we wish to test H q-./i  < 0 against H i’.fi > 0 with size a  at ft = 0 and power 
1 — /? at /i =  5, as described on page 3. We allow a maximum of K  analyses, with groups 
of n  observations being taken between analyses. Each observation X i is independent 
and has distribution iV(/z, a2) with a2 known. The test is defined by choosing a value 
of the param eter A, which determines constants c\ and C2 as described below. Once 
these constants are determined, the number of observations per group, n, is given by
n =  M e i  +  c2) j 2g2A- 2
At analysis z, the total number of observations is rii =  ni and we calculate Sni = 
Y^jLi X j. We then reject H q if Sni > bi, accept Ho if Sni < a{ and continue to analysis 
i +  1 if Sni 6  [a*, bi\, where and bi are given by
d i =  Srii — C2ZA _ 1 / 2 \ /n ic r 2 (2 -1 )
and bi = cizA - 1 / 2 \/n iC 2, 
where a x  = bx  to ensure tha t H q will be either accepted or rejected a t analysis K ,
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should the trial proceed that far.
The constants c\ and c<i are determined by the choice of A, and can be found from 
tables in the paper by Pampallona & Tsiatis (1994). Alternatively, they can be found 
by fixing A and then carrying out a numerical search over possible values of C\ and C2 to 
find the values of these constants which give a test with the desired error probabilities 
a  and (3.
If the trial is to be designed for a sequence of non-equal group sizes, one possible 
adaptation is to replace the term iA ~ 1/ 2 in the definitions of ai and b{ (equations (2 .1 )) 
by (ATni/n/c)A_1/2. This reduces to equations (2.1) in the case of equal group sizes.
2.3 T h e error sp en d in g  m eth od
The error spending (or alpha spending) approach was proposed by Lan & DeMets 
(1983). Unlike earlier schemes (Pocock, 1977; O’Brien &; Fleming, 1979), the 
error spending method does not require the number of analyses and the number of 
observations taken at each analysis to be specified in advance. In our notation, the 
maximum number of analysis K , and the sample sizes at which these analyses will 
be performed, { n i , . . . , n x }  need not be specified as part of the trial design. An 
intermediate design, by Slud Sz Wei (1982), required K  to be fixed but did not require 
specification of the { n i , . . . ,  n # }.
The error spending approach does not require a fixed maximum number of analyses K  
and allows the analyses to be carried out after an unspecified number of observations. 
This may be appropriate if we wish to analyse the data every 6  months and are unsure 
as to the anticipated rate of accrual of information, or in a survival study where the 
information level is proportional to the number of observed events, which may be 
unpredictable. The number of observations at analysis i is still denoted as n^, and the 
maximum number of analyses as K ,  but we note that the values K  and { n i , . . .  , n#}
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are not fixed in advance.
Instead of fixing K  and { n i , . . .  , n/r}, we specify a maximum number of observations 
nmax• We also select an error-spending function a*, which has £**(0) =  0 and ot*(t) = a  
for any t > 1, where a  is the type I error of the test. Then the cumulative type I error at 
analysis i is given by a* (n ;/n maa;). Thus, once the target sample size n max is exceeded, 
the total type I error of the test is a. While it is not a formal requirement tha t a*(t) be 
continuous, discontinuous error spending functions can be problematical (Li & Geller, 
1991; Proschan, Follman & Waclawiw, 1992).
In §2.3.1, we describe how a two-sided test is determined by a* and n maa;, as was 
initially proposed by Lan & DeMets. In §2.3.2 we go on to describe the alterations 
needed to design and implement a one-sided error spending test, while §2.3.3 defines 
several possible choices for a*, including two rich families of error spending functions.
2 .3 .1  T w o -s id ed  error sp en d in g  te s t s
The error spending function a* and n max are used to determine the stopping boundary 
as follows. Consider testing the null hypothesis Ho’.fj, =  0 against the two-sided 
alternative H^-li 7  ^ 0 with desired type I error a  and error spending function a*. 
Observations . . .  can be taken, and Xi  ~  N(n,  a2) independently of each other.
At the first analysis, n\  observations will have been taken yielding the summary statistic 
value 5ni — ]Cj=i X j .  Then Ho will be rejected if Sni < —c\ or 5ni > ci, where ci 
is defined by Po{|'S'nil >  0 } =  a i ,  where 0 1  =  a * (n i/n maa;). Thus, a\  type I error is 
“spent” at analysis one.
In general, if the trial reaches analysis i, Ho is rejected if >  q , where
Po {|5n i | <  ci n . . .  n  I S ^ I  < Ci_i n  |Sni| >  Ci} =  a* ( — )  -  a* ( — )  -
\  Tlmax / \  ^ mai /
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spending a* (n j/n max) — a* (rii-i/ n max) type I error at analysis i. This continues until 
either |5n{ | >  Ci for some i, in which case H q is rejected, or rii >  n max. If the maximum 
number of observations has been taken and the trial terminated at analysis k with 
|£ n j  < Cfc, Ho is accepted.
Using the error spending approach for a two-sided test ensures tha t the size of the test 
will be a. The power of the test will be determined by the sequence of analysis times 
{ n i , . . .  , n max}. If a particular power is required, the analysis times must be chosen 
appropriately, necessitating a numerical search which utilises the fact tha t increasing 
Umax will increase the power of the test, while reducing nmax will reduce the power of 
the test if the ratios {n%/rij\i < j  < K }  are kept constant. Further details add to the 
complexity of this search; these are discussed, in the one-sided context, in §2.3.2.
2 .3 .2  O n e-s id ed  error sp en d in g  te s t s
We shall first consider the design of a one-sided error spending test, then discuss the 
practical implementation of the test design.
D esign
To adapt the error spending approach for a one-sided test, two error spending functions 
must be specified. We shall use this method to test the null hypothesis Hoijj, <  0 against 
the alternative > 0 with type I error a  and type II error (3 at y, = 0 and /i =  S 
respectively. This necessitates the specification of two error spending functions, a*(t) 
and (3*(t): which may be identical or different.
We propose a planned maximum number of analyses K  and sequence of information 
levels to — 0 < t\  <  . . .  <  t x  — 1. Then at analysis i, the sample size is given by 
m  = Urimax• Note that the trial can then be carried out in a more flexible manner 
and the planned analysis schedule deviated from, but this will perturb the power of
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the test, as discussed below. At analysis z, the trial will be stopped and H q rejected if 
^  6^5 similarly the trial will be stopped and i?Q accepted if a.i, where di and
bi are given by
Wo{Sni G (ai, 61) n  . : .  D Sni_l e  (ai_i, 6»_i) n  Sni > bi} =  a*(U) -  a*(ti- i)  (2.2) 
and
^ s { s ni e  (01, 61) n . . .  n  <S'ni_1 e  K _ i , 6*_i) n  5ni <  a.} =  /?•(**) -  /T (^_ i) .  (2.3)
Having selected our error spending functions and specified a planned schedule of 
analyses, we find n max to ensure tha t the boundaries converge at the end of the trial 
if the planned schedule of analyses is adhered to. If nmax is larger than necessary, the 
boundaries will cross, while if n max is too small the boundaries will not converge. As 
a starting point, we note that nmax > n /ix, thus the upper and lower boundaries of a 
design with n max =  rifix will not converge at analysis K.  Successively larger values of 
nmax are considered until one is found where the boundaries cross, giving clk > hx- 
These maximum sample sizes form a bracket for a simple numerical search for the value 
of n max such tha t a x  = bx-
Im p le m e n ta tio n
Despite having proposed a schedule of analyses in the design of a trial using the error 
spending approach, we are not constrained to follow this schedule precisely. This is the 
advantage of the error spending approach, but it does lead to some small complications 
in the implementation of the trial and to perturbations in the achieved power.
In practice, the boundaries may fail to converge precisely at the first analysis where 
ni > nmax-, either crossing before this point or failing to converge at all. In either case,
18
the usual response is to act to preserve the type I error of the test. We can do this 
by finding the upper boundary point bi as normal from equation (2 .2 ), but instead of 
using equation (2.3) to determine ai, we set a\ — bi. This will result in the achieved 
power being greater than  nominal if the boundaries had crossed and ai is reduced and 
less than nominal if the boundaries had failed to converge.
One further possible complication exists. Consider the situation where, after analysis 
z, oti = ol — ofini/rimax) type I error remains to be spent, but the continuation region 
(ai, bi) is such that
Po{s ni e  (a i,6 i ) n . . . n s ni e  (a*,^)} <  c^.
In such a case it will not be possible to find 6{+i such that
M S ni ^ (®i) &i) n ... n sni £ (ai, bi) n 1} — qjx.
An analogous situation can occur if there is less continuation probability than the 
unspent type II error probability. W hether this will occur at analysis z can be checked 
once the number of observations seen at analysis z is known but before the data  is 
analysed. We calculate the lower and upper limits of the continuation region, ai and 
bi, as usual and if ai > bi we can terminate the trial by setting ai = bi.
2 .3 .3  P o ss ib le  error sp en d in g  fu n ctio n s
Several possible error spending functions have been proposed in the literature. A one­
sided error spending function was proposed by Jennison (1987), but this function is 
complicated and requires a three-dimensional search to find param eter values. Eales 
& Jennison (1992) have proposed using a one-sided error spending function formed by 
finding the error spent at each analysis under optimal schemes and interpolating these 
values. This is discussed in §3.4.3. The functions discussed below were all proposed in
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the two-sided context, but can be used in the one-sided case.
A family of error spending functions a*(t, p) = a tp, p > 0 incorporates several functions 
considered in the literature, including p =  1 (Lan & DeMets, 1983) and p = 1.5 and 2 
(Kim &; DeMets, 1987). We shall refer to these error spending functions as the p-family 
of error spending functions.
We also consider a second family of error-spending functions which we refer to as the 
7 -family, proposed by Hwang, Shih & DeCani (1990). These error spending functions 
are defined by
Hwang, Shih &; DeCani note tha t the choice of 7  will depend on the situation, suggesting 
values between —5 and 4. Chang, Hwang & Shih (1998) use this error spending function 
with 7  =  4 in a one-sided example and refer to its use in the Scandinavian Simvastatin 
Survival Study (1993), a clinical trial involving the treatm ent of coronary artery disease.
the Pocock (1977) and O’Brien & Fleming (1979) repeated significance test schemes. Of
crossing a horizontal boundary, which is the continuous time analogue of the O’Brien 
h  Fleming scheme, while the Pocock function is empirically chosen to give behaviour 
close to tha t of Pocock’s scheme for up to 8  interim analyses. These functions were first
Proschan (1999) investigates theoretical properties of these error spending functions
7 ^ 0  
7 =  0.at
In the two-sided context, error spending functions exist which emulate the behaviour of
these, the O’Brien &; Fleming function is based on the probability of a Brownian motion
used by Lan & DeMets (1983) and are defined here as a*P {t) and a£)(£) respectively
a*P(t) =  cdog{l +  (e — 1 )t] a'0 (t) = 2{1 -  $ ( Z a/2 t - 1' 2)}.
when used to define two-sided tests. He finds that a£)(£) gives better results in terms
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Figure 2-1: Sample error spending functions from the 7 - and p-families of 
such functions. The pseudo-Pocock and psuedo-O’Brien & Fleming error 
spending functions are also shown.
of the resulting boundaries being more robust to the number of looks taken at the data 
as the trial progresses. Jennison & Turnbull (1990) note that the p-family produces 
error spending functions close to a*p (t) and &o(t) with p = 0.8 and 3 respectively.
These error spending functions are shown in figure 2-1 for comparison. The p family 
error spending functions shown are for p =  0.5, 1, 2, 3 and 4 and the 7 -family error 
spending functions are for 7  =  —4, —3, . . . ,  4. The solid lines on these graphs are the 
error spending functions with p = 0.5 and 7  =  —4, with other values of p and 7  being 
represented by dotted lines. The dashed lines on these graphs are the pseudo-O’Brien & 
Fleming error spending function (on the p-family graph) and the pseudo-Pocock error 
spending function (on the 7 -family graph). These functions are very close to members 
of the p- and 7 -families, as can be seen.
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Chapter 3
Optim al sym m etric group 
sequential tests
Finding optimal group sequential tests is a highly computationally intensive task. 
Simply searching over the space of possible boundaries is not feasible for medium to 
large K  (Pocock, 1982; Jennison, 1987). In §3.1, we describe a method due to Eales &; 
Jennison (1992), following work by Lai (1973), which uses an artificially constructed 
Bayesian decision problem for which the optimal Bayes strategy corresponds to the 
optimal group sequential test we wish to find. In §3.1.1 the frequentist problem 
is defined and notation introduced, while §3.1.2 introduces the Bayesian problem 
identified with this frequentist question and §3.1.3 gives details of the backward 
induction algorithm used to solve the Bayesian problem. The performance of the 
optimal group sequential tests thus found is discussed in §3.2 and finally in §3.3 -  §3.5 
the optimal tests are used to assess the performance of the existing group sequential 
test designs introduced in chapter 2 .
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3.1 F in d in g  op tim al group sequentia l te s ts  v ia  a B ayes  
d ecision  prob lem
3 .1 .1  S ta t is t ic a l fo rm u la tio n  an d  o p tim a lity  cr iter ia
Assume that the available data are a realisation of the variates X \ , X 2 , —  Each
analysis if not before then. Define rii to be the cumulative number of observations at 
the zth analysis. For now, we consider only the case where K  and { n i , . . .  , t i k }  are 
known in advance as a part of the trial design. The requirement of a fixed sequence 
of group sizes will be relaxed in chapter 5 and in chapter 6  we will consider tests 
when the number of analyses is not fixed in advance. We also define the summary 
statistic Sn = X j which has the distribution Sn ~  N(nn,ncr2). Finally, define 
the random variable N  to be the actual number of observations taken up to the 
point when the trial terminates; then N  can take values in the set { n i , . . . ,  n/r}, with 
PM{JV =  m } = P/Z{trial terminates at analysis z}. Suppose we wish to test Hq:h <  0 
against H\:fi > o, with both type I and type II error probability equal to a. We fix 
the type I error at fi = 0  and the type II error is fixed at /z =  8 , where 8  is a medically 
significant value of treatm ent efficacy chosen as part of the design of the clinical trial.
We consider a subset of all possible group sequential tests, those which are symmetric 
about /i =  8/2. The test is defined by a set of values {ci , . . . , t i k }  with c* >  0 for 
i = 1 , . . . ,  K.  These values form the group sequential test boundary and determine the 
action taken at each analysis as follows.
observation is independent and identically N ( f i ,a 2) distributed, with a 2 assumed to 




s t o p ,  accept Ho, 
continue to next analysis, 
s t o p ,  reject H q.
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We set ck = 0  to ensure termination of the trial at the Kth. analysis, if the trial has 
not already term inated at an earlier time.
As stated above, this group sequential test is symmetric about the intermediate value of 
/i — 5/2, a value of /i “midway” between H q and H\.  This symmetry can be seen more 
clearly in the notation used by Eales k  Jennison (1992). In their paper, H\:fi = —S 
was tested against =  +^j m  which case the symmetry is about /i =  0. It is easy 
to switch between these two situations by a simple transformation, as is noted in the 
paper by Eales k  Jennison.
Following Jennison (1987) and Eales k  Jennison (1992), we define objective functions 
F1 - F 5  in our notation as follows.
Given S, a, a, K  and { n i , . . . ,  npc} a group sequential test can be found which minimises
depend on the plausible treatment difference and on the treatm ent difference for which 
early stopping is most desirable. Objective function F\ is the expected sample size
which the test is symmetric. The two expectations given in the definition of F2  are
are set. These two expectations axe equal due to the symmetric nature of the tests
F , =  % 2W
F2  = Eb{AT} =  15s{iV}
F3  = %isi2 { N )
Ft =  1 E e « /4 {jv}
i= 2
any one of these objective functions. The choice of objective function to minimise will
if there is a small difference in favour of the new treatment; this is the value about
the expected sample size for the values of fi at which the type I and type II error rate
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considered. Objective function F3 represents a situation where the treatm ent effect is 
in fact greater than hypothesised. This objective function is also the expected sample 
size if n = —<5/2, tha t is if the new treatm ent is actually inferior to the control, due to 
the symmetry of the problem. Objective function T4 is averaged over n  values ranging 
from a small positive treatm ent difference to greater than predicted difference in favour 
of the new treatment. Objective function F5 is the expected sample size averaged over 
a range of fi values weighted by a normal distribution with mean <5/2 and standard 
deviation <5/2.
Minimising certain objective functions was considered for small K  (up to 10) by 
Jennison (1987), who searched over the space of possible {ci , . . . ,  ck} to find optimal 
tests. The following method, by Eales & Jennison (1992) and following work by Lai 
(1973), is more stable, faster in execution and able to deal with K  up to 200. In their 
paper, Eales & Jennison worked with equal group sizes rti =  itlk/ K  for i = 1 , . . . ,  K.  
However, the generalisation to fixed but non-equal group sizes is immediate and 
obvious; the following description is presented with this generalisation in place and 
in terms of our problem of testing Ho'fi <  0  against Hi'.fi > 0 .
3 .1 .2  T h e  B a y es  d ec is io n  p ro b lem
Say we wish to minimise F2  — Eo{AT}. Eales & Jennison (1992) did this by means of 
an artificially constructed Bayes decision problem. Define a prior on jn as 7r(^x) =  1/2 
for fi =  0  or 8 , with zero prior probability elsewhere and let the cost of sampling one 
observation be c{fi) =  1 for fi =  0 or <5 and c(fi) — 0 otherwise. The decision problem 
has two possible decisions; Do : = O’ and D$ : lfi = 8 ’. The losses associated with
these decisions are L i(Dq,8 ) =  Li(Dj ,0)  =  d and = 0 otherwise.
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The expected cost of this decision problem is
E{cost} =  E{cost of sampling} +  E{cost of decision}
=  c(0)Eo { AT}tt(0) +  c(5)E^ {JV}tt {6) +  
dP*{.Do}7r(tf) + d P 0 {Z?j}7r(0 )
=  i  +  lE^iV} +  d P jp o }  +  dPo{£>*}]
=  F2 +  id [P {{D0 }+Po{i>«}]-
If the solution to the Bayes decision problem satisfies P^I^Do} =  Po{As} =  oc, then this 
solution also gives the optimal group sequential test desired. Any other decision rule 
for selecting between Do and D$ with the stated probabilities of an incorrect choice 
must have a greater expected cost as this is the Bayes rule. Thus, these other rules 
must have greater expected sample sizes under fi = 0 or 6 . As each possible decision 
rule corresponds to a unique group sequential test, the Bayes rule uniquely identifies 
the group sequential test with the desired error rate a  minimising ¥ 2 -
To identify the Bayes rule associated with the group sequential tests with equal error 
rates a , the appropriate Bayes rule is found for a fixed error cost d. The error rates for 
the corresponding group sequential test can be quickly calculated by means of numerical 
integration of the joint distribution of {5ni , . . . ,  -Sn^}. Efficient computation for this 
integration is discussed by Jennison (1994). A given cost d thus leads to an achieved 
error probability and a search can be carried out over d to achieve the desired error 
probability a. For any specific value of d, the relevant test can be quickly calculated 
via a backward induction algorithm described in §3.1.3.
O ther objective functions can be minimised by defining the loss function L\  as for F2  
and altering the prior and cost of sampling functions 7r(/x) and c(/x) as follows. For 
F i, we take it (fi) =  1/3 for fi = 0, <5/2 or 8  and zero otherwise, with c(6 / 2) =  1 and
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c(fi) = 0 for fi ^  8/2. For F3 , we take 7r(/x) =  1/4 for /i = —8/2, 0, 8, and 35/2 and 
zero otherwise, with c(fi) =  1 for /i =  —<5/2 and n  =  3(5/2, with c(/i) =  0 otherwise. For 
F4, 7r(/i) =  1/10 at fi = 1 8 / 4 for i =  —2 , . . .  , 6  except for 7t(5 /2) =  1/5. We also take 
c(/i) =  1 for all [l for F4. Objective function F 5 requires a more complex formulation. 
We take a prior on fi with probability mass 1/3 at /i =  0  and 8 and with a density 
2 d- 1 0 {(2 /i — 8) /8} /3, where <j) is the density function of a standard normal variable, 
on R, with c(/i) =  1 for all p  E R\{0, <5} and c(fi) = 0 for /i =  0 or <5.
3 .1 .3  T h e  back w ards in d u c tio n  a lg o r ith m
Let the posterior probability that fi = /jl0  a t analysis i with the observed data 
summarised as Sni be written as p(l\fjLo\Sni). If we are to stop and make a decision 
at analysis i , we shall decide in favour of whichever alternative has the higher 
posterior probability. Hence we shall decide Do if p ^ ( 0 \ S ni ) > pW ^ISn.) and Dg 
if pU(6\Sni) > Thus, the expected loss of taking this decision when the
observed cumulative sum of the first rii data values is sni is given by
Let f ^ +l\ s ni+1 \sni) and F^l+1 \ s ni+l\sni) be the probability density function and 
cumulative distribution function respectively of 5nt+1, the sum of observations at 
analysis i +  1, given an observed value sni of Sni. We note tha t for i = 2 , . . . ,  K.
= /  { P(l)(^ |Sn i)41+1)(s„i+1|sni) >dsni+1,
[fieM J
where M. is the set of values given positive prior probability by the prior n  on /z; this 
set alters depending on the objective function specified; for example, if we wish to
7  (t)(snJ =  dm in{pw (0|sni) ,p (l)((5|sni)} for i = 1 , . . . ,  K.
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minimise F2, M  = {0 , £}.
At analysis K  — 1 , with an observed value sT l K _ 1 of Sni<_l , the expected cost of 
continuing to the next analysis and proceeding optimally there is
(3^ K~ 1 \ s nK_l ) = E{cost of taking sample K }  +
E{cost of acting optimally at analysis K }
=  (jiK - n K- i )  X ! c{^)P{K~l\ ^ \ snK-i )  +  C3-1)
[  {SnK)dF^K) (SnK |snK_x )•
J — 00
Then for i = 1 , . . . ,  K  — 2, the expected cost of continuing to the next analysis and 
proceeding optimally there is given by
/3^ ( sni) = E{cost of taking sample * +  1} +
E{cost of acting optimally at analysis i +  1}
=  (ni+i -  rii) ^ 2  c(fi )p^(fi \sni) + (3.2)
J  min{/?(l+1) (s„i+1), 7 (i+1) (s„ i+1 )}dF(t+1) (s„ i+1 \sni).
We start by setting ck = 0; this is done to ensure termination at the final analysis 
if the trial has not already concluded by then. The symmetry of the problem ensures 
tha t the final boundary point is half way between the values 0  and tikS, the means 
of the distributions of SnK under Do and D$ respectively. Then we search for the 
positive value ck-  1 where 7 ^ - 1^(n^_i<5 / 2  +  ck-  1) = /3(*-i>(ntf-ic5/2 + <*_!). If 
7 (^ - 1)(n/('_i(5/ 2 ) <  p^K~1 \ n K - i S / 2 ) then there is no point where the expected costs 
of stopping and continuing are equal. In this situation the expected cost of stopping 
and making a decision is less than tha t of continuing optimally, even if the data 
support each hypothesis equally strongly. In this case we set c/c-i =  0 and proceed
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to analysis c k - 2 - In order to evaluate the integral in equation (3.2) numerically when 
i = K  — 2, the function p(K~l\ S TlK_1) is evaluated on a grid of points in the region 
[ r iK - \8/2  — CK-i,r iK-i8/2  4- c k - i]- This enables us to evaluate @K~2 (SnK_2) and find 
c k - 2 - This iterative procedure is carried out for each analysis in turn, proceeding 
backwards to finding c\. This is summarised below in algorithm 1.
The search for the boundary point at analysis % rely upon monotonicity of 
7 ^ ( 5n J  — P^Hsni)- This monotonicity has been proven by Lai (1973) for the situation 
when we are minimising F\ and by Brown, Cohen & Strawderman (1981) when we 
are minimising F2 , while we assume this property for other objective functions. Eales 
(1991) reports tha t numerical checks have supported this assumption and, like Eales, 
we have found no counterexamples where this monotonicity does not hold. In the 
two-sided setting, Chang (1996) has shown that this monotonicity holds under certain 
conditions. Consider testing =  0 against H 2 'H ^  0  with type II error fixed at 
fi = ±£2 , then Chang shows that the monotonicity we require holds when the expected 
sample size is being minimised given any value of fi E [—<^2 , <$2]-
A l g o r i t h m  1: S y m m e t r i c  f i x e d  g r o u p s  a l g o r i t h m
• Set ck = 0.
• Find c k -  1 by searching for sn ,K _ 1 such tha t 7 ^ _ 1^(sn/c_i) =  P^K~ 1HsUk_1).
•  Evaluate P^K~ 1 \ s TlK_1) on a grid of values of sn K _ 1 from t i k - \8/2 — c k -  1 to 
n K - \ 8 / 2  +  c k - i-
• For i = K - 2 , . . . , 2
o Find Ci by searching for sni such that 7 ^ ( sn,0 =  P^Hsni)- 
o Evaluate P ^ ( s ni) on a grid of values of sni from riiS/ 2  — Ci to riiS/ 2  -f C{.
•  Find ci by searching for sni such tha t 7 ^ ( n i )  =  P ^ { s ni).
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3.2 P erform ance o f th e  op tim al sym m etr ic  te s ts
We now consider the reduction in expected sample size which can be achieved by the 
optimal tests discussed in §3.1. In §3.2.1 we discuss the expected sample sizes of the 
optimal tests found via the Bayesian decision theory problem described in §3.1. We then 
discuss the performance of each optimal test with respect to the objective functions 
for which the tests have not been optimised in §3.2.2. It is desirable tha t the optimal 
tests be robust as an important factor in choosing a test may be the performance of 
the design with respect to unexpected treatm ent efficacy.
3 .2 .1  O p tim a l red u c tio n  in  e x p e c te d  sa m p le  s ize
Here, we present some results indicating the reductions in expected sample size achieved 
by the optimal group sequential tests calculated by the method set out in this chapter. 
The results in table 3.1 of optimal values of F i , F2 , F 3 , and F 5 have already been 
presented by Eales & Jennison (1992) and in more detail in Eales (1991), but are given 
here for comparing with the efficiency gains possible by other group sequential schemes. 
The optimal values of F4 presented in table 3.2 are not printed in these references, but 
correspond to and expand upon figures in Jennison (1987). The results for objective 
functions F i , F 2 , F 3 , and F5 are discussed in more detail by Eales (1991).
Tables 3.1 and 3.2 show the objective function values attained by the optimal tests. 
The tests are specified by K  and t, where K  is the maximum number of analyses and 
these analyses occur after equally sized groups of observations are taken. The maximum 
sample size t ik  is determined by t  as follows. Define rifix to be the required number of 
observations for a fixed sample size test of HQ-.fi < 0 against Hi'./j, > 0 with type I error 
probability a  at fi = 0 and power 1 — a  fixed at /i =  8 . If observations are independent
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and identically N(/j,,cr2) distributed, with a 2  known, njix is given by
n fix = j $ -1(l - a ) ^ }  •
where $  is the cumulative density function of the standard normal distribution.
We then determine the maximum sample size of the group sequential test to be 
tik =  trifix . Note tha t these values n x  and rifix are not restricted to the integers as 
they have a wider interpretation than as number of observations. In more complicated 
cases which have the same asymptotic joint distribution as the normal data case, n  
is more correctly interpreted as information level than sample size and takes positive 
real values, as discussed on page 4. Although we have presented results for t  up to 
1 .6 , we are primarily interested in t  < 1 . 2  as higher values of t result in tests where 
the maximum sample size is considerably higher than the fixed sample size. If we are 
interested in early stopping of the trial, it is preferable not to allow the possibility of 
the trial continuing to the point where, for example, over 150% of the fixed sample size 
of observations have been taken.
The tabulated values are 100 x Fr /rifix, for r = 1 , . . . ,  5, for tests with the the specified 
maximum sample size and i f  equally spaced analyses. All the results given in this 
chapter are for tests with type I and type II error probabilities equal to 0.05. So, 
for example, from table 3.1 a test with 5 interim analyses and n x  = 1.5rifix which is 
optimal for Fi (the expected sample size when fi =  <5/2) has F\ equal to 79% of the 
fixed sample size.
Several general patterns apply to the results for all the objective functions considered. If 
t is fixed, increasing K  reduces the optimum value of the objective function. McPherson 
(1982) reported results where increasing K  increased the expected sample size, but 
this was for a class of schemes where altering K  caused a change in n x • When the 




10 15 20 t 2 5
K
10 15 20
i.Ol 93.4 87.9 85.7 84.9 84.5 1.01 80.9 72.2 69.1 68.1 67.6
1.05 88.9 82.5 80.0 79.1 76.1 1.05 74.5 65.2 62.1 61.0 60.5
1.10 87.3 80.2 77.5 76.5 76.1 1.10 72.8 62.2 59.0 57.9 57.4
1.15 87.0 79.1 76.2 75.3 74.8 1.15 72.7 60.7 57.4 56.2 55.7
1.20 87.2 78.6 75.6 74.5 74.0 1.20 73.2 59.8 56.3 55.2 54.6
1.30 88.3 78.4 75.0 73.9 73.3 1.30 75.3 59.0 55.2 53.9 53.3
1.40 90.0 78.6 74.9 73.7 73.1 1.40 78.1 58.7 54.6 53.3 52.6
1.50 91.7 79.0 75.0 73.7 73.1 1.50 81.2 58.8 54.4 53.0 52.2




10 15 20 t 2 5
K
10 15 20
1.01 59.7 48.6 45.1 44.0 43.4 1.01 83.3 75.9 73.1 72.2 71.7
1.05 57.0 41.7 38.4 37.3 36.7 1.05 78.2 69.6 66.7 65.7 65.2
1.10 57.9 39.1 35.6 34.4 33.8 1.10 76.8 67.0 63.9 62.9 62.4
1.15 59.5 37.8 34.0 32.9 32.3 1.15 76.8 65.7 62.5 61.4 60.9
1.20 61.5 37.2 33.1 31.8 31.2 1.20 77.4 65.0 61.7 60.6 60.0
1.30 65.9 36.8 31.9 30.6 29.9 1.30 79.4 64.5 60.9 59.7 59.0
1.40 70.5 37.1 31.3 29.8 29.2 1.40 81.9 64.6 60.6 59.3 58.6
1.50 75.3 37.7 31.0 29.4 28.7 1.50 84.7 64.9 60.6 59.2 58.5
1.60 80.2 38.6 30.8 29.1 28.3 1.60 87.7 65.4 60.7 59.2 58.5
Fj F5
Table 3.1: Optimal values of the specified objective functions, given as
percentages of the sample size required for the equivalent nonsequential test, 
for sequential designs with K  equally spaced analyses. Maximum sample size 
is t times the fixed sample size, type I  error is 0.05 and power is 0.95. The 
bold figures are the minimum values over t for each fixed K .
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15 20 30 50 100
1.01 78.7 74.4 72.2 70.7 67.8 66.8 66.4 65.9 65.5 65.4
1.05 73.8 68.2 65.8 64.3 61.3 60.3 59.8 59.3 59.0 58.7
1.10 72.9 65.9 63.2 61.7 58.5 57.5 57.0 56.5 56.1 55.8
1.15 73.2 65.1 62.0 60.4 57.1 56.0 55.5 54.9 54.5 54.2
1.20 74.0 64.9 61.5 59.7 56.3 55.1 54.6 54.0 53.6 53.3
1.30 76.5 65.4 61.3 59.2 55.4 54.2 53.6 53.0 52.5 52.2
1.40 79.4 66.5 61.7 59.2 55.1 53.8 53.1 52.5 52.0 51.6
1.50 82.6 68.0 62.4 59.6 55.1 53.7 52.9 52.2 51.7 51.3
1.60 86.0 69.7 63.3 60.2 55.2 53.7 52.9 52.2 51.6 51.1
Table 3.2: Optimal values of F\, given as percentages of the sample size 
required, for the equivalent non-sequential test for sequential designs with K  
equally spaced analyses. Maximum sample size is t times the fixed sample 
size, type I  error is 0.05 and power is 0.95. The bold figures are the minimum  
values over t for each fixed K .
reduces the optimum objective function values. However, the improvement attained by 
adding an extra interim analysis is modest for over roughly 5 analyses. In practice, the 
increased logistical problems caused by frequent interim analyses will preclude the use 
of a very large number of analyses; it is for precisely this reason that group sequential 
schemes have been developed as an alternative to fully sequential methods. While the 
improvement in efficiency made possible by increasing the maximum number of analyses 
is only an observed pattern for general increases in K , multiplying K  by some integer 
constant will, at worst, result in the same optimal values of the objective functions. 
To see this, consider two group sequential tests which are equivalent in terms of all 
parameters other than the number of analyses. Assume that one test has a maximum 
of K \ analyses, while the second test has a maximum of kK \ analyses, where k is a 
positive integer, with both tests having the interim analyses equally spaced throughout 
the trial. The set of all possible tests with kK \ analyses includes the set of all possible 
tests with a maximum of K \ looks at the data. In particular, the optimal test with 
a maximum of K \ analyses can be considered as a test with kK \ analyses when the 
boundaries at certain analysis times are infinite. Thus, the test with the larger number
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of analyses must have optimum objective function values no worse than the test with 
a smaller number of analyses.
For any fixed K  and any specific objective function, there is a value of t  which will 
minimise the objective function over the t  values considered. In general, the objective 
function at first decreases as t  is increased until this minimising value is found, and as 
t increases further the objective function will increase again. However, most of these 
minimising values of t are larger (in many cases much larger) than we would wish to 
consider for practicable test designs, as discussed above. Thus, selecting a test design 
can require a trade-off between minimising the expected sample size and keeping the 
maximum sample size within reasonable limits. However, there is a large reduction 
in expected sample sizes if a maximum sample size only a little greater than rifix is 
allowed. The further reduction in expected sample size achieved by having a larger 
maximum sample size is in most cases relatively modest compared to the benefit of 
allowing a maximum sample size a little larger than rifix .
The lowest achievable objective function values are for F3 , with the expected sample 
size in this case being below half the fixed sample size with only 5 analyses for as little 
as a 1% increase in the maximum sample size over njix. This is attributable to the 
fact that F3 refers to the situation where there is a large positive treatm ent effect or 
a small negative effect. These situations are the most extreme that we consider, and 
it is not surprising tha t under these circumstances it is possible to stop the trial very 
early. Objective functions F2 , F4  and F5 have reductions of similar magnitude to each 
other, all being more modest than those achieved by F 3 , while the smallest reductions 
are for Fi. Minimising F\ is the Keifer-Weiss problem (Weiss, 1962) of minimising 
the expected sample size under the worst situation with respect to the true treatm ent 
efficacy, as /i =  S/ 2  is the value of [i where the minimum expected sample size is 
maximised. That is, for any fi /  6 / 2, {TV} <  Etf/2 {N}-
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3 .2 .2  P er fo rm a n ce  o f  o p tim a l te s t s  w ith  re sp ec t to  o th er  o b je c t iv e  
fu n c tio n s
This section explores the behaviour of the optimal symmetric tests with respect to the 
objective functions for which they have not been optimised. Throughout this thesis, 
we shall refer to a test optimised for objective function Fr as OPTr.
Figure 3-1 shows how well the various optimal tests do in terms of achieved values 
of the objective functions for which the tests are not optimised. For each graph, the 
horizontal axis gives the maximum sample size of the tests as a percentage of the fixed 
sample size n fix while the vertical axis gives the achieved value of the objective function 
in question, again as a percentage of the fixed sample size. The separate graphs are 
for Fi to P5, as indicated by the labels on the vertical axes. Values for tests with a 
maximum sample size larger than 140% of rifix have been excluded, for the reasons 
discussed in the previous section. All the tests used to produce this figure had K  = 10 
equally spaced analyses; similar patterns of results were seen for K  = 5,15 and 20.
It can clearly be seen that the O PT3 tests perform worst for the other objective 
functions, having the highest achieved values for all other objective functions. The 
graph of achieved P 3 values also shows tha t it is for this objective function that the 
tests optimised for other objective functions are furthest from being optimal. However, 
even the worst of them (OPTi) has achieved values of P 3 which are below 40% of nj ix.
The OPT 2 , OPT 4  and OPT5 tests all achieve very nearly optimal results with respect 
to objective functions P2 ,P 4 and P5 , while OPTi  performs worse than this trio for all 
objective functions other than Pi.
Overall, it seems tha t O PTi should only be considered as a candidate design if placing 
all emphasis on a small positive treatment difference is deemed sensible. Similarly, 
O PT 3 tests are only sensible if the most im portant consideration is the behaviour of 
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Figure 3-1: Achieved values of F\ to F5 for tests optimising these objective 
functions. All tests have type I  error 0.05 and power 0.95 with 10 equally 
spaced analyses. Maximum sample size and objective function values are 
given as percentages of the fixed sample size nf iX.
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Conversely, the OPT 2 ,O P T 4 and OPT5 tests perform well over the range of objective 
functions. All of these require similar computing power to find the optimal tests, but 
the evaluation of F5 requires considerably more computing power to evaluate, due to 
the extra numerical integration required for dealing with a prior which consists of both 
point masses and a continuous density. Since the performance of all the tests we have 
considered is similar for both F 4 and F5 , OPT4 seems a good choice for a test when 
good expected sample size properties are required across a range of objective functions, 
without requiring the extra computation involved by considering F 5 .
It would be simple to alter the prior and cost of sampling functions used in the Bayes 
problem which was defined in §3.1.2 to produce tests which optimise other objective 
functions. However, before such tests were used, it would be wise to consider the 
behaviour of such tests with respect to other objective functions as has been done in 
this section.
3.3  P erform an ce o f th e  A -fam ily
In section §2.2, we introduced the A-family of group sequential tests. In this section, 
we use the optimal tests examined in the preceding section to assess the performance 
of the A-family tests with respect to their expected sample sizes.
Table 3.3 shows the maximum sample size and achieved values of objective functions 
F\ -  F5 for A-family tests of Hq:[i <  0 against H\\^i >  0  with type I error probability 
0.05 at n = 0 and power 0.95 fixed at [1 = 8 . The results are for K  = 2, 5, 10, 15 and 
2 0  equally spaced analyses and for A =  —0.5, —0.3, —0.1,0 . 1  and 0.3. Recall tha t the 
maximum sample sizes of the tests are determined by the choice of A; these values are 
given as percentages of the fixed sample size rifix . For each value of A we compute the 
optimal group sequential tests which minimise F\ to F 5 amongst all group sequential 




10 15 20 A 2 5
K
10 15 20
-0.5 100.0 101.9 103.9 104.9 105.6 -0.5 100.0 102.2 104.2 105.3 105.9
-0.3 100.3 103.4 106.0 107.3 108.2 -0.3 100.0 102.1 103.8 104.7 105.2
-0.1 101.5 106.2 109.6 111.4 112.4 -0.1 100.0 101.7 103.1 103.7 104.1
0.1 104.8 111.8 116.7 119.1 120.5 0.1 100.0 101.0 101.8 102.1 102.4
0.3 111.9 125.1 133.2 137.1 139.5 0.3 100.0 100.2 100.5 100.6 100.6
Maximum sample sizes. Relative performances for F i .
A 2 5
K
10 15 20 A 2 5
K
10 15 20
-0.5 100.0 109.2 113.8 115.9 117.2 -0.5 100.0 133.1 143.1 148.1 151.1
-0.3 100.0 108.6 112.5 114.3 115.4 -0.3 100.0 129.5 139.1 143.3 145.9
-0.1 100.0 107.3 110.4 111.9 112.7 -0.1 100.0 126.3 133.3 136.8 138.8
0.1 100.0 105.4 107.4 108.4 109.0 0.1 100.0 120.7 125.6 127.9 129.4
0.3 100.0 102.7 103.6 104.0 104.2 0.3 100.0 110.0 115.9 117.0 117.7
Relative performances for Fi- Relative performances for F3 .
A 2 5
K
10 15 20 A 2 5
K
10 15 20
-0.5 100.0 110.3 114.4 116.3 117.5 -0.5 100.0 107.2 110.7 112.3 113.3
-0.3 100.0 109.2 112.7 114.4 115.3 -0.3 100.0 106.5 109.5 110.9 111.7
-0.1 100.0 107.6 110.3 111.6 112.3 -0.1 100.0 105.4 107.7 108.7 109.4
0.1 100.0 105.4 106.9 107.7 108.1 0.1 100.0 103.7 105.0 105.6 106.0
0.3 100.0 102.1 102.6 102.8 102.9 0.3 100.0 101.3 101.7 101.9 101.9
Relative performances for F4 . Relative performances for F$.
Table 3.3: Tabulated values are 100 x n /( /n /;x (top left) and relative
performances for objective functions F\ - JF5 achieved by A-family tests with 
type I error 0.05, power 0.95 and K  equally spaced analyses.
results are the values of F\ to F5 achieved by the A-family tests, given as percentages of 
the optimal objective function values. In the discussions in this and later sections, we 
refer to the percentage comparison of achieved and optimal objective function values 
as relative performance.
The maximum sample sizes of these tests increase as as A increases and as K  increases, 
and this trend continues for tests with larger K  and A than than those shown in table 
3.3. In order to keep the maximum sample size at a reasonable level, A must be chosen 
appropriately. For small K  and negative A, the maximum sample sizes are quite good
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and are still reasonable for low K  and small positive A.
The most striking point of the relative performances shown in table 3.3 is the fact that 
all tests with K  = 2 have relative performance of 100%, i.e. they achieve the same 
objective function values as the optimal tests. This is because, with the final boundary 
point fixed by the symmetric nature of the problem, the error rates of the test can only 
be altered by the placing of the boundary points at the first analysis. This means that 
there is only one symmetric two-analysis test of our hypothesis which has the desired 
error rates, and hence all methods find this single two-analysis test.
For all the tests shown, the relative performance of the A-family tests improves with 
respect to all the objective functions as A increases. This means that improvement in 
relative performance is gained at the cost of increasing the maximum sample size of 
the test. The best relative performances are for F i, with good to fair performance for 
all values of K  and A. Considering the relatively poor performance of the OPTi  tests 
with respect to F3 in §3.2.2, it is therefore not surprising to see that the A-family tests 
perform especially poorly with respect to F 3 . The relative performances for F2 , F4 and 
F 5 are reasonable to poor, with the best being for F5 . W ith A =  0.3, the A-family tests 
are very nearly optimal for Fi and near optimal for F2 , F4 and F 5 , but this performance 
comes at the cost of a large maximum sample size.
The advantage of the A-family tests over the optimal tests we have considered lies in 
their ease of calculation. Once the parameter A is chosen and the constants c\ and C2 
determined, either by numerical searches or by consulting tables such as those given by 
Pampallona h  Tsiatis (1994), the remaining calculations are simple. However, these 
relative performances make it clear that this simplicity of design comes at the cost of 
poor performance for F3 and somewhat inadequate performance with respect to F 2 , F 4 
and F 5 . The good relative performance for F i makes the A-family a sensible choice 
with regards to the expected sample size in this situation.
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3.4  P erform ance o f th e  error sp en d in g  m eth od
In this section, we use the optimal tests discussed in this chapter to assess the 
performance of error spending tests using the p-family and 7 -family error spending 
functions described in §2.3.3. All the error spending tests referred to in this section 
have been designed for a sequence of I f  equally spaced analyses, as described in §2.3.2. 
However, they do of course retain the flexibility of the error spending method and can 
be applied to other sequences of group sizes, although this will perturb the achieved 
power and efficiency of these tests.
3 .4 .1  T h e  7 - fa m ily  o f  error sp en d in g  te s ts
Table 3.4 shows maximum sample size and relative performance results for the error 
spending tests using the 7 -family error spending functions for 7  =  —4, —3 , . . . ,  1 . The 
maximum sample size figures are given as percentages of the fixed sample size and the 
relative performance figures are the objective function values achieved by the 7 -family 
tests percentages of the optimal objective function values for matching tests, as defined 
in the previous section.
The maximum sample size figures are reasonably low for negative values of 7 , but 
increase with increasing 7  and are higher for larger K.  Maximum sample size figures 
for values of 7  larger than those tabulated rapidly become unreasonably large.
Relative performance values for F\ are very good and are slightly better for lower 7 , 
corresponding to smaller maximum sample sizes. This is in contrast to all the other 
objective functions studied, where the relative performances are better for higher 7 , 
corresponding to larger maximum sample sizes. The relative performance of the 7 - 
family tests is good for F5 , although not as good as for and good to fair for F2  and 




10 15 20 7 2 5
K
10 15 20
-4 101.5 103.9 105.4 106.1 106.4 -4 100.0 100.4 100.9 101.2 101.3
3 102.8 106.5 108.4 109.2 109.6 -3 100.0 100.4 100.9 101.2 101.3
-2 105.0 110.4 113.0 113.9 114.4 -2 100.0 100.4 101.0 101.3 101.4
-1 108.6 116.4 119.7 120.9 121.5 -1 100.0 100.5 101.2 101.5 101.7
0 113.9 125.0 129.3 130.8 131.6 0 100.0 100.6 101.6 102.0 102.2
1 121.1 136.5 142.2 144.2 145.2 1 100.0 100.8 102.2 102.8 103.1
Maximum sample sizes. Relative performances for F i .
7 2 5
K
10 15 20 7 2 5
K
10 15 20
-4 100.0 101.4 102.8 103.4 103.8 -4 100.0 106.7 109.4 110.8 111.5
-3 100.0 101.2 102.5 103.0 103.3 -3 100.0 106.5 108.6 109.7 110.4
-2 100.0 101.1 102.1 102.6 102.8 -2 100.0 106.1 107.8 108.7 109.3
-1 100.0 100.9 101.7 102.2 102.4 -1 100.0 105.7 107.2 107.9 108.4
0 100.0 100.7 101.4 101.8 102.1 0 100.0 105.1 106.7 107.3 107.7
1 100.0 100.5 101.0 101.5 101.8 1 100.0 104.4 106.4 106.8 107.2
Relative performances for F2 . Relative performances for F3 .
7 2 5
K
10 15 20 7 2 5
K
10 15 20
-4 100.0 101.2 102.3 102.9 103.2 -4 100.0 100.7 101.7 102.2 102.4
-3 100.0 101.0 101.9 102.4 102.6 -3 100.0 100.6 101.4 101.8 102.0
-2 100.0 100.8 101.5 101.9 102.1 -2 100.0 100.5 101.2 101.5 101.7
-1 100.0 100.6 101.1 101.4 101.7 -1 100.0 100.3 100.9 101.3 101.5
0 100.0 100.3 100.7 101.1 101.3 0 100.0 100.2 100.7 101.1 101.3
1 100.0 100.1 100.4 100.8 101.1 1 100.0 100.1 100.6 101.1 101.4
Relative performances for F \ . Relative performances for F$.
Table 3.4: Tabulated values are 100 x n ^ /n /ix  (top left) and relative
performances for objective functions F\ -  F5 achieved by error spending tests 
using the j-fam ily of error spending function with type I  error 0.05, power 
0.95 and K  equally spaced analyses.
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The combination of lower maximum sample size and better relative performance make 
it clear tha t the lowest values of 7  are best if the minimisation of Fi is the primary 
goal, in a sequential design using the 7 -family. At these lower values of 7 , the relative 
performance for ^ 2 , ^ 4  and F5 is also good. However, if any other objective function 
than F\ is of primary importance, it is necessary to strike a balance between maximum 
sample size and relative performance. For tests with a maximum of 5 or 10 analyses, 
choosing 7  =  —2 or —3 will give a test design with good to reasonable maximum sample 
size and expected samples sizes within about 4% of optimal for objective functions 
F \ , F2 , F 4 and F5 .
3 .4 .2  T h e  p -fam ily  o f  error sp en d in g  te s ts
Maximum sample size and relative performance results for tests using the p-family error 
spending function with p =  1,2,3, and 4 are shown in table 3.5. The maximum sample 
size increases as p decreases and as K  increases. Once more, relative performance figures 
are good for F\, with the best values for p — 2. All other objective functions show 
better relative performance for low values of p than for high, corresponding to better 
relative performance when the maximum sample size is larger. Objective function F 5 
shows good relative performance, while results for F2  and F4  are good to fair. Once 
more, the results for F3  are less impressive, although better than for the A-family and 
7 -family tests.
For tests with a maximum of 5 or 10 analyses, a test with maximum sample size within 
about 10% of the fixed samples size can be gained by choosing p =  2  or 3. This choice 
gives good relative performance with respect to objective functions F \ ,F 2 ,F 4  and F 5 , 




10 15 20 P 2 5
K
10 15 20
1.0 113.9 125.0 129.3 130.8 131.6 1.0 100.0 100.6 101.6 102.0 102.2
2.0 104.5 110.1 112.7 113.7 114.2 2.0 100.0 100.2 100.5 100.6 100.7
3.0 101.6 105.0 106.9 107.6 108.0 3.0 100.0 100.4 100.9 101.0 101.2
4.0 100.6 102.6 104.1 104.7 105.0 4.0 100.0 100.6 101.2 101.5 101.7
Maximum sample sizes. Relative performances for F \ .
P 2 5
K
10 15 20 P 2 5
K
10 15 20
1.0 100.0 100.7 101.4 101.8 102.1 1.0 100.0 105.1 106.7 107.3 107.7
2.0 100.0 102.0 102.6 102.9 103.1 2.0 100.0 110.3 111.7 112.3 112.7
3.0 100.0 102.9 104.1 104.6 104.8 3.0 100.0 113.1 115.3 116.4 116.9
4.0 100.0 103.4 105.2 105.9 106.3 4.0 100.0 114.4 118.0 119.5 120.4
Relative performances for F2 . Relative performances for F3 .
P 2 5
K
10 15 20 P 2 5
K
10 15 20
1.0 100.0 100.3 100.7 101.1 101.3 1.0 100.0 100.2 100.7 101.1 101.3
2.0 100.0 101.9 102.2 102.4 102.5 2.0 100.0 101.1 101.4 101.6 101.7
3.0 100.0 103.0 103.8 104.2 104.4 3.0 100.0 101.9 102.6 103.0 103.1
4.0 100.0 103.6 105.1 105.7 106.0 4.0 100.0 102.4 103.6 104.1 104.4
Relative performances for Fa . Relative performances fo r F5 .
Table 3.5: Tabulated values are 100 x (top left) and relative
performances for objective functions F\ -  F5 achieved by error spending tests 
using the p-family of error spending function with type I error 0.05, power 
0.95 and K  equally spaced analyses.
3.4.3 Error spending functions defined from optim al tests
A number of authors have proposed forming an error spending function by evaluating 
the error spent at each analysis by some existing repeated significance test scheme 
and interpolating a function through these points, either as a linear interpolation or 
in some more complicated fashion. If the accrual of information was in accordance 
with that anticipated by the repeated significance test scheme in question, using the 
error spending function thus defined would recover the original test. This would allow 
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Figure 3-2: Error spending functions defined by interpolating the error spent 
by optimal tests. Tests are optimised for F%, with rtx =  1-01 x rifix and for 
K  = 2 (uppermost line), 4, 10, 20 and 100 (lowermost line).
An example is given in Eales &: Jennison (1992), where the error spending function is 
defined by finding the OPT2 test with 1 0 0  analyses and using using linear interpolation. 
This error spending function is then used to carry out a test with 6  analyses. The 
relative performance of the resulting test for F2 is approximately 101.4%, with n x  
being approximately 110% of ri f ix . The nearest comparable case from tables 3.4 and 
3.5 show relative performance of 102.0% for p = 2.0 or 101.1% for 7  =  —2, although 
these are not directly comparable figures as Eales & Jennison’s example has 6  unequal 
group sizes and the results from tables 3.4 and 3.5 are for 5 equally spaced analyses. 
However, this does illustrate that the simple parametric error spending functions are
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highly efficient if the value of p or 7  is chosen with care.
This approach assumes that there is an underlying optimal error spending function 
and tha t the implicit error spending function derived by interpolation from an optimal 
test will be an approximation to this. Further, by using an optimal test with a large 
number of analyses, it is hoped to make this estimate of the optimal error spending 
function as smooth as possible. Figure 3-2 shows the error spending functions which 
are implied by tests optimised for F 3 when T  = 1.01 and for K  = 2, 4, 10, 20 and 200. 
There are clear differences between these error spending functions for different values 
of K ,  implying that the error spending function defined by the optimal test with large 
K  may not be the most suitable for trials where only a small number of analyses will 
be carried out, as was observed by Eales & Jennison.
3.5 C om paring th e  A -fam ily, 7- fam ily  and p-fam ily te s ts
Figure 3-3 compares the performance of the A-family, 7 -family and p-family tests 
directly. The plots axe of the maximum sample size against the achieved objective 
function valuos, both given as percentages of the fixed sample size rifix . Optimal 
values for each objective function are included for reference. The dotted line represents 
A-family tests for which A =  —0.5, —0.45 ,... ,0.3, with tests which had a maximum 
sample size of over 135% of rifix excluded. Similarly, 7 - and p-family tests in this figure 
are for 7  =  —5.0, —4 .5 ,. . . ,  0.5 and p =  0 .9 ,1 .0 ,... ,  4.0
Looking at the results for the maximum sample size being no more than 120% of 
rifix, it is clear that the A-family tests are the furthest from optimal, while the two 
families of error spending tests have similar performance, with the the 7 -family being 
slightly superior For objective functions F2  to F 5 , although the p-family tests are slightly 
superior to the 7 -family tests for F\.
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1 0 0  X 1 0 0  X n K / n f i x
100 110 120 130 140
1 0 0  X n K / n f i x
Figure 3-3: Achieved values of F\ to F5 for A-family, 7- family and p-family 
tests. All tests have type I  error 0.05 and power 0.95, with 10 equally spaced 
analyses. Optimal objective function values are included for comparison.
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constants c\ and 0 1  are found from tables in Pampallona & Tsiatis (1994) or Jennison Sz 
Turnbull (2000; chapter 4), the calculations involved are simple. In contrast, an error 
spending test involves lengthy computation and is not available in many commonly 
used statistical software packages. However, this advantage is overshadowed by the 
flexibility of the error spending method and the fact that the error spending tests have 
a clear performance advantage. Error spending tests using 7  =  —3 or —2, or using p =  2 
or 3 have both good maximum sample size and expected sample size properties, as we 
have seen. These tests, therefore, are a good choice if the optimal group sequential 




Optim al asym m etric group 
sequential tests
W ithout further modification, the method used in chapter 3 only finds optimal group 
sequential tests for symmetric problems, that is tests with equal type I and type II error 
probabilities. Also, the set of tests searched over to find the optimal test only includes 
test boundaries which are symmetric about the mean of the hypothesised differences 
in efficacy between the experimental and control treatments. The symmetric nature 
of the problem with equal error rates ensures that the optimal test is in this subset 
of all possible group sequential tests. In this chapter, we extend this method to find 
optimal group sequential tests which have unequal error rates, necessitating a search 
over the larger set of test boundaries which are not symmetric about the mean of the 
hypothesised differences in efficacy.
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4.1 T h e in du ced  asym m etry  and som e con sequ en ces
The statistical formulation of the problem given on page 23 is restated here for 
convenience. Recall that up to K  groups of observations are taken with cumulative 
sample sizes ni, 722,..., t ik-  Each observation is independent and identically distributed 
with a iV(/i, a 2) distribution, where a 2 is known. We wish to test Ho:fi < 0 against 
> 0 with type I error a  at fi =  0 and type II error (3 at n =  8 . We define N  to 
be the number of observations taken by the termination of the trial, and we also define 
the summary statistic Sn =  -X"* for n = n i , . . . , n#.
In the previous chapter, we dealt with this problem when the error rates are equal, 
that is when a  = (3. However, in practice this is often not the case. For example, if the 
trial is examining the efficacy of a treatm ent for a rare medical condition or seeking 
a small improvement in efficacy, the required sample size will be very large and in 
such situations a lower power is often considered an acceptable price to pay for a more 
reasonable sample size. Thus, we now consider tests where the error rates axe unequal.
The symmetry between the error rates in the previous chapter implied an attitude tha t 
the null and alternative hypotheses are of equal importance. This attitude is reflected 
in some of the objective functions defined on page 24. For example, F2  and F3  are 
defined as being
F2  =  Eo { N } = E s { N }
F 3 =  — E3 5 /2  {-^} -
The symmetry of the problem ensures that the expected sample size under fi = 0 equals 
that when n  =  5; similarly the expected sample sizes when fj, = —5/2 and /x =  3£/2 
are equal. However, these expectations are only equal if the test has a  = (3 arid is 
symmetric about the mean of the hypothesised differences in efficacy. In the case of 
asymmetric tests, we may wish to place different emphasis on the expected sample size
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when /i =  0 to tha t when f i  =  8 .  Thus, we consider several new objective functions.
f2 i =  i(Eo{JV} +  E « { A r } )  F22 =  Eo{iV} F^ =  Es{N }
^31 =  2 (^-.5/2 + 3^<S/2 {-^}) F22 ~  {N\  F2.3 =  ^35/2 {N}
These objective functions replace F2 and F3. Note that F21, F22, and F23 reduce to F2 
in the symmetric case and in this situation, Fs i ,F s2, and F33 reduce to F3. Of these 
new objective functions, F21 and F31 are the closest to the spirit of the original F2 and 
F3 proposed by Jennison (1987). The definition of F4 on page 24 is re-written as
*4 =  l % 2w  +  - l  E  e u m -
i=-2,i^2
This is the mean expected sample size over values of f i  from —8 / 2  to 38 / 2 , with double 
weight placed on // =  8/ 2 . In the case of symmetric group sequential tests, this is equal 
to the formula given on page 24. We retain the existing definitions of F\ and F5;
F ,= E « /2{Ar} f 5 =
Allowing unequal error rates breaks the symmetry of the test boundary about the 
mean of the hypothesised differences in efficacy, 8 / 2 , where the continuation region at 
analysis i was [n^ /2  ±  Ci], for some ci >  0 (page 24). Instead, the action taken at 
analysis i, for i =  1, . . . ,  K  is determined by values a,i and bi, where a; < bi, as follows.
If Sni <  a , i s t o p ,  accept H o ,
if d i  <  Sni <  b i  continue to next analysis,
and if b i  <  Sni STOP, reject H o .
To ensure term ination of the trial at analysis K ,  we set clk = bx- Thus, the symmetric 
problem is a special case of this more general formulation, with a; = riid/ 2  — q  and
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bi = rii8/2-\-Ci. As we shall see in the next section, this increases the complexity of both 
the Bayes decision theory problem which we use to find out optimal group sequential 
test and the backward induction algorithm used to solve the decision theory problem.
4.2 A d a p tin g  th e  B ayes d ecision  prob lem  m eth o d  to  
asym m etr ic  te s ts
Both the Bayes decision theory problem which has a solution corresponding to the 
optimal group sequential test we seek and the backward induction algorithm we use to 
find the solution to this problem must be modified to cope with the asymmetric case 
we discuss in this chapter. In this section, we consider the necessary modifications, first 
to the Bayes problem in §4.2.1, then to the backward induction algorithm in §4.2.2.
4 .2 .1  A lte r a t io n s  to  th e  B a y es d ec is io n  p ro b lem
Recall the Bayes decision problem defined in §3.1.2 for minimising F2 . We now consider 
finding the asymmetric group sequential test which minimises F2 1 . As in the symmetric 
case, we wish to choose between decisions Do : ‘/i =  O’ and D$ : ‘/i — with a prior 
on n  of 7r(/x) =  1/2 for \l = 0 or 8  and zero otherwise. The cost of sampling is 
c(/i) =  1 for fi = 0 and 8 , but zero otherwise, also as in the symmetric case. The loss 
function now changes from the symmetric case, and the cost of a wrong decision is 
now L 2 {Do,8 ) = cfo,L2 (A j,0 ) =  do and L,2 {D,n) = 0 otherwise. The critical change 
from the symmetric case we discussed in chapter 3 is that the cost of the two possible 
wrong decisions are not constrained to be equal. This reflects our desire to place greater 
emphasis on avoiding one of the two possible wrong decisions, rather than being equally 
concerned over the two possible errors.
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The expected cost of any decision rule for this problem is
E{cost} =  E{cost of sampling} +  Ejcost of decision}
=  c(0)Eo {N}tt (0 ) +  c(5)Es {A^}tt(5) +  
d<jP(j{JD0}7r(J) + GfoPoiAsM0)
=  i(E o{JV } +  l B < { A r }  +  (i i Pi {Z»o} +  dolP,o{£»4})
= 2^2i + -  (djP^{D°} + d°P°{jDi}).
Thus, if the Bayes rule minimising the total expected cost satisfies Po{As} =  ol and 
P<s{A)} =  fit this Bayes rule minimises F2 1  amongst all decision strategies with the 
probabilities of making a wrong decision being a  and (3. Thus, this Bayes rule identifies 
the group sequential test with the desired error rates that minimises F2 1 . To find the 
Bayes rule with the desired probabilities of making a wrong decision, we now conduct 
a two-dimensional search over do and d$ in place of the one dimensional search over 
the cost parameter d required in the symmetric case.
As in the symmetric case, the optimisation of other objective functions is accomplished 
by altering the prior n(fi) and cost of sampling function c(fi), while the loss function 
1 /2  (D , fi) remains unchanged regardless of which objective function is being minimised. 
For F2 2  and F 2 3 , 7r(/x) is the same as for F 2 1 , but for F2 2  c(0) =  1 and c(/z) =  0 for 
/i 0, while for F23 c{8 / 2) =  1 and c(n) =  0 for fi 7  ^ 5/2. When minimising ^ 31,^32 
and F33, the prior takes value 1/4 for /i =  — 8/2 ,0 ,5/2 and 3J/2  while being zero for any 
other value of /i. For F 3 1 , the only non-zero values of c(fi) are c{—5/2) — c{Z5/2) = 1, 
for F 32 c{—8/2) =  1 is the only non-zero value of c(//) and for F 33 c(3£/2) =  1 is the 
only non-zero value of The objective functions F i, F4  and F 5 are unchanged and 
so the priors and sampling cost functions for these objective functions are as given on 
page 27, however we now use loss function L 2 (D,fi) rather than Li(D,f i) .
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4.2.2 A lterations to  the backward induction algorithm
Most of the backward induction algorithm used to find the Bayes rule in the symmetric
case in §3.1.3 remains unchanged. However, the breaking of the symmetry about 
H = S/2 does add some complications. The upper and lower boundary points at 
analysis i are no longer equidistant from riibf 2 , and indeed will both be above or below 
this point at some analyses.
As before, we start at analysis K.  Recall that the posterior probability tha t (i = p,o 
given an observed value snK of SnK is written as p^K\p o \ s nK) ■ As we must stop at 
analysis AT, if we have not done so already, we shall decide Do if the expected loss of 
this decision is less than the expected loss of deciding D$. That is, we shall decide D q
if dsp(K\ 6 \snK) < d0 p ^ ( 0 \ s nK) and Ds if d o P ^ (° l5 n*) <  dsp^K\ d \ s nK). Thus, the
point where we are balanced between the two choices is s* , where s* is such that
and we set a x  = bf. = s* .
At analysis K  — 1, we can still calculate the expected cost of stopping and making a
there, j ( K 1 \ s nK_1) and (3^ K 1^(snK_1) respectively, as described in §3.1.3. However, 
it is no longer true tha t the boundary points a x - i, b x ~i are given by finding the single
dsp {K)(5\s*nK) = d0p{K)(0 \s*nK).
Solving this equation for s*^, we find that
(4.1)
decision and the expected cost of continuing to the next analysis and acting optimally
value ck- i and setting the boundary points to tik- i S/2 ±  ck- i - Instead, we must find 
clk- \  and b x - i  separately.
If we stop the trial at analysis K  — 1, we shall decide decision D q if dsp^K ^  (<5|sniC_1) <
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d0 p(K ^(Olsntf-i) andDrf if d0 p(K l\ 0 \ s nK_l ) < dsp^K Thus, we can find
snK - 1  such tha t the expected costs of the two decisions are equal; this value can be found 
using equation (4.1) with the obvious alterations for analysis K  — 1 instead of analysis 
K  and we can deduce that a x - 1  <  5 njc-i — ^ x - i- lu  order to find the boundary 
points, we first find s^K l  and then check whether '-y(i*r~ 1)(s*A:_i ) < f t K~l\ s ^ K_x). If 
this is the case, the expected cost of stopping and making a decision is less than the 
expected cost of continuing to the final analysis and continuing optimally there. In this 
situation, we shall stop if we observe SnK_l = s„ and hence we shall stop for any 
observed value of STlK_1, so we set a x - i  =  bx - i  =  snK_
we search for two values of Sn K l  such tha t the 
expected costs of stopping and continuing optimally are equal and we set our boundary 
points to these values, with a x - i <  sn)K-i — ^K-\  Having found these points, we 
then evaluate f t K~ 1 \ S TlK_l ) on a grid of values of S n K _ 1 from a x - i to b x - i  in order 
to be able to evaluate f t K~2 \ S nK_2), as in the symmetric case. We then proceed 
backwards to analysis 1, finding {s*., a^, 6{} and evaluating f t l\ S ni) on a grid of values 
of Sni G [a*, bi] at analysis i for i = K  — 2, K  — 3 , . . . ,  1. This is summarised in algorithm 
2 , below.
As in the symmetric case, the uniqueness of the boundary points (a^, bi) at each analysis 
i and the convergence of our searches for these points depend upon the monotonicity 
of the expected costs of stopping and continuing optimally, as discussed on page 29. 
Numerical checks have supported our assumption of monotonicity.
It is clear from comparing algorithm 2 to algorithm 1 on page 29 tha t the two are 
fundamentally similar. However, each single search in the case of the symmetric 
algorithm has been replaced by two searches here and the one-dimensional search over 
the cost param eter d in the symmetric case is replaced by a two-dimensional search 
over do and d$ in the asymmetric case.
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A lg o r ith m  2: A sy m m etr ic  fixed  groups a lgorith m
A n a l y s i s  K
•  Find s^K such tha t dsp^K\5 \ s*K) =  d0p(K){0\s*n]<).
• Set aK = bK = s^K.
A n a l y s e s  K  -  1 , . . .  , 2
• For i — K  — 2 , . . . ,  2 :
o Find 5 *. such that .) =  doP^(0|5 ni)-
o I f 7 <i) « ) > ^ i)(3 *j) :
• Find a,i such that 7 ^  (a;) =  with ai <  s*..
• Find bi such that 7 ^(&i) =  with bi > s*..
• Evaluate P^l\ S ni) on a grid of values of Sni from ai to bi. 
o Otherwise, set ai = bi =  s*..
A n a l y s i s  1
• Find s*x such tha t =  dopM(0|s*i).
•  I f 7 ( 1 ) « ! )  > / ? ( 1 ) ( 5 n J  :
o Find a\ such that 7 ^^(ai) =  / ^ ( a i ) ,  with a\ < s*r  
o Find 61 such that 7 ^^ (6 1 ) =  with 61 >  s*r
• Otherwise, set a\ = b\ = s* x.
This increased dimensionality creates a practical problem with the search for costs of 
wrong decisions. In the symmetric case, we had a one-dimensional search, and knew 
tha t we were seeking a positive real value. Thus, we could take zero as one end of 
a search bracket, and steadily increase the cost of a wrong decision until a cost was
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found tha t gave a the probability of a wrong decision to be less than a. This gave us 
the other end of a search bracket, and a simple numerical algorithm could be used to 
find the cost of a wrong decision which resulted in the desired probability of a wrong 
decision. However, in the two-dimensional search arising from our asymmetric problem, 
it is not possible to bracket the point we seek, where the values of do and d$ result in 
probabilities of the two wrong decisions being a  and (3. Numerical checks are required 
for the convergence of these searches, and in the small number of cases where the search 
was not initially successful, alternative starting points were used.
4 .3  P erform an ce o f  th e  op tim al asym m etr ic  te s ts
In this section, we consider the performance of the optimal asymmetric tests. Firstly, 
in §4.3.1 we consider the minimum objective function values attained for objective 
functions F i, F2 1 , F 3 1 , F 4 and F 5 . Objective functions F \, F4 and F 5 are unchanged from 
the symmetric case discussed in chapter 3, while F21  and F 31 are the closest analogues 
to objective functions F2  and F3 . In §4.3.2 we consider the tests optimised for F 2 1 , F 2 2 , 
and F2 3  and for ^ 3 1 , ^ 3 2 , and F3 3 . Finally, in §4.3.3 we discuss the performance of 
the optimised group sequential tests with respect to objective functions other than the 
ones for which they are optimal.
4 .3 .1  O p tim a l re d u c tio n  in  e x p e c te d  sa m p le  s ize
Table 4.1 shows the minimum values of objective functions F \ , F2 1 , F 3 1 , F4 and F5 for 
tests of Ho’. l^ <  0 against H\:fi > 0, with type I error probability a  = 0.05 at // =  0 
and type II error probability (3 = 0.10 fixed at fi = 5. Up to K  interim analyses 
are permitted, occurring after equally sized groups of observations. The maximum 
number of observations is u k  = trifix, where nf{x is the sample size required for the 




10 15 2 0
1 .0 1 92.9 87.4 85.2 84.4 84.0
1.05 8 8 .1 81.7 79.2 78.3 77.9
1 .1 0 86.4 79.2 76.5 75.6 75.1
1.15 86.0 78.0 75.2 74.2 73.7
1 .2 0 8 6 .2 77.4 74.4 73.4 72.8
1.30 87.3 77.0 73.7 72.5 72.0
1.40 88.9 77.1 73.5 72.2 71.6
1.50 90.8 77.4 73.5 72.2 71.5




10 15 2 0
1 .0 1 63.6 53.0 49.5 48.4 47.9
1.05 59.6 45.7 42.4 41.3 40.7
1 .1 0 59.8 42.8 39.3 38.2 37.6
1.15 61.1 41.3 37.6 36.5 35.9
1 .2 0 62.8 40.5 36.5 35.3 34.7
1.30 6 6 .8 39.9 35.2 33.9 33.2
1.40 71.2 39.9 34.4 33.0 32.3
1.50 75.8 40.4 34.0 32.4 31.7
1.60 80.5 41.1 33.8 32.1 31.3
F31
t 2 5
1 .0 1 84.6 77.3
1.05 79.2 70.9
1 .1 0 77.7 6 8 .1
1.15 77.6 66.7







1 0 15 2 0
1 .0 1 82.9 74.7 71.8 70.8 70.3
1.05 76.6 67.7 64.7 63.7 63.2
1 .1 0 74.8 64.7 61.5 60.5 50.0
1.15 74.6 63.1 59.8 58.7 58.2
1 .2 0 75.0 62.1 58.7 57.6 57.0
1.30 76.9 61.2 57.5 56.3 55.7
1.40 79.4 60.9 56.9 55.5 54.9
1.50 82.4 61.0 56.6 55.2 54.5




1 0 15 2 0
1 .0 1 80.6 72.8 69.9 69.0 68.5
1.05 75.3 6 6 .2 63.2 62.2 61.8
1 .1 0 74.1 63.3 60.3 59.2 58.7
1.15 74.2 61.9 58.7 57.6 57.1
1 .2 0 74.9 61.1 57.8 56.7 56.1
1.30 77.1 60.5 56.8 55.5 54.9
1.40 79.9 60.4 56.3 55.0 54.4
1.50 83.0 60.7 56.2 54.8 54.1
1.60 8 6 .2 61.2 56.2 54.7 54.0
F4
K
10 15 2 0
74.6 73.7 73.3








Table 4.1: Tabulated values are the optimal values of the specified objective 
functions, given as percentages of the sample size required for the equivalent 
nonsequential test. Sequential designs have K  equally spaced analyses. 
Maximum sample size is t times the fixed sample size, type I  error is 0.05 
and power is 0.90. The bold figures are the minimum values over t for each 
fixed K .
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given as percentages of njix. For definitions of the objective functions, see page 50.
In the case of the symmetric tests considered in chapter 3, objective functions F 21 and 
F 31 are equal to F2  and F3 respectively. Thus, the values in table 4.1 can be directly 
compared with those in tables 3.1 and 3.2. The patterns shown by these optimal 
asymmetric tests are similar to those seen for the symmetric tests. In particular, for 
any fixed K  the minimum over t  of each objective function occurs at very similar values 
of t for the symmetric and asymmetric cases. These minimising values of t  are in most 
cases larger than we would like, leading to group sequential tests with maximum sample 
sizes considerably larger than the fixed sample size, but the majority of the reduction 
in expected sample size can be gained with a relatively small increase in maximum 
sample size. For example, allowing a five analysis test to have a maximum sample size 
of 1 1 0 % of rifix will reduce the minimum achievable value of F5 to 6 8 .1 % of rifix, but 
raising the maximum sample size to 140% of n/ix only reduces the optimal values of 
F5  by a further 2.9% of njix .
The achieved values of F\ are slightly lower in the asymmetric case, but those of the 
other objective functions considered are higher for the asymmetric tests than  for the 
symmetric tests. However, these differences are not large, and the relative pattern  of 
the lowest objective function values being for F3 1 , with F2 1 , F 4 and F5 achieving similar 
optima and F\ having the largest values which was observed in the symmetric case is 
still true here. Overall, the results for these optimal asymmetric tests are very similar 
to those found in the symmetric case.
4 .3 .2  A sy m m e tr ic  o b je c t iv e  fu n ctio n s
In the previous section, we considered the behaviour of the symmetric objective 
functions. These objective functions are symmetric in tha t they give equal weight 




10 15 2 0 t 2 5
K
10 15 2 0
1 .0 1 77.1 68.7 65.7 64.7 64.2 1 .0 1 83.2 75.6 72.8 71.9 71.4
1.05 70.7 60.7 57.8 56.8 56.3 1.05 77.4 69.0 6 6 .1 65.1 64.6
1 .1 0 69.7 57.7 54.6 53.6 53.1 1 .1 0 76.2 66.5 63.5 62.5 62.0
1.15 70.2 56.4 53.2 52.1 51.5 1.15 76.2 65.4 62.2 61.2 60.7
1 .2 0 71.3 55.7 52.3 51.2 50.7 1 .2 0 76.8 64.9 61.5 60.4 59.9
1.30 74.0 55.4 51.6 50.4 49.8 1.30 78.8 64.4 60.8 59.6 59.0
1.40 77.2 55.6 51.4 50.1 49.4 1.40 81.2 64.5 60.6 59.2 58.6
1.50 80.7 56.1 51.4 50.0 49.3 1.50 83.9 64.7 60.5 59.1 58.4
1.60 84.3 56.6 51.4 50.0 49.2 1.60 86.9 65.1 60.5 59.0 58.3
Fyi F23
Table 4.2: Optimal values of objective functions F2 2  and F2 3 , given as
percentages of the sample size required for the equivalent nonsequential test. 
Sequential designs have K  equally spaced analyses. Maximum sample size 
is t times the fixed sample size, type I  error is 0.05 and power is 0.90. The 
bold figures are the minimum values over t for each fixed K .
we will not always give equal importance to the expected sample sizes when p =  0  and 
when p =  8 , hence the introduction of objective functions F2 2 , -^235 -F32 and F 3 3 . In this 
section, we consider the behaviour of these asymmetric objective functions and discuss 
when they may be useful.
We shall first consider objective functions F21 to F2 3 . Recall that they are defined as 
follows.
*21 =  i ( E o { i V }  +  I Zs{N}) F22 =  Eo
Note that in the case of symmetric tests, these three objective functions are all 
equivalent to the objective function F2 used in the discussion of symmetric tests. 
Objective function F21  retains the spirit of the symmetric F2 , and optimum values 
for F21 are in table 4.1, while equivalent values for F2 2  and F23 are in table 4.2. All 
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Figure 4-1: Achieved values 0/ ^ 215-^22 and F23  for tests optimising these 
objective functions. All tests have type I  error 0.05 and power 0.90 with 
10 equally spaced analyses. Recall that F21 is the average of the expected 
sample sizes under Ho and H i, while F2 2  and F2 3  are the expected sample 
sizes under Hq and H\ respectively.
power 1 — /3 = 0.90 fixed at p = 5. The optimum objective function values for F2 2  and 
F23 occur at the same values of t for any fixed K , while those for F21  occur at slightly 
higher t for the same K .
The greatest achieved reduction in objective function values are for F2 2 , with F2 3  having 
the least reduction in achieved objective function values. The achieved efficiency gains 
for F21 are between those for F2 2  and F2 3 . The optimum values of F2 2  are lowest since 
they represent the expected sample size under Ho, and with a < /3 it is harder to reject 
Ho when p = 0 than it is to accept Ho when p = 5. The effect of this is to move the
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boundaries of the test upwards, making early stopping more likely when fi = 0 .
Recall that we refer to a test optimised for objective function Fr as the O P T r test. 
Figure 4-1 shows the values of F 2 1 , F22 and F23 achieved by the O PT 2 1 , OPT22  and 
OPT23 tests over a range of maximum sample sizes. The horizontal axis gives the 
maximum sample size as a percentage of n  fix , the sample size required by the equivalent 
fixed sample test, while the vertical axis gives the achieved value of the relevant 
objective function, again as a percentage of rifix . In each case, there was a maximum 
of 1 0  equally spaced analyses.
All three tests perform similarly with respect to F 2 1 , although the difference is largest 
for lower maximum sample sizes. Unsurprisingly, the OPT22 and OPT23 tests do poorly 
with respect to objective functions F 23 and F2 2  respectively; this is to be expected as 
the situation for which they are optimised differ greatly. It is, however, noteworthy 
tha t the OPT21 test comes close to the optimal values of both F22 and F 2 3 . This 
suggests that, in general use, the OPT 21 tests have more desirable expected sample 
size characteristics than the OPT22 and OPT23 tests.
There are, however, examples where the use of the OPT22 or OPT23 tests would be 
suitable. Figure 4-1 suggests that optimising a test for its performance under Ho or P i  
should only be done if there is a specific reason for desiring early stopping under tha t 
hypothesis. For example, if we were examining the performance of a new treatm ent 
which has superior secondary characteristics to an established treatm ent, we might 
test Hq.ii < —S against H[:fi > —S, S > 0 as we would accept the new treatm ent so 
long as it was not clinically significantly worse than the existing treatment. In this 
situation, we would desire early stopping under Hq, as in tha t case the new treatm ent 
would be significantly inferior to the existing one, but we would prefer to gather more 
information to assess the secondary characteristics of the new treatm ent if we were 
going to recommend use of the new treatment. By suitable translating our standard 
problem of testing Ho'.fi <  0  against H\:fi > 0 , we could use an OPT22 test in this
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situation, which would stop early under H q, when we would want early stopping, but 
allow a longer study of the secondary characteristics of the treatm ent under H[.
The symmetric objective function F3 gives rise to F31 and the asymmetric objective 
functions F 32 and F 33 in the same way as F2 lead to F2 1 , F 22 and F2 3 . Examination of 
optimal objective function values and relative performances of .F3 1 , P 32 and F 33 showed 
the same patterns as seen in table 4.2 and figure 4-1, as did other examples with 
different numbers of analyses for both F21 to T23 and F 31 to F3 3 .
The optimal tests considered in this section show that tests optimised for objective 
function F2 1  perform extremely well with respect to their expected sample size when 
/i =  0 or n  =  8 . However, tests optimised for one of these fi values perform poorly under 
the other hypothesis. Hence, in the following sections we concentrate on considering 
tests optimised for F2 1  as in most cases these tests will be more useful than  those 
optimised for /i =  0 or // =  8 . Similarly, we consider the F 31 tests, which are optimised 
for the mean of the expected sample sizes when fi — —8/2 and /i =  3<5/2, rather than 
the tests optimised for fi = —8/2 or 3<5/2.
4 .3 .3  P er fo rm a n ce  o f  o p tim a l te s t s  w ith  re sp e c t to  o th e r  o b je c t iv e  
fu n c tio n s
The behaviour of symmetric tests optimised for objective functions F\ to F 5 with 
respect to those objective functions for which they were not optimised was explored 
in §3.2.2. Figure 4-2 shows similar comparisons of the performance of tests 
O P T i, OPT21, OPT31, OPT4  and O PT5 with respect to the objective functions for 
which they are not optimal. All tests had 10 equally spaced analyses, with the 
maximum sample size as given on the horizontal axis and achieved objective function 
values given on the vertical axis, both as percentages of rifix . Tests with other numbers 
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Figure 4-2: Achieved values of F i, F 2 1 , F3 1 , F4  and F5 for tests optimising 
these objective functions. All tests have type I  error 0.05 and power 0.90 with 
10 equally spaced analyses. Maximum sample sizes and objective function  
values are given as percentages of the fixed sample size ri f ix .
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The results in figure 4-2 axe extremely similar to those seen in figure 3-1 for the 
symmetric case. The OPT\  and OPT 31  tests perform poorly for all objective functions 
other than those for which they are optimised and especially poorly for objective 
functions F31 and Fi respectively. The tests optimised for F2 1 , F4 and F5 have similar 
performance in most cases, with the O PT 5 tests being slightly better with respect to 
F\ and the OPT 2 1  and OPT 4 tests being slightly better for F 3 . Overall, the O PT 2 1  
and OPT 4  tests are more practically useful than the OPT 5 tests due to their lower 
computational burden.
4 .4  P erform an ce o f th e  A -fam ily
In this section we discuss the performance of the A-family of group sequential tests 
when the type I and II error probabilities are not equal. The performance is assessed 
with respect to the expected sample sizes attained, with consideration also given to the 
maximum sample sizes of the tests.
Table 4.3 shows the maximum sample sizes and achieved objective function values for 
A-family tests over a range of A and K.  All tests are of H q-.h < 0 against H\:/jl > 0, 
with type I error probability a  =  0.05 and power 1 — (3 = 0.90 at /i0 and fj, = 5 
respectively. The maximum sample size values are given as a percentage of n /^ ,  while 
the achieved objective function values are given as percentages of the optimal values 
of the specified objective functions for tests with the same group sizes. These ratios of 
achieved to optimal objective function values are referred to as relative performances.
The maximum sample size of the A-family tests increases as A increases and is larger 
for tests with a higher maximum number of analyses. For 5 analyses, A < 0 .1  gives 
a group sequential test with maximum sample size less than 1 2 0 % of rifix, while for 
K  = 10,15 or 20, A < —0.1 keeps the maximum sample size below this threshold.





0.50 100.2 102.9 105.2 106.5 107.3
0.30 100.8 104.8 107.8 109.4 110.3
0.10 102.6 108.3 112.3 114.3 115.5
0.10 106.8 115.2 120.8 123.6 125.3





0.50 100.7 108.3 112.2 114.0 115.1
0.30 100.5 107.5 110.9 112.5 113.4
0.10 100.3 106.3 109.0 110.2 111.0
0.10 100.1 104.5 106.3 107.1 107.5
0.30 100.0 102.2 103.0 103.3 103.5




0.50 100.9 109.3 113.1 114.8 115.9
0.30 100.5 108.2 111.5 113.0 113.9
■0.10 100.2 106.9 109.2 110.4 111.1
0.10 100.0 104.7 106.1 106.8 107.2
0.30 100.0 101.8 102.3 102.5 102.5




-0.50 100.1 102.6 104.6 105.7 106.3
-0.30 100.0 102.4 104.1 105.0 105.5
-0.10 100.0 101.9 103.2 103.9 104.3
0.10 100.0 101.1 101.8 102.2 102.4
0.30 100.0 100.3 100.5 100.6 100.7




-0.50 102.6 127.4 136.2 140.3 142.8
-0.30 101.6 124.8 132.6 136.2 138.3
-0.10 100.7 122.0 127.7 130.6 132.3
0.10 100.3 116.4 121.2 123.2 124.4
0.30 100.1 108.9 113.2 114.4 114.9




-0.50 100.6 106.8 110.0 111.5 112.4
-0.30 100.4 106.0 108.8 110.1 110.8
-0.10 100.1 105.0 107.0 108.0 108.6
0.10 100.0 103.3 104.5 105.1 105.4
0.30 100.0 101.1 101.5 101.7 101.7
Relative performances fo r F5
Table 4.3: Tabulated values are 100 x (top left) and relative
performances for objective functions F\, F2 1 , F 3 1 , F4 and F5 achieved by A- 
family tests with type I error 0.05, power 0.90 and K  equally spaced analyses.
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i 2^ i , and F5  are moderate to poor, with the best being for F5 and the worst for F 4 ,
although the relative performances for these three objective functions are similar. The 
best relative performances are for Fi, with good relative performance for A =  —0.3 
or —0.1. For all these objective functions, the relative performance improves as A 
increases, but this is at the expense of increasing the maximum sample size. Overall, 
the A-family test is a sensible choice if the primary concern is early stopping when 
H = 5 j2, in which case A =  —0.3 or —0.1 would be a suitable choice for a 5 or 10 
analysis design.
Comparing these results with those for symmetric tests in §3.3, the overall patterns are 
similar. The most striking difference is tha t the relative performances for K  =  2 are 
no longer uniformly 100.0. As was noted in the discussion of the symmetric results, 
there is only one degree of freedom available in selecting a symmetric test with two 
groups of observations, and this is used to achieve the desired error probability. Here, 
we have three degrees of freedom to choose the upper and lower boundary points as the 
two points axe equal at the last analysis. Placing the boundaries to satisfy the unequal 
type I and type II error probabilities uses two of these degrees of freedom, thus there is 
no unique asymmetric two-analysis test with the desired error rates. Apart from this, 
the other main difference between the symmetric and asymmetric cases is tha t here we 
have a slightly different recommendation for A.
4.5  P erform an ce o f th e  error sp en d in g  m eth o d
In this section, we consider the efficiency of asymmetric error spending tests, relative 
to the optimal tests found by backwards induction. In forming an asymmetric error 
spending test, we use two error spending functions which are equal in form but not in 
scale to determine the error spent at each analysis. If we wish to have a test with type 
I and type II error rates a  and (3 respectively, and wish to use a 7 -family test with
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7 =  —2.0, we would use error spending functions a *  and f3* where
a*(ni/riK) = ol ( l  — e2(n*/nK^  ^ 1  — e2) 
and /?*(rii/riK) =  /? ( l  — e2(ni//n/<r^  ( l  — e2) .
A test could be designed using error spending functions with different values of the 
param eter 7  or p to determine the type I and type II error probabilities spent at each 
analysis, but this has not been considered here. Nor has the case where the two error 
spending functions used are from the two different families that we consider.
All tests in this section are of H^.^i < 0 against H\:fi > 0 with type I error 
probability 0.05 and power 0.90 fixed at n  =  0 and /jl = 5 respectively, with K  
equally spaced analyses. Maximum sample sizes are given as percentages of njix and 
relative performances are the achieved values of the relevant objective functions given 
as percentages of the optimal values over all tests with the same error rates and the 
same sequence of group sizes.
4 .5 .1  T h e  7 - fa m ily  o f  error sp en d in g  te s ts
Table 4.4 shows maximum sample sizes and relative performances for tests using the 
7 -family of error spending functions, with 7  taking values —4.0, —3.0, —2.0, —1.0, and 
0.0. Maximum sample sizes are good for lower values of 7  and K ,  remaining below 
120% of rifix for 7  < —2.0 for all values of K  considered.
The best relative performance values for the 7 -family tests are for objective function 
which are within 2.5% of the optimal values in all cases considered. The relative 
performance for F\ also increases as 7  is lowered, so the 7 -family tests with the lowest 
maximum sample sizes are also those with the best relative performance for F i . Relative 





-4.0 101.4 103.8 105.2 105.9 106.2
-3.0 102.7 106.3 108.3 109.0 109.5
-2.0 105.0 110.4 113.0 113.9 114.4
-1.0 108.7 116.7 120.0 121.3 121.9





•4.0 100.1 101.3 102.6 103.1 103.5
•3.0 100.1 101.2 102.3 102.8 103.1
•2.0 100.1 101.0 102.0 102.4 102.7
1.0 100.0 100.9 101.7 102.1 102.4
0.0 100.0 100.7 101.4 101.8 102.1




•4.0 100.1 101.2 102.4 102.9 103.2
3.0 100.1 101.1 102.0 102.5 102.7
•2.0 100.1 100.9 101.7 102.1 102.3
1.0 100.1 100.7 101.3 101.7 101.9
0.0 100.0 100.5 101.0 101.3 101.6
Relative performances for F4
K
7 2 5 10 15 20
-4.0 100.3 100.7 101.3 101.6 101.8
-3.0 100.3 100.8 101.3 101.6 101.8
-2.0 100.3 100.8 101.4 101.6 101.8
- 1.0 100.2 100.8 101.4 101.8 101.9
0.0 100.2 100.8 101.6 102.1 102.3




-4.0 100.0 105.2 107.7 108.9 109.6
-3.0 100.0 105.0 107.0 108.1 108.6
-2.0 100.0 104.8 106.4 107.3 107.8
-1.0 100.0 104.6 106.0 106.6 107.1
0.0 100.0 104.3 105.7 106.2 106.6




-4.0 100.2 100.9 101.9 102.4 102.6
-3.0 100.1 100.8 101.7 102.1 102.3
-2.0 100.1 100.7 101.4 101.8 102.0
-1.0 100.1 100.5 101.2 101.5 101.8
0.0 100.1 100.4 101.0 101.4 101.6
Relative performances for F*,
Table 4.4: Tabulated values are 100 x nx/rifix  (top left) and relative
performances for objective functions F \ , F2 1 , T3 1 , F4 and F5 achieved by error 
spending tests using the 7 -family of error spending function with type I  error 
0.05, power 0.90 and K  equally spaced analyses.
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most cases the improvement is slow. The relative performances for F2 1 , F4 and F 5 
are all good, especially those for F5 , while the values for F 31 are good to moderate. 
Overall, the tests using the 7 -family of error spending functions show very good relative 
efficiency and maximum sample size properties, producing highly efficient tests. A test 
with 7  =  —2.0 or —3.0 would be a good test, or possibly using 7  =  —4.0 if the main 
concern was the behaviour of the test when p = 8 / 2 .
This behaviour is mostly unchanged from the symmetric case, with both maximum 
sample sizes and relative efficiency figures being very similar in both cases. The greatest 
difference is found by comparing the relative performance values for F 3 in table 3.4 to 
the corresponding values for F31 in table 4.4, and even in this case, the difference in 
relative performance values do not exceed approximately 2 % of the relevant optimal 
values. Recommendations for suitable choices of 7  are the same as in the symmetric 
case, 7  =  —2.0 or —3.0.
4 .5 .2  T h e  p -fam ily  o f  error sp en d in g  te s ts
Table 4.5 shows relative performance and maximum sample size values for tests defined 
by the p-family of error spending functions for a range of values of p and maximum 
numbers of analyses K.  Calculations for other vales of p and K  continue the patterns 
seen in this table.
The maximum sample size values increase as p and K  increase, with a reasonable 
maximum sample size for all K  considered if p > 2 .0  and also if p = 1.0 when K  =  2 . 
This pattern  is similar to that observed in the symmetric case, although here the 
maximum sample sizes are slightly larger.
Relative performance is worst for F 3 1 , with values which are moderate to poor. Relative 
performances for objective functions F 2 1 ,F 4 , and F 5 are of similar magnitude and are 




10 15 20 P 2 5
K
10 15 20
1.0 114.3 125.7 130.2 131.8 132.6 1.0 100.2 100.8 101.6 102.0 102.3
2.0 104.4 110.0 112.6 113.5 114.0 2.0 100.3 100.6 100.9 101.1 101.2
3.0 101.5 104.8 106.6 107.3 107.7 3.0 100.3 100.9 101.4 101.6 101.7
4.0 100.5 102.5 103.8 104.4 104.8 4.0 100.3 101.0 101.7 102.1 102.3
Maximum sample sizes Relative performancesi for Fi
K K
P 2 5 10 15 20 P 2 5 10 15 20
1.0 100.0 100.7 101.4 101.8 102.1 1.0 100.0 104.3 105.7 106.2 106.6
2.0 100.1 101.9 102.5 102.7 102.9 2.0 100.0 108.4 109.7 110.2 110.6
3.0 100.1 102.6 103.7 104.2 104.4 3.0 100.0 110.5 112.7 113.6 114.2
4.0 100.2 103.0 104.6 105.3 105.7 4.0 100.0 111.5 114.9 116.3 117.0
Relative performances for F2 1  Relative performances for  F31
P 2 5
K
10 15 20 P 2 5
K
10 15 20
1.0 100.0 100.5 101.0 101.3 101.6 1.0 100.1 100.4 101.0 101.4 101.6
2.0 100.1 101.9 102.3 102.5 102.6 2.0 100.1 101.3 101.7 101.9 102.0
3.0 100.1 102.8 103.7 104.1 104.3 3.0 100.1 102.0 102.8 103.1 103.3
4.0 100.1 103.3 104.8 105.4 105.8 4.0 100.2 102.3 103.6 104.1 104.4
Relative performances for F4  Relative performances for F&
Table 4.5: Tabulated values are 100 x nj^/fifix (top left) and relative
performances for objective functions F\, F2 1 , F3 1 .F4 and F$ achieved by error 
spending tests using the p-family of error spending function with type I  error 
0.05, power 0.90 and K  equally spaced analyses.
tests proving highly efficient here. In all cases, the relative performance improves 
as p decreases, so a choice of a value for p must balance concerns of restraining the 
maximum sample size while achieving good efficiency. Overall, there is a combination 
of good maximum sample size and relative performance indicating a family of efficient 
tests. A choice of p = 2.0 or 3.0 would give a test with good properties. Again, this is 
very similar to the symmetric case.
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4.6  C om paring th e  A -fam ily, 7 -fam ily  and p-fam ily te s ts
Figure 4-3 compares the achieved values of objective functions Fi, F21, F31, F4 and F5 
for A-family, 7 -family and p-family tests, with optimal values of each of these objective 
functions. Plotted values are of achieved objective function against maximum sample 
size, with both values being given as percentages of the fixed sample size rifix . The 
plotted lines join points representing tests with specific parameter values; the A-family 
tests are for A =  —0.5,—0 .4 5 ,... ,  0.25, the p-family tests have p =  0 .8 ,1 .0 ,... ,  4.0 
and the 7 -family tests have parameter values 7  =  —4.0, —3 .5 ,. . . ,  0.5. Recall from the 
definitions of these tests in chapter 2  tha t the parameter value determines the maximum 
sample size as well as the shape of the boundary. All tests have size 0.05 and power 0.9, 
with 10 equally spaced analyses. Tests with K  = 5,15 and 20 show the same patterns 
as are seen in figure 4-3, while in the case where K  = 2 there is little difference in 
performance between any of the methods.
The patterns shown are extremely similar to those observed in the symmetric case, 
which were shown in figure 3-3. In all cases with tlk <  1.2 x n /^ ,  the A-family tests 
have the worst achieved objective function values, in some cases by a considerable 
margin. The two families of error spending function considered lead to tests which 
have similar performance as regards achieved objective function values. The p-family 
is slightly superior for F i, while the 7 -family is slightly superior for the other objective 
functions considered. Thus, the 7 -family is, overall, the better choice of test design.
In practice, the A-family tests are much easier to design and implement, which is a 
considerable advantage. However, the error spending tests have the advantage of their 
flexibility, and figure 4-3 shows that they achieve significantly better expected sample 
size values. Thus, they are to be preferred in use to the A-family tests.
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Figure 4-3: Achieved values of F \ , F2 1 , F 3 1 , F4 and F5 for A-family, 7 -family 
and p-family tests. All tests have type I  error 0.05 and power 0.90, with 1 0  
equally spaced analyses. Optimal objective function values are included for 
comparison. Maximum sample sizes and objective function values are given 
as percentages of the fixed sample size nj ix .
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Chapter 5
Optim al group sequential tests  
w ith random group sizes
In chapters 3 and 4, we considered optimal group sequential tests when the sequence of 
cumulative sample sizes n i, n 2 , . . . ,  n x  was fixed and known in advance. We now move 
on to consider a situation where this is not the case and optimise group sequential tests 
when the sequence of sample sizes is uncertain at the design stage of the trial. We 
start in §5.1 by outlining a framework for optimising group sequential tests where the 
sequence of sample sizes is uncertain.
Once we have discussed a means of incorporating uncertainty as to the possible sample 
sizes tha t may be seen in the trial, we consider the properties of the resulting tests 
in §5.2. While the optimal tests are of interest in their own right, our primary 
motivation in developing these tests is to provide a method of assessing the performance 
of existing methods when the group sizes deviate from those planned. We consider the 
performance of the A-family and error spending tests in these circumstances in §5.3, 
using the optimal group sequential tests from §5.1 as a benchmark. Through the 
use of our optimal group sequential tests which incorporate group size uncertainty as a
73
benchmark, we can investigate the relative performance of these existing methods. This 
allows us to give recommendations for the design of trials where there is uncertainty 
as to the numbers of observations seen at each analysis, and to comment on how well 
the methods examined fare when the number of observations seen depart from the 
anticipated schedule.
Throughout this chapter, we shall refer to a sequence n i, n<i, . . . ,  u k  of the total number 
of observations seen at each analysis as a sequence of sample sizes. We shall denote 
a sample size sequence by n  =  ( n i , . . . , tlk)-, and we shall refer to tests designed with 
several possible sample size sequences in mind as random group sequential tests, as 
opposed to the fixed group sequential tests discussed in chapters 3 and 4.
5.1 O p tim isin g  over a sam ple size m od el
In chapters 3 and 4, we found optimal symmetric and asymmetric group sequential tests 
when the number of observations taken in each group was known in advance. This will 
not always be the case, and in this section we shall discuss a framework for introducing 
uncertainty as to the actual sequence of sample sizes into the group sequential trial. 
We do this by selecting a model for possible sample size sequences and optimising the 
performance of the group sequential test averaged over this sample size model.
The Bayes decision theory problem discussed in §3.1.2 and §4.2.1 needs no further 
modification to deal with this situation, but is restated for convenience in §5.1.2. 
However, the backward induction algorithm used to solve the Bayes decision theory 
problem must be altered to deal with the situation where we average over a sample 
size model, and these alterations are discussed in §5.1.3. Several possible sample size 
models are described in §5.1.5.
Several authors, including Pocock (1977) and Emerson & Fleming (1989), have noted 
the robustness of group sequential schemes to small deviations from the planned
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sample size sequence. Usually, these discussions have focussed upon the achieved error 
probabilities, but given this robustness, it is reasonable to assume that there will be only 
small alterations to the expected sample size properties of a group sequential scheme if 
there are small perturbations from the planned sample size sequence. However, larger 
deviation from the planned sample size sequence can lead to greater perturbations in 
the achieved error probabilities and expected sample sizes, as we shall see later in this 
chapter.
It must be noted tha t it will not always be possible to describe a model for the 
sequence of sample sizes, much as it is not always possible to specify a fixed sequence 
of group sizes and adhere firmly to that schedule of analyses. However, under some 
circumstances it will be possible to describe the expected rate of arrival of data in such 
a fashion. Even if this is not the case, by considering several plausible sample size 
models we can investigate the performance of other group sequential schemes to help 
plan a clinical trial.
5 .1 .1  D e fin it io n s
Recall tha t we wish to investigate the difference in efficacy between a new treatm ent and 
a control, which may be a placebo or an existing treatment. We denote the difference 
in efficacy between the new and control treatments by /q with positive values of fi 
indicating superiority of the new treatment. Our aim is to test the null hypothesis 
Ho'.fi <  0  against the one-sided alternative H\:fi >  0 , with type I error probability a  
at fi = 0 and type II error probability (3 at ^  =  5. For the optimal group sequential 
tests which we shall discuss in this chapter, these error probabilities are to be averaged 
over a sample size model. We do not require the error probabilities of our optimal 
tests conditional upon a specific sample size sequence to achieve these nominal values. 
In later sections, we shall discuss the use of A-family and error spending tests with 
uncertain group sizes and these methods will not be required to have average error
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probabilities a  and (3. We can take observations X i, X 2 , . . where each observation 
is independently iV(/i, cr2) distributed, with o2  known and we can take a maximum of 
K  groups of observations. For the remainder of this chapter, we use z to denote the 
analysis or group of observations under consideration. Unless stated otherwise, z takes 
values in the set {1 , . . . ,  K }.
Rather than fix the number of observations taken at each analysis in advance, we 
consider several possible sample sizes for each analysis. Define Vi to be the number 
of possible values for the sample size at analysis z, then we write n ^ i , . . . ,  for the 
possible sample sizes at analysis z. Let the sample size at analysis z be A^, where 
Ni is a random variable taking values in the set {n^i , . . . ,  n ^ } .  We define transition 
probabilities and r  -^ as follows.
r l0) =  P fM  =  «!,*}
Tj'k =  V{N i+ 1 =  =  r ii j j
Thus, the probability of a particular sample size sequence n i j 1,n 2 j 2, •.. ,riK,jK 
occurring is
P {Ni = n U l niv2 =  n 2j 2 n ... n N K = n K,jK) =  ■ ■ ■ r ^ ] K. (5.1)
As noted above, we shall be finding group sequential tests with error probabilities 
a  and /3 at /i =  0 and fi = 6  respectively. However, these error probabilities are 
averaged over the sample size model, rather than holding for each possible sample size 
sequence. Any specific sample size sequence n  will have associated error probabilities 
and the contribution these probabilities make to the overall error rate is weighted by 
the probability of the sample size sequence n  occurring, as given by equation (5.1).
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k = 1 , . . . ,  i/i
i = l , . . . , K - l
< 7 =  1 , . . . , ^
k = 1 , . .  . , v i + 1V
As we shall see in §5.2, the error probabilities conditional upon different sample size 
sequences can vary considerably.
For the rest of this chapter, we reserve the subscript j  for use as an index of the possible 
sample sizes at analysis i. Thus, unless stated otherwise, j  takes values 1 , 2 , . . . ,  As 
in the fixed groups case discussed in chapters 3 and 4, we define N  to be the number of 
observations taken by the termination of the trial and we define the summary statistic 
of the first n  observations, Sn, to be Sn = ]C/t=i ^fc- Thus, Sn ~  N(nfj,,na2).
The action taken at analysis i depends upon the number of observations seen, the sum 
of these observations, and the number of analyses already carried out. However, our 
action does not depend upon the sequence of cumulative sample sizes n i, . . . ,  rii other 
than through the current sample size rii. Thus, whether we stop the trial or continue 
to the next analysis having seen riij observations with sum Snij is determined by 
constants a ij  and b i j , with a*><7- < b i j , as follows.
If Sni j < a ij  s t o p , accept Hq,
if a^j < Snij < bij continue to analysis i + 1,
and if bij < Sni j STOP, reject Hq.
To ensure termination of the trial at analysis AT, we set aK j — b K j• Thus, if we reach 
analysis K  we shall either accept or reject H q.
This type of random group sequential boundary is different from the fixed group 
sequential boundaries discussed in earlier chapters. When the sample size sequence 
is fixed and known in advance, there is a single continuation region (ai,bi) a t each 
analysis i. Here, we have a set of different continuation regions bij)}  at analysis
i , and which region is used is dependent upon the observed sample size at analysis i.
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5.1.2 The Bayes problem
The Bayes decision theory problem used to find optimal asymmetric group sequential 
tests with fixed group sizes described in §4.2.1 is used without further modifications 
to find the optimal random group sequential test averaged over a sample size 
model. H ow ever, the implementation via a backward induction algorithm requires 
modifications, which are detailed in the following section. We restate the Bayesian 
decision theory problem here for convenience.
We wish to choose between possible decisions Do: ‘/i =  O’ and D$: £/i =  6 \  We place 
a prior tt(/i) on fi and define the cost of taking one observation to be c(/i). We define 
M. to be the set of values of \i upon which the prior 7r(/i) places a non-zero probability 
mass. We also define the loss function L 2(D , /i) which gives the cost of wrong decisions 
to be L 2 {D0 ,S) = ds, L 2 (Ds,0) = do and L 2 (D ,fi) =  0 otherwise.
Our goal is to find a test minimising one of the objective functions defined on page 50. 
The expected cost of any decision rule is
E{cost} =  E{ cost of sampling} +  E{ cost of decision}
= kiFr -1- k2  (cfo7r(£)P<s{A)} + do7r(0 )Po{d<s}) 1
where Fr is the objective function we wish to minimise and the constants ki and 
k2  are determined by the choice of objective function. If we wish to minimise F i, 
ki =  k2  = 1/3, if we are minimising F 2 1 , k\ = 1 and k2 = 1/2, if we are minimising F 31 
then k\ =  1/2 and k 2  = 1/4, and if we wish to minimise F4 , then k\ = 1 and k2  = 1/10. 
Appropriate priors and cost of sampling functions were defined in §4.2.1 and remain 
unchanged.
For any given values of do and cfo, the Bayes rule will have probabilities of making 
incorrect decisions P^AI^o,ds} and Fo{Ds\do,ds}, and the Bayes rule will minimise
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the total expected cost of all decision rules with these probabilities of wrong decisions. 
Hence, the Bayes rule must minimise Fr amongst all decision rules with these 
probabilities of wrong decisions. We then search over do and ds to find the Bayes rule 
which has probabilities of wrong decisions Fs{Do\do, ds} = a  and Po{As|do, ds} = (3 
and thus identify the group sequential test with the desired error probabilities a  and 
/3 averaged over our sample size model.
One complication tha t arises from using this approach for random sample sizes occurs 
when calculating Fs{Do\do,ds} and lPo{As|do, ds] for the Bayes rule specified by 
particular values of do and ds. The method used in the fixed group case proves to 
be impractical here and so an iterative method, described in §5.1.4 is used.
5 .1 .3  A d a p tin g  th e  backw ard  in d u ctio n  a lg o r ith m  to  ra n d o m  sa m p le  
s izes
The overall structure of the backwards induction algorithm described in §3.1.3 and 
§4.2.2 remains unchanged. However, when we calculate the expected cost of continuing 
to the next analysis and proceeding optimally there, we must now consider the different 
possible sizes of the next group of observations.
The posterior probability of any value of n  G M. at analysis i, given riij observations 
and an observed value sn. . of the summary statistic Sni j , is
°c 7iir if j j tH sm j) ,
( i )where / / r  is the probability density function of Sni j with each observation having 
mean {.z;
f ( i ) (  \   ^ f  ( S n i,j ~  1
,  I  - * * * •  ) '
We note tha t the posterior probability for /i is also a function of n^j, but suppress the
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sample size in our notation for simplicity. The dependence on the sample size can be 
seen through the subscript of sni J .
We start by considering what action to take at analysis K ,  should the trial proceed that 
far. In order to ensure termination of the trial, we set the boundary points a,K,j = b x j  • 
These points are set to the value of SnK . such that the expected losses of making either 
decision D q or Ds are equal; we label this value s^Kj and solve the equation
E { cost of D01 SnK j = s*nK j } =  E { cost of Ds \ SnK j = s*nK j }
=S> d5p{K){8 \s*nKj) =  d0 p iK)(0 \s*nKj)
to find that
For analyses i = 1 , . . . ,  K  — 1, we define 7 ^ { s ni j ) to be the expected cost of stopping 
and making a decision given sample size riij and an observed value snij  of the summary 
statistic Sn i j . Similarly, we define P ^ \ s niJ) to be the expected cost of continuing to 
the next analysis and acting optimally there. As with the posterior for p, we suppress 
the sample size riij in this notation for simplicity.
At analysis «, we consider the boundary points for each possible group size riij. To 
determine the boundary points aij  and b^j, we first calculate s*. , using equation (5.2) 
with riij in place of riK,j- If the expected cost of stopping and making a decision when 
Sn . . = s*. is less than that of continuing to analysis i +  1 and proceeding optimally, 
we shall set a^j — bij = s*j. Otherwise, we search for two values of Sni j satisfying 
the equation 7 ^ \ s n i j ) = (3(l\ s niJ), with one of these values above s* and the other 
below 5* .  . We then set the boundary points to these values, with a ij  < s^..  < bij. 
As in the fixed group sequential tests in chapters 3 and 4, these searches rely upon the 
monotonicity of 7 ^ ( s n i j ) — j3 ^ \s niJ), which was discussed on page 29.
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We now need to discuss the calculation of and p ^ ( s n i j ). Firstly, we define
^ i+ U : (s™i+1 fclsn»,j) to be the cumulative distribution function of S n i+ 1  k given 
riij and sni ., again suppressing the term riij in this notation for simplicity. Thus,
WP(*+1) (e |o \
U ni+i,k  v * " t + i , f c  J
— 9  ^ ' Hsni+1^ \snij)dsni+lk
— Y j (tJ,\s ni j )h^1+  ^(5ni+lifc|^*+l,fc, s rii j  ) }  d s n .+l  fc,
neM
where g is the density function of SUi+l k given rii+1^, riij and sni . and h is the density 
function of Sni+l k given snid and fi.
The expected cost of stopping and making a decision at analysis i with sample size riij 
and observed value sni . of the summary statistic Sni J , is
7 (l)(-snij.) =  min{d,jp(t)(^|sn.i:;.),doP(l)(0|snij.)} >
which is easy to calculate once the posterior probabilities of // =  0 and n = 8  are 
known. Calculating the expected cost of continuing to the next analysis and proceeding 
optimally there is more complicated, as it is necessary to consider the different possible 
values of Ni+\. The expected cost of continuing to the next analysis and acting 
optimally there is given by
P ^ { sm j)  — E{cost of observing group i +  1} +
E{cost of optimal action at analysis i + 1} .
For analysis i , i = 1 , . . . ,  I f  — 1, the expected cost of observing group i +  1 when the 
current sample size is riij is
E
' V i  +  l
k=i
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If we continue from analysis K  — 1, the expected cost of acting optimally at analysis 
K ,  given the current sample size tik- i j  and an observed value snK_l j  of SnK_l j  is
E (Ti,t_1) f ^ K)^nKii)dFi^k(snKk\snK_ltj) \ .
k = l  k J K  J
For analyses i =  1 , . . . ,  K  — 2, we must also consider the possibility of continuing past 
analysis i +  1. Thus, if we continue to analysis i +  1, the expected cost of acting 
optimally there, given the current sample size n^j and observed value sni j of S nij is 
given by
e  { JK min {7<t+1) (sni+!.‘) ’/3<,+1) )} dF%tti )} •
Hence, the expected cost of proceeding optimally from analysis i (i = 1 , . . . ,  K  — 2)
after riij observations with sum sni j is
P{lHsniJ) = Y  (  Y  Tj i ( n i+l,k -  n i,j)
u £ M  L I k = l
Vi +1
+  (5.3)
fc=l k j K J
and the expected cost of proceeding optimally from analysis K  — 1 after n x - i j  
observations with sum snK_l j is
0 {K = E
(i€M.
c{fl)p(K 1}(/i|SnK_ltj) < Y  Tj!k 1](nK,k ~ nK- l j )  
u = i
ERr1’ /fc=l k J R J
These equations are the same as equations (3.1) and (3.2) in the fixed groups case, 
with the addition of the sums over the possible sample sizes at analysis i +  1.
The integral of p(t+1 \ s n i+ 1  k) in equation (5.3) is calculated numerically, requiring
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the evaluation of ^ l+1 \ n i+i^^ sn i+ 1  k) on a grid of points in the region [ai+ijjt, 6*+i,fe]. 
These values are evaluated for each of the sample sizes ,  n;+ i , v i + 1  immediately
after finding the boundary points { a ^ i ^ ,  k = 1 , . . . ,  I'i+i}, before considering the
action to be taken at analysis i. Thus, we start by considering the optimal course of 
action at analysis K , then proceed backwards to analysis K  — 1, K  — 2, and so on to 
analysis 1. This is summarised in algorithm 3.
A lgorithm  3: A sym m etric random  groups algorithm
A n aly s is  K
•  For j  =
o Find s*nK . such that d5p^K){8 \s*nK .) = d0p(K\0 \ s ^ K j).
o Set aKj  = bKj  = s*K ..
A n a ly se s  K  -  1 , . . . ,  2
• For i = K  — 1 , . . . ,  2 :
o For j  =  1
o Find s*n. . such tha t dsp ^ ( 6 \s^. .) = d0p^(0 |s* . ). 
o I f 7 (i)(s; . . ) > / ? ( 0 (4 . . ) :
• Find aij  such that 7 — P ^ \ ai,j)i with a ij < s^. .
• Find bij such that j ^ ( b i j )  — (3^ {bij), with bij > s
• Evaluate /3^{sn i j ) on a grid of values of sniJ from a^j to b i j . 
o Otherwise, set a ij  = bij = s*. .
A nalysis 1
• For j  =
o Find Snltj such that d s p ^ ^ s ^ . )  =  doP^H0! ^ ) -
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O If7<1)« , i)>/3(1)K J):
o Find a i j  such that 7^H a i j )  =  / ^ ( a i,.7')> with a \ j  < s ^ . .  
o Find b i j  such that {bij) = /3^{b ij) ,  with b ij  >  s ^ . .  
o Otherwise, set a i j  = b ij  = s* 1 .
Comparing this algorithm to those for the symmetric and asymmetric fixed-groups 
problems on pages 29 and 55, it can clearly be seen that this algorithm is fundamentally 
similar to those algorithms, with the added complication of considering the different 
possible sample sizes at the next analysis.
5 .1 .4  I te r a t iv e  error p ro b a b ility  an d  o b je c t iv e  fu n c tio n  ev a lu a tio n
Extending the method of finding optimal group sequential tests by means of a Bayes 
decision theory problem to finding group sequential tests averaged over a model 
for possible sample size sequences creates complications when calculating the error 
probabilities of a specific boundary. In the search for a Bayes rule with the desired 
probabilities of making a wrong decision, the probabilities of making each of the two 
possible incorrect decisions must be calculated for each pair of values of do and ds 
considered. In the fixed groups case, this was achieved by finding the group sequential 
boundary implied by the Bayesian decision theory problem with particular values of 
do and ds via the backward induction algorithm and then using numerical integration 
of the joint distribution of the summary statistics { 5 ^ , . . . ,  5 ^ }  to determine the 
probabilities of falsely accepting and rejecting Ho under fi = 5 and fi = 0  respectively. 
An efficient algorithm for these calculations is given by Jennison (1994). However, this 
approach only calculates the error probabilities for a specific sequence of sample sizes n. 
W ith the introduction of a model for this sequence, calculating the error probabilities 
for each possible sequence of sample sizes and weighting the resulting error probabilities 
by the product of the transition probabilities for the sample size sequence in question,
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given in equation (5.1), would be inefficient. Instead, we find the error probabilities 
by means of an iterative calculation. Define the probabilities of incorrectly rejecting 
or accepting Ho if we continue from analysis z, when we have seen riij observations 
yielding a summary statistic value of sni . at analysis z to be respectively
ip u \ sm j)  = IPo{reject Hq at analysis z +  1 or later|sni .} 
and = ^ {accep t Ho at analysis z +  1 or la ter |sni .}.
Then at analysis K  — 1,
VK- 1
= Y  Tj !k~ 1]^ 0 { SnK,k > bK ,k\SnK- ltj}, 
k =1
and at analysis z, for z =  1 , . . . ,  K  — 2,
'i+i
= Y i  Tj i
k =1
(5.4)
with similar iterative equations for At each analysis z, and for each possible
sample size n^-, these functions can be evaluated on a grid of values of sni . in order to 
numerically evaluate the integral in equation (5.4) when calculating and
The grid of points used is the same as the grid upon which P ^ ( s nitj) is evaluated and 
these calculations are carried out concurrently with the backwards induction algorithm 
used to find the optimal random group sequential test. The probabilities of falsely 
rejecting and accepting Ho are then (0,0) and i p ^  (0,0) respectively.
A similar method can be used to calculate the expected sample sizes under different 
values of /z, by defining w ^ (sWi j ) to be the expected additional number of observations 
to be taken after continuing from analysis z, given a sample size riij at analysis z, with 
an observed summary statistic value sni ..
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5.1.5 Som e sam ple size m odels
Several models for the possible sample sizes will be considered in the following 
discussions. In this section, we introduce and describe these models. They are defined 
by the maximum number of analyses, the possible sample sizes at each analysis and 
the transition probabilities between possible sample sizes at the current and subsequent 
analyses. In contrast to the discussions in chapters 3 and 4, we also specify the values 
of S and a 2  as the sample sizes are given as actual numbers of observations rather than 
percentages of the fixed sample size n /ix . It would be perfectly feasible to specify these 
sample sizes relative to n /;x, thus making these results invariant to 6  and cr2, but the 
tests are more intuitively understandable when discussed in terms of the numbers of 
observations. We note that, as discussed on page 4, non-integer sample sizes have a 
valid interpretation in generalising these results to trials which have more complicated 
statistical formulations than our simple sum of independent and identically distributed 
normal random variables. However, all the examples discussed in this chapter have 
integer sample sizes.
For all the models we consider, we are testing Hoifi <  0 against H\:fi > 0 with type I 
and type II error probabilities a  and (3 set at n = 0 and fi = 5 respectively. Recall tha t 
these error probabilities are averaged over the sample size model, and tha t the error 
probabilities conditional upon the observed sample size sequence are allowed to vary. 
Observations are independently N (fi , a2) distributed, with a 2  known. For the examples 
studied in this chapter, 5 = 0.25, or =  1.0 and the error probabilities are a  = (3 = 0.05. 
These values lead to a required sample size of 43.30 (to 2 decimal places) if no interim 
analyses are to be carried out.
For models 1, 2, and 3, the maximum number of analyses is is three. We also consider 
three models (models 4, 5, and 6) which permit a maximum of five analyses. Of these, 
model 4 is similar in spirit to model 1, model 4 is similar to model 2, and model 6 is
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similar in spirit to model 1.
M odel 1
For this model, the possible sample sizes at analysis i (i =  1,2,3) are
Ni E {15z, 15z ±  4 ,15z ±  6} .
The probabilities of each sample size occurring at any given analysis are in the ratio 
1:2:3:2:1. More explicitly, the possible sample sizes are
For this relatively simple model, it is easier to list the sample sizes and transition 
probabilities explicitly. However, the other models we shall consider are more complex 
and it will be simpler to describe those models in the more compact form used above.
This model represents a situation where there is the same degree of uncertainty at each 
analysis and there is no sample size which could occur at more than one analysis. The 
total sample size at earlier analyses has no effect upon the total sample size at later 
analyses, although the early total sample sizes do affect the group sizes which occur
and
Ni  E {9,11,15,19,21}, 
N 2  E {24,26,30,34,36}, 
N 3  E {39,41,45,49,51},
and transition probabilities are
r!°> =  r f  =  1/9
T(°> =  rj0) =  2/9
r f  =  1/3
i  =  1,2
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later in the trial. This would be appropriate if we could reschedule later analyses after 
seeing the rate at which observations are accrued early in the trial. While rescheduling 
later analyses in light of observed data will violate the design of any group sequential 
test, we are allowed to alter the schedule of analyses to allow for quicker or slower 
accrual of data than was anticipated.
M odel 2
For this model, the possible sample sizes at analysis i are
Ni E {15*, 15* ±  2,15* ±  4,15* ±  6,15* ±  8,15* ±  10} .
In most cases, the probabilities of the possible sample sizes at the next analysis are in 
the ratio 1:2:3:4:5:6:5:4:3:2:1, but there are situations where some of the possible sample 
sizes at the next analysis are not feasible since they have already been reached or even 
exceeded. In this case, the probabilities of these impossible group sizes occurring are 
set to zero and the remaining transition probabilities re-normalised to sum to one. For 
example, if we see n \ = 25, the greatest possible size for the first group, N 2  cannot take 
values 20, 22, or 24. We then set 2 — r n ^3 — 0? and the remaining transition
probabilities for going from n\ = 25 to N 2  = ri2 are set in the ratio 4:5:6:5:4:3:2:1.
As with model 1, there is the same degree of uncertainty as to the possible sample size at 
each analysis. However, in this model the degree of uncertainty is much greater. Apart 
from prohibiting impossible group sizes and re-normalising the remaining transition 
probabilities, the total sample size at earlier analyses does not affect the size of the 
next group of observations.
M o d el 3
This is the third three-analysis model considered and is different in style to models 
1 and 2. In this model, whatever the current sample size, we have the possibility of 
there being 12, 15 or 18 observations in the next group. In each case, the probability 
of the next group consisting of 12 observations is 0.25, the probability of seeing 15 
observations in the next group is 0.5 and the probability of seeing 18 observations is 
0.25. This results in possible sample sizes
Nx € {12,15,18},
N2 e  {24,27,30,33,36}, 
and N3 6  {36,39,42,45,48,51,54}
and transition probabilities
Tj0) =  0.25 r f ] =  0.5 4 0) = 0.25
and r « = 0 . 2 5  r « + 1  =  0.5 r g + 2  =  0.25
for i = 1 , 2  and j  =  l , . . . , i ^ .  Unlike models 1 and 2 , the size of early groups of 
observations strongly affects the possible sample sizes at later analyses, but not the 
subsequent group sizes.
M odel 4
This is the first five-analysis model we consider. For this model, possible sample size 
values at analysis i are
Ni e  {10z, 10i ±  3,10^ ±  5}.
Transition probabilities are in the ratio 1:2:3:2:1, except for the largest possible sample
( i )size at each analysis, when 75  { =  0 , and the remaining transition probabilities are in
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the ratio 2:3:2:1. This model is similar in sprit to model 1, but with a greater number 
of analyses allowed.
M odel 5
This model has the greatest number of possible sample sizes of all the models considered 
in this chapter. There are a maximum of five analyses allowed, and for each analysis z 
the possible sample sizes are
Ni £  {1 0 2 , lOz ±  1, lOz ±  2, lOz ±  4, lOz ±  6 , lOz ±  8 } .
There are eleven possible sample sizes at each analysis, and the probabilities of each 
sample size occurring are usually in the ratio 1:2:3:4:5:6:5:4:3:2:1. As for models 2  and 
4, in the case of impossible transitions (for example going from n\ = 18 to n 2  =  16), the 
relevant transition probabilities are set to zero and the remaining values re-normalised.
M odel 6
In this model, whatever the current sample size, we have the possibility of there being 6 , 
9 or 12 observations in the next group, with probability 0.25, 0.5 and 0.25 respectively. 
This results in the possible sample sizes at each analysis being
Ni e {6,9,12},
n 2 6 {12,15,18,21,24},
n 3 e {18,21,24,27,30,33,36},
n 4 £ {24,27,30,33,36, 39,42,45,48},
and A/5 £ {30,33,36,39,42,45,48,51,54, 57,60}
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The transition probabilities for this model are
T[<0) =  0.25 r |0) =  0.5 T.p =  0.25
and r j’j  =  0.25 rj^+1 =  0.5 t$ +2 =  0.25
for i = 1 , . . . ,  4 and j  = 1 , . . . ,
In models 3 and 6, the sample size at later analyses depends greatly upon the size of 
earlier groups, while in models 1, 2, 4, and 5 this dependence is much weaker, being 
limited to the prohibiting of impossible transitions. Models 1, 2, 4, and 5 would be 
suitable for a trial where the calendar time of future analyses could be rescheduled 
in light of the rate of accrual, while models 3 and 6 represent a situation where the 
calendar time between analyses is fixed and thus lower than anticipated accrual at early 
analyses would reduce the final sample size possible. This results in greater uncertainty 
as to the final sample size than about the sample size at earlier analyses.
5 .1 .6  A n  e x a m p le  o f  a  ran d om  grou p  seq u en tia l t e s t
Figure 5-1 shows the boundaries of an optimal random group sequential test. The 
boundaries are designed to test <  0 against Hi'.fi > 0 with type I error probability 
a  = 0.05 at \i = 0 and type II error probability ft = 0.05 at fi =  0.25. The test follows 
sample size model 5 and is optimised for F\ = £^=0.125 {A}. Sample size model 5 is 
based upon an anticipated sample size path n =  (10,20,30,40,50), with a large degree 
of possible variation about this anticipated schedule of analyses. The boundaries show 
how several different continuation regions are possible at each analysis, and also how 
the continuation region after a particular number of observations may vary depending 
upon how many analyses have been taken before reaching tha t point. In this example, 
a total of 16 observations could be seen at the first analysis or after two analyses have 
been carried out.





5 0 6 00 3 0
n
Figure 5-1: An optimal random group sequential test. The test follows sample 
size model 5 and is optimised for objective function F \. Overall type I  and 
type II  error probabilities are 0.05.
the trial being terminated after 4 analyses with the conclusion to accept Hq. This 
hypothetical trial has seen a large initial group of 16 observations, followed by three 
smaller groups of 8 , 6 , and 6  observations.
5.2 C onditional perform ance o f th e op tim al random  
group sequential tests
Using the method discussed in §5.1, we can find optimal group sequential tests averaged 
over sample size models which minimise the objective functions we defined on page 50. 
We refer to these tests as being random group sequential tests, as opposed to fixed 
group sequential tests as discussed in chapters 3 and 4. Several candidate sample size 
models were described in §5.1.5. The resulting tests have a set of boundary values for 
use at each analysis; which pair of values are used for the upper and lower bounds of 
the continuation region at analysis i will depend upon the observed value of the sample
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size Ni. In practice, a realisation of the sample size sequence n  =  (niJ15. . .  ,riK,jK) 
would be observed, leading to a fixed group sequential test with a single continuation 
region ( a ^ ,  frijJ at each analysis i. Thus, the random group sequential test consists 
of a set of fixed group sequential tests.
A major motivation for developing this method of calculating optimal random group 
sequential tests is to provide a benchmark to assess the performance of existing 
methods, such as the A-family and error spending tests we have discussed in earlier 
chapters. However, we also wish to examine the properties of our optimal random 
group sequential tests in their own right. They are unusual, in frequentist terms, in 
tha t they permit variation in type I error probability, depending upon the observed 
sample size sequence. We shall consider the properties of our random group sequential 
tests conditional upon the sample size sequence observed. Firstly, we consider the 
achieved error probabilities in §5.2.1, then move on to consider the expected sample 
sizes of these tests in §5.2.2. We also consider the conditional performance of the 
corresponding decision rule from a Bayesian perspective in §5.2.3.
5 .2 .1  A ch iev ed  error p ro b a b ilit ie s
We define 5(n) to be the achieved type I error probability of the random group 
sequential test with sample size sequence n =  ( n i , . . . ,  n x ) ,  and similarly we define 
(3{n) to be the achieved type II error probability for the sample sample size sequence. 
Any random group sequential test will have a range of values of 5(n) and n), 
corresponding to the different possible sample size sequences.
Figure 5-2 shows values of 5(n) achieved by a symmetric test with a  = (3 = 0.05 using 
sample size model 1. Recall that this model permits a maximum of K  — 3 analyses, and 
there is no overlap between the sets of possible sample sizes at consecutive analyses. 
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Figure 5-2: Achieved type I  error probability conditional upon sample size 
sequences for an optimal random group sequential test. The test sample 
sizes follow model 1 and the test is optimised for F\. Overall type I  and type 
II error probabilities are 0.05. The histogram and upper scatter plot show 
all values of a (n ), while the lower graph shows only error probabilities for 
sample size sequences where n$ =  45.
test is symmetric, 5(n) =  ( 3 ( n )  for any n =  (n ijx , n2j2 > n3 ,j3 ) • The histogram shows 
tha t achieved conditional error probabilities are sharply divided into discrete subsets, 
with the overall range of values of 5(n) being from 0.0402 to 0.0611. The subsets of 
conditional error probabilities correspond to differing maximum sample sizes, as shown 
in the centre graph in figure 5-2, which plots the achieved value of 5(n) against the 
maximum sample size n$ of the sample size sequence n. Larger maximum sample 
sizes result in lower conditional error probabilities, as would be expected. The lower 
graph in figure 5-2 is of achieved error probabilities against the value of n 2 for those 
sample size sequences which have n 3 =  45; note that the vertical scale of this plot 
is much larger than tha t for the graph above. This plot shows tha t the variability 
in error probability among sample size paths with the same maximum sample size is 
systematically affected by the sample size at the penultimate analysis, with lower 5 (n ) 
generally being associated with sample size sequences which have larger 712. The same 
pattern  is shown by plotting 5(n) against 712 for other values of 713.
Figure 5-3 shows the achieved values of 5(n) for random group sequential tests with 
sample sizes following models 2 and 3. Broadly similar patterns to those seen for 
model 1 in figure 5-2 are clearly visible, but the greater degree of uncertainty as to 
the possible maximum sample size results in the range of values of 5(n) being much 
greater. There is also far less distinction between the subsets of 5(n) values in the 
results for model 2, due to the fact that for any particular value of 713, there are far 
more possible values of n\  and 712- In contrast, a particular value of 713 in model 3 can 
only be achieved after a relatively small number of values of N\  and JV2 ; in this case, the 
distinction between subsets of achieved <3(n) values is much greater. Similar patterns 
have been observed for models 4, 5, and 6, although the patterns are less distinct in 
tests following the five-analysis models. This is due to the fact tha t these models have 
a greater range of different possible sample size paths. In each case, the discretisation 
of 5(n) values was primarily caused by the achieved value of the maximum possible 
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Figure 5-3: Achieved type I  error probability conditional upon sample size 
sequences for optimal random group sequential tests. The upper graphs are 
for a test with sample sizes following model 2, while the lower graphs are for 
a test following model 3. Both tests are optimised for F\. Overall type I  and 
type II error probabilities are 0.05.
Random group sequential tests following sample size models 1 to 6  and minimising 
objective functions F2 1 , F 31 and F4 were also found. Recall that these objective 
functions are defined to be «
F21 =  1 (E o{JV} +  1 Ks{N}) F31 =  i  (E_J/2{iV} +  IE3J/2{iV})
F4 =  i % 2{iV} +  i  £  E,i/4 {iV}.
Since results for F5 in chapters 3 and 4 were close to those for F4 , we have not
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Model Range of a(n) Maximum sample size
Fi ^31 n K ^ K /  flfix
1 0.040 -  0.061 0.039 - 0.063 39 -  51 0.90 - 1.18
2 0.035 -  0.071 0.033 - 0.073 3 5 - 5 5 0.81 - 1.27
3 0.037 -  0.068 0.036 - 0.069 36 -  54 0.83 - 1.25
4 0.043 -  0.057 0.039 - 0.062 45 -  55 1.04 - 1.27
5 0.040 -  0.062 0.034 - 0.070 42 -  58 0 . 97- 1.34
6 0.031 -  0.086 0.030 - 0.087 3 0 - 6 0 0.69 - 1.39
Table 5.1: Tabulated values are maximum and minimum values of 5(n) 
and of nj{ for random group sequential tests minimising F\ and F$\. Three 
analysis tests considered follow sample size models one, two, and three, while 
five analysis tests follow sample size models four,five, and six.
considered random group sequential tests optimised for F5 . As we only present results 
for symmetric tests, with a  = we do not consider the asymmetric objective functions 
F2 2 , -^23 5 -F3 2 , and F3 3 .
The greatest range of values of 5(n) for the random group sequential tests was for 
tests minimising F$ 1 , while the smallest range was for the tests minimising F\. These 
values are shown in table 5.1 for tests following all the sample size models we defined 
in §5.1.5, along with the maximum sample sizes for each model. It is clear th a t the 
range of achieved a(n) values is greater for those models with more uncertainty as 
to the maximum sample size which may be achieved by the test. Thus, in practice 
we would wish to control the maximum sample sizes possible under our sample size 
model in order to ensure the variation in achievable 5(n) values would be acceptable 
in frequentist terms.
5 .2 .2  A ch iev ed  o b je c t iv e  fu n c tio n  va lu es
Following the notation used for the achieved error probability conditional on a 
particular sample size sequence n =  . . .  ,nK,jK), we define Fr(n) to be the value










. i l l  l l l l i i i  j i . . .  i . .  a
1.000 1.001 1.002 1.003
F2i { n ) / F ° x ( n ,a ( n ) )
in
.iililiilLiIllll R.II.
1.0000 1.0005 1.0010 1.0015
h i ( n ) / %  (n ,a (n ) )
II.. I..1. .1
1.000 1.001 1.002 1.003 1.004
F4(n ) /F 4° (n ,a ( n ) )
Figure 5-4: Expected sample size results for the random group size test based 
on model 1 and optimising objective functions F i,F 2 1 ,F 31 and F4 . Overall 
error probabilities are a  = P = 0.05. Displayed values are ratios of Fk{n) to 
F£ (n, 5(n)) for the objective functions considered.
sample size sequence n is observed. We also define F f  (n, «(n)) to be the optimal value 
of Fr amongst all fixed group sequential tests with sample size sequence n  and error 
probabilities 5(n) and (3(n). That is, if we had known in advance what n would be, and 
had allowed the error probabilities 5(n) and p{n), F f  (n, 5(n)) would be the minimum 
value of objective function Fr achievable. Finally, we shall denote the average values 
of Fr (n) and F f  (n, 5(n)) by Fr and F f respectively, the averaging being weighted by 
the sample size model chosen. We consider objective functions F\, F2 1 , F31 and F4 . We 
use the superscript ~ to indicate an achieved value of the objective function Fr , while 
the value of Fr achieved conditional upon sample size sequence n is indicated by the 
inclusion of n.
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Model r Fr F° Fr frifix
1 38.17 38.16 0.882
1
2 1 31.64 31.62 0.731
31 22.08 22.07 0.510
4 31.08 31.07 0.718
1 38.47 38.46 0.889
2 1 32.07 32.04 0.741z 31 22.70 2 2 .6 8 0.524
4 31.53 31.51 0.728
1 37.85 37.85 0.874
Q 2 1 30.97 30.97 0.715O 31 2 1 . 1 2 2 1 .1 2 0.488
4 30.41 30.41 0.702
Model r Fr Fr° Fr / r i f i x
1 34.70 34.69 0.802
A 2 1 26.92 26.89 0.622
31 17.22 17.20 0.398
4 26.79 26.77 0.619
1 34.72 34.71 0.802
c 2 1 26.95 26.92 0.622O 31 17.31 17.29 0.400
4 26.83 26.81 0.620
1 36.97 36.96 0.854
p. 2 1 29.62 29.60 0.684O 31 19.37 19.35 0.447
4 29.16 29.15 0.674
Table 5.2: Achieved objective function values for tests following sample size 
models 1 to 6  and optimised for objective functions ^ 1 , ^ 215-^31  and F4 . 
Values are averaged over the sample size model and all tests have average 
error rates a  = (3 =  0.05.
Figure 5-4 shows results for objective functions F i, F2 1 , F31 and F4 when the sample 
sizes follow model 1. The values given are ratios of the achieved Fr (n) to F°  (n, a(n))  
when r  =  1,21,31 or 4. Clearly, the random group size test is near-optimal for each 
possible sample size sequence, with the achieved objective function value being within 
0.4% of the optimal value in all cases.
Table 5.2 shows the average objective function values achieved by the optimal random 
group sequential tests averaged over all the sample size models considered. In each 
case, the average of the conditionally optimal objective function values, F f,  is only 
slightly smaller than the achieved average, Fr. It is clear that knowledge of n  in F°  
does not lead to a significant decrease in the average achieved objective function value.
5 .2 .3  B a y e s  r is k  o f  t h e  o p t im a l  r a n d o m  g ro u p  s e q u e n t ia l  t e s t s
In the previous section, we considered the efficiency of the optimal random group 
sequential tests from the frequentist point of view, both conditionally upon the achieved
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sample size sequence n  and averaged over the sample size model. This efficiency was 
measured in term of the expected sample sizes of tests with matching error rates. We 
now consider an alternative efficiency measure, which combines the expected sample 
sizes and error rates of the tests.
Recall that we wish to decide between the decisions Do: lji = . 0 ’ and D$: lfi = 6 \
with a prior 7r(/i) on /i. The costs of incorrectly deciding D$ and Do are do and d$
respectively. Define the cost of wrong decision vector d  =  (do-, ds), and let d opt be
the value of d  which gives the Bayes rule corresponding to our optimal random group
sequential test. T hat is, d opt is the decision cost vector which gives a Bayes rule with
(R)the probabilities of making a wrong decision a  and j3. We then write V}r (dopt) for 
the Bayes risk of the decision rule which corresponds to our optimal random group 
sequential test optimising objective function Fr. The risk of a decision rule is simply 
the expected cost of the rule, and our problem has been constructed to have
f t r ^ ( d opt) = kiFr +  k2  (d*7r(<5)P*{.Do} +  do7r(0)Po{^}) , (5.5)
as discussed in §5.1.2. The Bayes decision theory problem can be designed so th a t its 
solution is a decision rule which minimises any one of the objective functions we have 
considered. In equation (5.5) the achieved value of the objective function of interest 
is Fr and the values of the constants k\ and k2  depend upon which objective function 
we wish to minimise, as discussed on page 78. We also define the risk of this rule, 
conditional upon an observed sample size sequence n  to be
1liR\ n , d opt) = kiFr (n) +  k2  ^ 7 r(5 )P i{ D 0|n} +  d07r(0)Po{^|n}) . (5.6)
If we knew in advance what sample size sequence was to occur in the trial, the same 
decision cost vector would give a different Bayes rule to that obtained as a special 
case of the random groups Bayes rule. We can easily calculate this rule using the
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Figure 5-5: Results for the Bayes rules minimising objective functions
(Ft) (F)Fi ,F 2 i , F 3 i, and F4 . Displayed values are R}r (n ,d opf) /  7?-r (n, d opt). All 
risks are calculated using the decision cost vector d opt, which gives a Bayes 
rule corresponding to the optimal random group sequential test with error 
rates a  = (3 = 0.05 and following sample size model 1.
backward induction algorithm from §5.1.3, optimising the objective function of our 
choice. Equation (5.6) can then be used to evaluate the risk of this Bayes rule, which
( F)we denote 7Zr (n ,d opf).
Figure 5-5 shows the values of 1zlR\ n ,  d opt)/1zlF\ n ,  d opt) for the Bayes rule following 
sample size model 1 and optimising each of F \ , F2 1 , F3 1 , and F4 . These graphs bear a 
strong resemblance to those in figure 5-4. However, the values in figure 5-4 ratios of 
expected sample sizes for tests which had been forced to have matching error rates. The 
results in figure 5-5 are risk ratios between decision rules which do not have matching 
error rates, but have the same costs for wrong decisions. The risks take both expected 
sample sizes and the error probabilities into account. We are comparing the expected
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costs of the overall Bayes procedure conditional upon a particular sample size sequence 
n  to the optimal Bayes rule for that n  given decision cost vector d opt. It is clear 
from these figures tha t the conditional risks 7liR  ^(n, d opt) are very close to the lowest 
possible risks for the same decision cost vector d opt and sample size sequence n. This 
indicates tha t the random groups Bayes rule defined by the decision cost vector d opt 
is very close to optimal for each possible sample size sequence individually, as well as 
having the minimum risk when averaged over the sample size model. Similar patterns 
were observed for the other sample size models studied.
5 .2 .4  C o n c lu s io n s
In §5.2.1 -  §5.2.3, we have considered the performance of the optimal random group 
sequential tests conditional upon the sample size sequences observed, both from a 
frequentist and a Bayesian point of view. The achieved error probabilities conditional 
upon a specific sample size path n  is mainly determined by the achieved value of the 
maximum sample size N k ] recall that due to the symmetry of our optimal random 
group sequential tests, 5(n) =  /3(n) for each sample size sequence n. As the range 
of possible maximum sample sizes increases, so does the range of achieved error 
probabilities. In all cases, the achieved objective function values conditional upon 
a specific sample size path are very nearly optimal over all tests with the same sample 
size path and achieved error probabilities. In the Bayesian setting, we have seen that 
the risks conditional upon the observed sample size sequences are similarly close to 
optimality. The achieved objective function and risk values we have seen indicate tha t 
the optimal random group sequential tests are close to conditional optimality for each 
n  both in terms of the expected sample size and expected cost. It is reassuring to see 
that these designs have both good Bayes and frequentist properties.
Part of our motivation in developing these optimal random group sequential tests was to 
provide a means of assessing the performance of existing methods when unanticipated
102
sample size sequences occur. However, the properties of the optimal random group 
sequential tests we have studied indicate that this method can be useful in its own 
right. As long as the range of possible maximum sample size values is controlled, the 
variation in achieved error rates will be within tolerable limits. Precisely how restricted 
the range of maximum sample sizes should be will depend on the degree of variation 
in achieved error probability that is considered acceptable.
Recall tha t our optimal random group sequential tests can be viewed as a collection 
of fixed group size tests. Each of these fixed group sequential tests will have expected 
sample size characteristics close to optimal among tests with the same sample size 
sequence n and error probabilities 5(n). The optimal random group sequential test 
minimises our chosen objective function among all tests which have our target error 
rates when averaged over the sample size model. Thus, in frequentist terms, we have a 
test which is optimal when averaged over all the possible sample size sequences in our 
chosen model and near-optimal conditional upon n and a(n). In the Bayesian setting, 
we have seen tha t the risks of these procedures will also be near optimal for each sample 
size sequence.
5.3  P erform an ce o f ex istin g  m eth od s
The error spending method of Lan Sz DeMets (1983), discussed in §2.3, is designed to 
deal with unanticipated sample size sequences. However, the A-family of Pampallona Sz 
Tsiatis (1994) discussed in §2.2 needs further modification to deal with an unanticipated 
sample size sequence. In §5.3.1, we discuss one method of adapting the A-family to 
unanticipated group sizes. We then go on to consider how well the A-family and error- 
spending tests preserve their nominal error rates when the group sizes deviate from 
the planned sequence in §5.3.2. Then, in §5.3.3, we compare the A-family and error 
spending tests to the optimal random group sequential tests defined in §5.1.
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5 .3 .1  A d a p tin g  th e  A -fa m ily  te s t s  to  ran d om  grou p  s izes
The A-family of tests, as described by Pampallona & Tsiatis (1994), is defined for a 
sequence of equally sized groups of observations. As we noted in §2.2, the method 
can easily be generalised to include non-equal group sizes, if the schedule of analyses 
is known in advance, but further modification is required to adapt the method to an 
observed sequence of sample sizes which differs from the planned sequence. In this 
section, we discuss a method of adapting the A-family tests to unanticipated group 
sizes from Jennison & Turnbull (2000, chapter 4).
We wish to test the null hypothesis Hoi/j, <  0 against the alternative hypothesis 
H n n  > 0 with type I and II error probabilities a  and (3 at fi =  0 and n = 5 respectively. 
We can take observations X i, X 2 , . . . ,  with each observation being independent and 
identically iV(/q a2) distributed, where we assume that a 2 is known. We define the 
summary statistic Sn to be the sum of the first n  observations and n jix to be the 
number of observations required for the equivalent non-sequential design. Recall from 
the description of the A-family in §2.2 tha t by choosing a value of the param eter A, 
we fix f ix  and define the boundary points at analysis i from the equations
a,i = Srii — C2«A-1^2\/ni(72, and hi =  ci«A-1/2\/nicr2,
where constants c\ and C2 are determined by the choice of A, as discussed in §2.2.
In designing a trial, we plan K  analyses at sample sizes n  =  ( n i , n 2 , ■ • • with
ni < nfix and tik > n fix • We can find a value A(n) of A to give a test which has 
interim analyses at the desired sample sizes and achieves the desired error probabilities. 
This gives rise to a group sequential boundary described by the boundary points 
{(di, &i); % =  1 , . . . ,  K }.  We then define the values and ^  to be
C}u) =  Po {Sni > bi} and Ci° =  Po {S^ <  a*} ,
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noting tha t these probabilities are calculated using the marginal distribution of Sni 
without considering the possibility of early stopping rather than the joint distribution 
of {Sn^, . . . ,  Snjf }.
During the trial, instead of taking observations in groups according to the planned 
schedule of analyses, we may instead see n7x observations at the first analysis and so on, 
resulting in an achieved sample size path n 7 =  (n^, . . . ,  n'K). At analysis i, we modify 
our boundary to allow for the achieved sample size by using boundary points a7, 
defined by the equations
P„ { s„ ; > 6;} =  ciu) and Po { s K < a[) =
Detailed formulae for the boundary points are given by Jennison & Turnbull (Jennison 
&; Turnbull, 2000, p. 96).
W ith this approach, we are keeping the boundary points constant on a standardised 
scale. Since both upper and lower boundaries are standardised under fi = 0, the 
boundaries will still converge at the final analysis. This approach also ensures th a t the 
type I error probability is kept close to the nominal value a , as we shall see in §5.3.2. 
This “significance level” method was been used by Pocock (1977) to modify group 
sequential tests to allow for analyses which do not comply with the planned schedule 
of group sizes. A different approach was taken by Emerson & Fleming (1989). These 
authors interpolated between boundary points of a repeated significance test scheme to 
cope with unpredictable group sizes, but this approach was less effective at preserving 
type I and type II error than the significance level approach.
5 .3 .2  D e v ia t io n s  from  n o m in a l error ra tes  for e x is t in g  m e th o d s
The error spending method was designed to deal with trials where the observed sequence 
of sample sizes differs from that planned, and we have described a means of adapting
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a A-family test to an unplanned sequence of sample sizes in §5.3.1. It is im portant to 
consider how well these methods cope when the sample size sequence departs from the 
planned schedule of analyses. In this section, we consider how well the error spending 
and modified A-family tests preserve the intended type I and type II error probabilities.
Usually, the primary concern is for the preservation of the type I error probability at 
or near its nominal level. The error spending method is designed to preserve type I 
error probability at exactly the nominal level regardless of the sample size sequence 
observed, but the type II error probability may vary freely. The method described in 
the previous section for adapting a A-family test to unexpected sample size sequences 
is approximate and hence does not preserve the type I error exactly. As we shall see, 
however, the modified A-family does well at preserving the type I error close to the 
intended value a.
To apply the A-family to one of the sample size models described in §5.1.5, we find 
the value of A which will give us a test with the required type I and type II error 
probabilities if the most likely sample size sequence is observed. Once this value of 
A is found, we can adapt the resulting test to the observed sample size sequence as 
described in §5.3.1. In all the models we have considered, this most likely sequence 
consists of equally sized groups of observations. For models 1, 2, and 3 the most likely 
sample size sequence is n  =  (15,30,45), for models 4 and 5 the most likely sample size 
sequence is n  =  (10,20,30,40,50), and for model six n  =  (9,18,27,36,45) is sequence 
most likely to occur. A value of A =  —0.07 specifies the desired test for models 1, 2, 
and 3, A =  0.18 results in the desired test for models 4 and 5 and for model 6  the 
desired test has A =  —0.25.
The histograms in figure 5-6 show the range of achieved type I and type II error 
probabilities of the A-family tests when applied to models 2 , 4 and 6  with equal nominal 
type I and type II error probabilities a  = (3 = 0.05. Recall from §5.2 tha t we define 
5(n) and /?(n) to be the error probabilities achieved by the test when sample size
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Figure 5-6: Achieved values ofa(n)  and (3(n) for A-family tests not following 
the planned sample size sequence. The top histograms includes all sample 
size sequences in model 2 , while the middle and lower histograms include all 
sample size sequences in models 4 and 6  respectively. All tests were designed 
for the most likely sequence of sample sizes for the respective models, with 
nominal error probabilities ex. — ,3 = 0.05.
107
8 92
sequence n  is observed. In each case, the range of observed values of 5(n) is quite 
small. For model 2, S(n) lies between 0.046 and 0.050, for model 4 5(n) lies between 
0.046 and 0.050 and for model 6  5(n) lies between 0.049 and 0.050. Thus, we can see 
tha t even in the worst case the achieved type I error probability is within 10% of its 
nominal value and tha t the deviations seen are almost always conservative. In cases 
where the observed ratios rii : n ;+i (i = 1 , . . . ,  K  — 1) are the same as in the planned 
sample size sequence, a(n ) =  a , tha t is that the type I error probability is preserved 
at exactly the nominal level. The deviation from the nominal value of a  increases as 
the ratios between the observed group sizes deviate further from the planned schedule.
However, figure 5-6 also shows that the type II error probabilities achieved by the A- 
family test vary much more than the type I error probabilities. The ranges of /?(n) 
are 0.026 — 0.120 for model 2, 0.032 — 0.082 for model 4 and 0.016 — 0.150 for 
model 6 . Unsurprisingly, the achieved value of /?(n) is very strongly influenced by 
the maximum sample size n 3 , with lower type II error probability occurring when the 
maximum sample size is greater than initially planned. Similar patterns of deviation 
in 5(n) and (3{n) are seen for the other models considered. In general, models with 
a greater range of different sample size sequences result in a larger range of observed 
conditional error rates.
The error spending method is designed to preserve type I error probability exactly, 
regardless of the observed sample size sequence. However, the type II error probability 
can vary freely with the number of observations seen. In order to assess the variability 
of the achieved type II error probabilities under different sample size sequences, for 
each of models 1 to 6 , error spending tests using both the 7 -family and p-family of 
error spending functions were defined in the same way as the A-family tests. In each 
case a value of the relevant design parameter was chosen to specify a test which had 
the nominal error probabilities under the most likely sample size sequence. The values 
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Figure 5-7: Achieved values of /3(n) for the A-family and error spending 
tests. Tests were designed for three analyses, each group consisting of 15 
observations, with type I  and type II errors a = (3 = 0.05. Plotted values are 
of /?(n) calculated for each possible sample size in model 2. The dotted lines 
indicate points where the tests have equal type II  error.
for models 4 and 5 and 7  =  —3.99 for model 6 . The equivalent values of p were 2.71, 
1.48, and 3.35 respectively. These tests were then applied to the cases where the other 
possible sample size sequences occurred. In each case, the range of possible values of 
/3(n) for both 7 -family and p-family error spending tests was less than for the A-family 
tests, despite the error spending tests having no flexibility as to the achieved type I 
error probability. The 7 -family tests had a smaller range of values of /3(n) than the 
p-family for models 1, 2, and 4 and a slightly larger range of /?(n) values for models 3, 
5, and 6 .
For each of the sample size models considered, the tests using the 7 -family and p-family 
error spending functions achieved very similar values of /3(n) for any specific sample 
size sequence n. This is demonstrated in the left hand plot in figure 5-7, which shows 
the values of /3(n) achieved by error spending tests using both 7 -family and p-family 
error spending functions designed for sample size sequence n  =  (15, 30,45) and applied 
to the possible sample size sequences found in model 1. The achieved value of /3{n) 
was also much more closely linked to the maximum sample size than was the case for
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Figure 5-8: Total deviation from the nominal error probabilities for tests 
based on sample size model one. Tests considered are the optimal random 
groups sequential test optimised for F\ (denoted ORGST) and the A-family, 
7 -family and p-family tests designed for three groups of 15 observations each. 
The optimal test was designed with overall error rates a = /3 = 0.05, while the 
other tests had these error rates under the most likely sample size sequence.
the A-family tests and was generally lower for the error spending tests than for the 
A-family tests, as is shown in the right hand side of figure 5-7. This plots the value 
of /3(n) achieved by the A-family test against those achieved by the 7 -family error 
spending test under the same circumstances as in the left hand plot.
The error spending tests have less variation in /3(n) values than the A-family tests as 
the error spending method responds to smaller than anticipated groups of observations 
by “spending” less type I and type II error probability than planned. The modified 
A-family test still uses the same significance levels if a smaller group of observations is 
seen, which is a less efficient use of the information contained within the data.
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Figure 5-9: Achieved 5(n) and (3{n) for optimal random group sequential 
tests, A-family tests and error spending tests. The optimal random group 
sequential test was designed for model 2  with overall error rates a  = (3 = 
0.05. The A-family and error spending tests were designed for three groups 
of 15 observations each, with a  = /3 = 0.05, and evaluated for all sample 
size sequences in model 2 .
the total deviation from the nominal error probability for any specific n  to be 
T (n) =  |5(n) — a | +  |/?(n) — /3\. Figure 5-8 shows this value calculated for all the 
possible sample size sequences in model 1 , evaluated for the optimal random group 
sequential test optimised for objective functions F\ and for the A-family, 7 -family and 
p-family tests. The smallest variability from the nominal error probability is seen for the 
optimal random group sequential test, with the greatest variation seen for the A-family 
tests. Of the error spending tests, there is slightly more variability for the p-family test. 
The total deviation from the nominal error probabilities for the other optimal random 
group sequential tests was also lower than for the error spending methods, although 
there was little difference between the random group sequential test optimised for F31 
and the 7 -family test. The same pattern was observed for the other sample size models.
I l l
Figure 5-9 compares the variability of achieved error rates for the optimal random group 
sequential tests, the A-family tests and the error spending tests. The achieved type I 
error is constant or nearly so for the A-family and error spending tests, while for the 
optimal random group sequential tests both error rates vary, with 5 (n )=  $ ( n ) .  This 
means tha t the optimal tests have less variation in (3{n) than the other methods, but if 
precise control of type I error is desired, this may make the optimal tests inappropriate.
5 .3 .3  C o m p a r in g  th e  effic ien cies o f  e x is t in g  m e th o d s  an d  o p tim a l t e s t s
In chapters 3 and 4 and in §5.2.2 we have measured the efficiency of group sequential 
designs by considering the expected sample size averaged over values of /i. These 
average expected sample sizes were referred to as objective functions. We cannot 
compare the achieved objective function values for the optimal random group sequential 
tests directly to the values achieved by the A-family and error spending tests since 
each test has different average error probabilities. Instead, we tu rn  to the Bayesian 
formulation of the problem and consider the risk or expected cost of each test. Recall 
th a t the risk of a decision rule is a weighted sum of the achieved objective function value 
and achieved error rates averaged over the sample size model, as given in equation (5.5) 
on page 100. For each combination of sample size model and objective function, there 
is a unique decision cost vector d opt for which the Bayes decision rule minimising the 
chosen objective function when the observed sample size sequences follow the specified 
model has the desired probabilities a  and (3 of making a wrong decision. All the risks 
in this section are calculated using the decision cost vector d opt from the Bayes rule 
corresponding to the relevant optimal random group sequential test.
Table 5.3. shows the achieved risks for A-family, 7 -family and p-family tests applied 
to sample size models 1 to 6 , given els percentages of the risk of the relevant optimal 
random group sequential tests. In each case, the tests are symmetric, designed for 
overall type I and type II error probability 0.05, although for many sample size paths
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Table 5.3: Tabulated values are average risks of random group sequential tests 
based on the A-family, j-family, and p-family designs, given as percentages 
of the risk of the relevant optimal random group sequential test. All risks 
are evaluated using the cost of a wrong decision from the appropriate optimal 
random group sequential test.
the achieved values of 5(n) and /3(n) will be different for the non-optimal tests. In each 
case the greatest risk is for the A-family tests, while the risks of the error spending 
tests are similar in all cases, and are noticeably lower than those for the A-family. Of 
the two families of error spending functions, the 7 -family has slightly lower risks. While 
it is difficult to compare the results for the three- and five-analysis tests, it seems tha t 
overall the five-analysis tests have lower relative risks.
An obvious question is how much of the departure from optimality seen in table 5.3 
is due to the A-family and error spending tests being non-optimal for the sample 
size sequences for which they were designed, and how much is due to the effect of 
unanticipated sample size sequences. To address this question, we consider the risks 
of the A-, 7 -, and p-family tests when applied to the single sample size sequence for 
which they were designed. These risks axe in table 5.4, given as percentages of the risks 
of the optimal fixed group sequential tests designed for the same sample size sequence 
and error rates. The risks are calculated using the decision cost vector d opt which gives
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1 0 0 .2
1 0 1 .1
103.9
1 0 1 .1
Table 5.4: Tabulated values are risks of fixed group sequential tests from the 
A-, 7 -, and p-families, designed for the most likely sample size sequence in 
each model, given as percentages of the risk of the relevant optimal fixed group 
sequential test. All risks are evaluated using the cost of a wrong decision from 
the appropriate optimal random group sequential test.
the relevant optimal random group sequential test in each case. These are the same 
decision costs which were used in calculating the results in table 5.3. When we consider 
the results relating to the minimisation of F \ , we can see tha t the bulk of the departure 
from optimality is due to the random sample sizes, although it is here tha t the risks 
are closest to the minimum possible values. In the case of objective functions F 21 and 
Fi, the non-optimality seems to be roughly evenly attributable to both sources and in 
the case of F31 the majority of the departure from optimality seems to be caused by 
the non-optimal nature of the A-, 7 -, and p-family tests in the fixed groups setting.
Figure 5-10 shows the conditional risks of the optimal random group sequential and 
7 -family tests conditional upon the sample size sequence n. The tests in the left plot 
follow model 1, while those in the right plot follow model 6 . The optimal test following 
model 1 minimises F2 1  and the optimal test following model 6  minimises F\, both 
tests having average error probabilities a  = (3 = 0.05. The error spending tests have 
been designed to have these error rates for the most likely sequences of sample sizes in
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Figure 5-10: Risks of the optimal random group sequential tests and 'y-family error 
spending tests conditional upon the sample size sequence n. Tests in the left hand 
plot follow model 1 and the optimal test here minimised F2 1 . In the right hand 
plot the optimal test minimises F i, with both tests following sample size model 6.
The optimal tests have average error probabilities a = /3 = 0.05. Error spending 
tests have these error probabilities under the most likely sample size sequence from 
each model. All risks are given as percentages of the average risk of the relevant 
optimal random group sequential test, and are calculated using the decision costs of 
this optimal test.
models 1 and 6 , n =  (15,30,45) and n = (9,18,27,36,45) respectively. All risks are 
calculated using the cost of wrong decision vector d opt which gives rise to the relevant 
optimal random group sequential tests; these are the same costs as were used in the 
calculation of tables 5.3 and 5.4. Values are given as percentages of the average risk 
of this optimal test, (dop*) for the tests following model 1 and Iz[R\dopt) for the
tests following model 6 .
The plots in figure 5-10 show that the conditional risks of the 7 -family tests are greater 
than those of the optimal random group sequential tests for any sample size sequence. 
However, the discrepancy in risks is not large in any of the cases represented in these 
plots. In all the examples we have seen, the conditional risk of the 7 -family test 
has never been more than approximately 4% greater than the conditional risk of the 
corresponding optimal group sequential test for the same sample size sequence.
As with other properties of random group sequential tests, the conditional risks are
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strongly correlated with the maximum sample size. Both plots in figure 5-10 show this, 
with each cluster of points corresponding to different values of N k • This is especially 
clear in the right hand plot. Larger risks occur when N k  is smaller; a larger value of 
N k  leads to more confidence in our decision and hence a lower risk, although there 
may be a higher expected sample size. However in chapter 3 the minimum value of F\ 
we observed with K  = 5 occurred when u k  =  1.3 x n ^ x. In this case, this corresponds 
to 71k  = 56.3; of the models we consider only model 6  allows this many observations.
It is also clear from figure 5-10 that there is a greater discrepancy between the 
conditional risks of the 7 -family and the optimal random group sequential tests when 
the maximum sample size is further from the most likely value. The error spending tests 
have been designed to reach this value and hence it is not surprising their performance 
deteriorates when we see greater or smaller maximum sample sizes. The degradation 
of the performance of the 7 -family tests is greater when we see less than the expected 
number of observations than when we exceed this value.
5 .3 .4  C o n c lu sio n s
Comparing the A-family tests to the optimal random group sequential tests we have 
found in this chapter, we can see tha t the A-family tests have the greatest range of 
deviation from the nominal error probabilities and the greatest increase in risk over 
the optimal random group sequential tests; the average risks for the A-family tests 
are up to 10% greater than the optimal values. It is not surprising that the A-family 
performs poorly in this setting, since the method was designed for a fixed sample size 
sequence. We have also considered applying the significance level approach which was 
used to adapt the A-family tests to the optimal fixed group sequential tests we found 
in chapter 3. The resulting random group sequential tests had lower risks than  the 
A-family tests, but greater risks than the error spending tests. This is because, like the 
A-family tests, these adapted optimal fixed group sequential designs could not react to
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larger or smaller groups of observations by altering the amount of type I error spent at 
each analysis, as the error spending method does.
The error spending method performs well, with the 7 -family tests being slightly superior 
the p-family tests in most cases. Average risks for the 7 -family within 5% of the risks 
of the optimal random group sequential tests, although this is at the cost of a greater 
variation in error probabilities than is seen for the optimal tests.
5.4  D iscu ssio n
We have found a means to minimise the expected sample sizes of group sequential 
tests when the number of observations seen at each analysis is not determined in 
advance. Our method does require a fixed maximum number of analyses, and that 
we can describe the possible total number of observations at each analysis by a simple 
probability distribution. Our goal in finding these optimal random group sequential 
tests was to provide a tool for assessing the efficiency of the A-family and error 
spending tests under these circumstances. However, we have seen tha t the overall 
error fluctuation of the optimal random group sequential tests is less than that for the 
A-family and error spending tests, albeit with a much greater variation in type I error. 
This variability is closely linked to the the range of maximum sample sizes possible 
under the sample size model. If the maximum total number of observations is not too 
variable, out optimal random group sequential designs would be viable procedures to 
use in monitoring a clinical trial, so long as it would be acceptable to have a test with, 
say, a ±10% fluctuation in type I error.
If the primary concern in the design of a group sequential clinical trial is the 
preservations of type I error at exactly the nominal level, then the error spending 
approach is to be preferred. Our results indicate that the 7 -family tests have slightly 
superior properties than the p-family tests. While the A-family tests have been shown
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to have less desirable properties than the optimal random group sequential designs and 
error spending tests, our results indicate that the significance level approach can be 
used to generalise a A-family tests to unanticipated group sizes with only a small to 
moderate impact upon their performance. This is reassuring for any researcher who 
has designed a trial using a A-family test but has then been faced with a departure 
from the planned schedule of analyses.
It is perhaps surprising that the random group sequential tests have so little variation 
in achieved error probabilities, since these tests can vary the conditional error rates 
in search of the test which minimises the relevant objective function value while 
maintaining the overall error probabilities. Given this, we might have expected to 
see greater variation in the values of 5(n) for the optimal tests.
The sample size models considered in this chapter are relatively simple and much more 
sophisticated models could be considered. These models do not have to be restricted 
to integer sample sizes, so the method we have used could be extended to situations 
where the data  are more complicated than the independent and identically distributed 
normal random variates we have considered. In such situations, we would measure 
groups in terms of information rather than the number of observations, as discussed on 
page 4. By considering models with a large number of possible “sample” sizes at each 
analysis, with little difference between them, we could approximate situations where 
the observed information statistic is a continuous function of the data.
The remaining advantage of the error spending approach is tha t the maximum number 
of analyses is not fixed, allowing as many analyses as are needed to meet a pre-specified 
information level. Our random group sequential tests are still restricted to a fixed 
maximum number of analyses. In the next chapter, we shall look at a method of 




A maximum information design
A popular approach for error spending test is the “maximum information” method of 
sampling (Lan &; Zucker, 1993; Lan, Reboussin, &; DeMets, 1994). In such a trial, 
sampling continues until a pre-specified level of information has been reached. In 
the simple case of independent and identically distributed normal data, this happens 
when the cumulative number of observations seen reaches a value fixed as part of 
the trial design. A characteristic of these maximum information designs is tha t the 
maximum number of observations K  is variable, rather than being fixed. This gives a 
very flexible sequential design and it is intuitively appealing to take this approach. In 
order to examine the properties of the error spending tests, we shall develop optimal 
tests which follow this sampling scheme and accrue observations until a threshold value 
riT is reached. The cumulative sample size at analysis i is denoted rii, thus we observe a 
non-decreasing sequence of cumulative sample sizes n i, 77,2 , —  We shall term inate the 
trial at the first analysis i where rii >  ny, if the trial has not already term inated due 
to crossing the sequential boundary. Throughout the remainder of this thesis we refer 
to these designs as threshold group sequential tests; we find that the term  “maximum 
information tests” can be misleading as the pre-specified “maximum” information level 
may be exceeded.
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In §6 .1  we look at the appropriate Bayesian decision theory problem, the backward 
induction algorithm used to solve it and some suitable group size models. Then, in 
§6 .2 , we look at the overall and conditional properties of the resulting optimal tests 
and in §6.3 we compare our optimal tests to the error spending tests using the 7 -family 
and p-family error spending functions. We no longer consider the A-family tests, as 
they are dependent upon a fixed maximum number of analyses.
6.1  O p tim isin g  to  an in form ation  thresh old
We now consider a method for designing an optimal group sequential test where the 
maximum number of analyses is not fixed as part of the test design. Instead, we 
specify a threshold of observations and terminate the trial at the first analysis where 
this number of observations is exceeded, if the trial has not already stopped due to 
crossing the group sequential boundary. In chapter 5, we specified models to describe 
the possible sequences of sample sizes which might be observed in the course of the trial. 
We shall use the same idea in this chapter, however the models we shall consider are 
more conveniently expressed in terms of the possible group size sequences. In §6.1.1, 
we define the frequentist problem we wish to solve and in §6 .1 .2  we state the Bayesian 
decision theory problem which has the same solution as our frequentist problem. The 
backward induction algorithm we use to find the Bayes rule of interest is described in 
§6.1.3, while in §6.1.4 we define several group size models which we shall use to explore 
the properties of our optimal threshold group sequential tests and the error spending 
designs.
6 .1 .1  D e fin it io n s
Recall tha t we wish to test Ho'.fi < 0 against the one-sided alternative Hi'.fj, > 0 with 
error probabilities a  and (3 at /j , = 0 and fi = S respectively. In our notation, /i is
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the difference in treatm ent efficacy between a new treatm ent and a control and S is a 
medically significant difference in efficacy. We can take observations X i , X 2 , . . . ,  each 
of which is assumed to be independent and to have a normal distribution with mean 
fi and known variance a2. We shall continue to observe groups of data until either the 
group sequential boundary is crossed or the total number of observations seen exceeds 
a fixed threshold value n r . We do not fix the number of observations taken between 
each analysis, but instead use a simple probability distribution to model the possible 
group sizes. We define the random variable N{ to be the sample size at the ith  analysis, 
and we also define the size of the zth group of observations to be M{. The subscript i 
is reserved for use as an index which denotes the analysis number under consideration. 
We still use K  for the analysis at which the trial will be forced to terminate, but this 
is now a random variable rather than a fixed number.
We consider models where the group size at each analysis is an independent and 
identically distributed random variable drawn from a simple discrete distribution. At 
each analysis i, the group size Mi can take any one of 77 possible values, m ( l ) , . . . ,  m{rf). 
The probability of group i consisting of m [j)  observations is defined to be Ej, th a t is 
IP {Mi = m (j)}  = £j for j  =  1 , . . . ,  77.
W ith this definition, we are restricted to models with the same possible group sizes 
at each analysis. The method we shall present could easily be extended to the more 
general case where the possible group sizes at different analyses axe not the same, or 
where the probabilities {e i , . . . , e^}  change from one analysis to the next. We could 
also generalise this method to allow the group sizes at one analysis to affect the possible 
group sizes at subsequent analyses.
Following the notation introduced in chapter 5, we write m  for a group size sequence 
( m i , . . . ,  m/r) and we write n  for the associated sample size sequence. Given the 
probabilities { e i , . . . ,  e^}, the probability of observing a particular group size sequence
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m  =  , m { j K ) j^ will be given by
P |M i  =  m (ji)  n  . . .  n  M k  =  m ( jK)} =  ejx . . .  ejK .
We define M  to be the set of possible cumulative sample sizes which may be observed 
at some point during the trial. This set will arise as a consequence of the possible 
group sizes and observation threshold nr-  We shall write its elements as J\f = 
| n ( l ) , . . . ,  n (L ) |,  where n( 1) <  n( 2) < ••• < n(L) and L  is the number of possible 
sample sizes which may arise during the course of the trial. Thus the cumulative sample 
size at analysis i is a random variable N{ which takes values in J\f (although not all the 
elements of M  are possible values of N{ at any given analysis i).
After seeing n(l) observations with the sum of these values being denoted Sn^ ,  our 
action will be determined by constants a(l) and b(l), with a(l) < b(l), as follows.
5n(q <  a(l) s t o p , accept Hq,
a(l) < Sn(i) < b(l) continue to next analysis,
6(0 < Sn{l) s t o p , reject H 0.
For every I such tha t n(Z) >  n j1, we shall set a(l) = b(l) to ensure tha t the trial will 
term inate once the number of observations seen has reached our chosen threshold.
Unlike the random group sequential tests discussed in chapter 5, these boundaries 
have a single continuation region after a specific number of observations have been 
seen, regardless of the number of analyses taken to reach tha t point. This is because 
once we have seen n(l) observations with sum Sn^  the probability distributions of 
the next group of observations and of the sum of these observations will be the same 
regardless of how many analyses have already been carried out. We refer to these 
tests as threshold group sequential tests. As with the random group sequential tests 





the group size sequence will result in a fixed group sequential test. The properties of 
these fixed group sequential tests, conditional upon an achieved group size sequence, 
are considered in §6 .2 .
We find our optimal threshold group sequential tests via the same Bayesian decision 
theory problem we have used in previous chapters. * The formulation has not changed 
from that discussed in §5.1.2, but we restate the problem in §6.1.2 for convenience. 
Some changes are necessary to the backward induction algorithm we use to solve the 
Bayesian problem, and these are discussed in section §6.1.3. We then go on to describe 
several possible group size models in section §6.1.4.
6 .1 .2  T h e  B a y es  p ro b lem
The formulation of our Bayes decision problem has not changed from tha t defined 
in §5.1.2, and hence we restate it briefly here. More details are given in the earlier 
discussion of this problem.
We wish to decide between Do:lfi = O’ and = 5 \  where fi is the difference in
efficacy between new and control treatments, with positive values of fi implying that 
the new treatm ent is superior. We place a prior 7r(/x) on fi and define the cost of taking 
one observation to be We also define the loss function L 2 (D,fi) which gives the 
cost of making a decision to be L2(Dq,5) =  ds, L,2 (D s,0 ) =  do and L,2 (D ,n)  =  0  
otherwise.
Our goal is to find a Bayes rule which corresponds to a threshold group sequential test 
minimising one of the objective functions defined on page 50. For any of the objective 
function we wish to minimise, we can construct a decision problem with objective 
function Fr , prior 7r(/i), decision costs do and d$ and constants k\ and &2 which has
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expected cost given by
E{cost} =  E{cost of sampling} +  E{cost of decision}
=  k\Fr +  k2 (di7r(<y)Pj{D0} +  d0 7r(0)Po{rfj}) ,
For any given values of do and d$, the Bayes rule will have probabilities of making 
incorrect decisions P<${£)o|do, ds} and Fo{Ds\do, d§}, and the Bayes rule will minimise 
the total expected cost of all decision rules with these probabilities of wrong decisions. 
Hence, the Bayes rule must minimise Fr amongst all decision rules with these 
probabilities of wrong decisions.
To identify the optimal threshold group sequential test minimising Fr with error rates 
a  and /5, we then search over do and ds to find the Bayes rule which has probabilities 
of wrong decisions P^{Z)o|do, d$} = a  and Po{A$|do) ds} = (3. As with the random 
group sequential tests found in the previous chapter, we use the iterative method of 
calculating error probabilities and objective functions described in §5.1.4 as evaluating 
the error probabilities for each group size sequence m  and weighting the average by 
the group size model would be inefficient.
6 .1 .3  B ack w ard  in d u c tio n  for th e  in fo rm a tio n  th r e sh o ld  d es ig n
The backward induction algorithms used to solve the Bayes decision theory problems in 
earlier chapters have all solved problems where the maximum number of analyses, AT, 
is fixed as part of the test design. This is no longer the case, and in this section we shall 
discuss using the backward induction method to find the optimal decision rule when 
we replace the maximum number of analyses by the information threshold. Instead of 
considering our actions at analysis K , then analysis K  — 1 and proceeding backwards to 
analysis 1 , we now work backwards through the set of possible sample sizes AT, finding 
the optimal continuation region for each possible sample size n(l) in decreasing order
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n(L) ,n (L — 1 ) , . . .  , n( l) .  As we noted in the previous section, our action at a specific 
sample size will be determined only by the number of observations seen and the sum of 
these observations, not by the number of analyses we have already carried out before 
reaching tha t point.
Let p(At|sn(/)) be the posterior probability for / i  after we have seen n ( / )  observations 
with sum The posterior is given by
where / At(sn(z)) is the probability density function of Sn^  if the mean of each observation 
is fi.
Given n(l) observations with the sum of these observations being sn^  at analysis z, we
also define the expected cost of taking a further group of observations and proceeding 
optimally once these observations have been seen to be j3(snp)).
n(L) > nr-, we shall wish to ensure the termination of the trial after n(L) observations, 
thus we shall set a(L) = b{L) = s*(£), where is such that
P(/*K(0) 7r(^ )//x(sn(0)
define the expected cost of stopping and choosing between D q and Ds to be 7 (sn(/)). We
We first consider the optimal action to take if we have seen n (L ) observations. Since
E{cost of DolS^i) = s ; (L)} =  E{cost of D 5\Sn{L) =  < (L)} 
d5P(s K ( L)) = rfop(0 | < (L)).
Solving this equation, we find that
(6.1)
125
We then consider the optimal action to take after seeing n(L  — 1 ) observations, then 
after n(L  — 2) observations and so on. For each I such that n{l) > tit, we set 
a(l) — b(l) =  where is found by replacing n (L ) with n(l) in equation (6 .1 ).
For each I such tha t n(l) < tit, we must find a{l) < s < b(l) to define the 
continuation region having seen n(l) observations with sum sn(q. Firstly, we find 
sn(i) an(  ^ evaluate the expected cost of stopping and the expected cost of continuing 
to the next analysis and proceeding optimally there if we observe Sn^  If
7 « ( / ) )  <  *^q), we minimise the expected cost of our action by stopping and
choosing whichever of Do and Ds has the lower expected cost. In this case, we set 
a(l) = b(l) =  s*(q- If, however, 7 (s*^) > we search for two values of sn^
such tha t 7 (sn(q) =  P(sn^)^  one value above and one value below <(/)• We then set 
a(l) and b(l) to these values, such tha t a(l) < < b(l). In order to carry out this
search, we require monotonicity of 7 (sn(q) — /3(sn(q), as discussed on page 29. As with 
the other Bayes decision problems we have considered, we have not found any examples 
where this monotonicity does not hold.
Having discussed the searches for the boundary points at each possible sample size we 
must now discuss the evaluation of 7 (sn(q) and /?(sn(z))- Before doing so it is necessary 
to define two pieces of notation. If we have seen n(l) data values and an observed value 
sn(q of S 'n ( i )  at analysis i we write n(k) for the sample size at analysis i +  1 . Thus k is 
such tha t n(k) = n(l) +  m (j)  for some j  £ {1 , . . .  , 77}. We then define the cumulative 
distribution function of Sn^  given particular values of n (k ) and sn^  to be
n ( l ) ) 9 f j i { s n ( k )  l ^ n ( i ) ) ^  , 
f i E M
where is the probability density function of Sn^  given both sn^  and a specific 
value of /i, and M. is the set of values of fi upon which the prior 7t(/l1) places positive 
probability mass.
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The expected cost of making a decision at analysis i with n(l) observations yielding a 
value sn(/) of the summary statistic Sn^  is
('))}>
which can easily be calculated once the posterior for fj, is known. For any I such that
n(l) > tit, we can not take a further group of observations, but for any I such that 
n(l) <  tit, the expected cost of continuing to the next analysis and acting optimally 
there is
In order to do this, we find the continuation regions sequentially, starting with the 
continuation region for the largest n(l) which is less than n r  and proceeding backwards 
to n(l) .  At each stage, once a(l) and b(l) have been found, we evaluate P(sn^ )  on a 
grid of values of snp) and use these values in subsequent numerical integrations.
This process is very similar to the backward induction algorithms which we used in 
earlier chapters. The key difference is that we no longer consider the action at the final 
analysis and work backwards to earlier analyses. Instead we first consider our action 
for the largest possible cumulative sample size that may occur, n(L), and proceed to 
find the optimal action for smaller possible sample sizes in decreasing order. This is 
summarised in algorithm 4.
(^MO) = c(/iM/il5n(0)13{eJmW)} +
H(zM. j = 1
Xj { £j ^ m i n {7(5n(Jk))5/?(Sri(fc))}^(Sn(fc)lSn(0)}  >
where n(k) = n(l) +  n(j).
In order to evaluate the integral over sn^)  numerically we need to know the expected 
cost of taking the optimal action for a grid of values of SVi(fc) for each possible n(k).
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A lg o r ith m  4: A sy m m etr ic  m axim u m  in form ation  a lgorith m
• For I =  L , . . . ,  1 :
°  F i n d  < ( < )  S U c h  t h a t  dSP{tK(l))  =  d O P ( 0 | s ; ( 0 ) .
O  If n(Z) >  n r  or if 7 « (z)) <  / ? « ( * ) ) >
• set a(l) = b(l) = s*n{l). 
o Otherwise,
• find a(l) such that 7 (a(Z)) =  j3(a(l)), with a(l) <
• find 6 (Z) such that 7 (&(/)) =  P(b(l)), with 6 (Z) >
• evaluate (3{sn on a grid of values of sn^  from a(l) to b(l).
Comparing this algorithm to that for the random group sequential tests of chapter 5 
on page 83, it can be seen that considering what action to take after a given number 
of observations, regardless of the number of analyses seen, simplifies the backward 
induction process.
6 .1 .4  S o m e grou p  s ize  m o d e ls
In this section we define several group size models which we shall use in the rest of this 
chapter to examine the properties of the threshold group sequential tests. Recall tha t 
we define our group size models by a set of possible group sizes | m ( l ) , . . . ,  771(77) |  
with associated probabilities £j = P and the information threshold
riT■ In all of the models we consider the sets of possible group sizes and associated 
probabilities do not depend on the number of analyses already carried out, thus the 
sets {771(1 ) , . . . , 77i(77)| and {^1 , • • ■, £77} are the same for each group size. We will force 
term ination of the trial at the first analysis where tit or more observations have been 
seen, if the trial has not already terminated by this point.
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For each model, specifying yn ( j) ,E j ' , j  = 1 , . . .  , 7 7 and nj- defines the model entirely. 
We define /C to be the set of possible values of K , the analysis at which the trial will be 
forced to term inate and Af to be the set of possible sample sizes which may be observed 
in the course of the trial. These sets are noted below in the description of each model 
in order to make comparisons of the models easier.
For all the examples considered in this chapter, we shall be testing H q-./j, < 0 against 
Hv.fi > 0 with type I error probability a  — 0.05 at fi =  0  and equal type II
error probability (3 = 0.05 at y, — 5 = 0.25. The variance of each observation is
o 2 = 1 .0 , leading to the number of observations required for a non-sequential test
being rifix =  43.30 to two decimal places.
M o d e l 1
m 1 0 15 2 0
II 0.25 0.50 0.25
riT =  45 /C =  {3,4,5} Af =  {10 ,15, . . . ,  60}
Model 1 is a simple model which represents an expectation tha t the group sizes 
will mostly follow an anticipated schedule, but with some possibility of groups being 
substantially larger or smaller than planned. This model is similar in spirit to the 
sample size models 3 and 6  in chapter 5.
M o d el 2
m 5 1 0 15 2 0 25
IP {M  = m} 0 .1 0 . 2 0.4 0 . 2 0 .1
nT = 45 /C =  (2, 3 , . . . ,  9} Af =  {5 ,10 , . . . ,  65}
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M o d el 3
m 1 0 15 2 0
¥ { M  = m} 1/3 1/3 1/3
tit = 45 JC =  {3,2,5} a rM  = {10,15, .. .  60}
Models 2 and 3 can both be thought of as extensions to model 1 with greater uncertainty 
as to the group sizes. In model 2 this uncertainty is expressed as a greater range of 
possible group sizes, while in model 3 we have the same possible group sizes as model 1 
but have equal probabilities of each group size occurring.
M o d el 4
m 10 11 • 20
II 1/11 1/11 ' • 1/11
nT = 45 JC — {3,4,5} M  = {10,11, .. .  ,64}
Model 4 can also be considered as an extension to model 1 where there is less certainty as 
to the possible group sizes. The range of possible group sizes is the same as in model 1, 
but we now consider groups which can be any size between 10 and 20 observations. If 
more frequent analyses with smaller group sizes were considered, this style of model 
could approach the state of discretised fully sequential monitoring, where the data 
could be analysed after every observation. We have assigned equal probability to each 
possible group size in this model, but an obvious alternative would be to use a Poisson 
distribution of some kind, truncating the possible group sizes and renormalising the 
probabilities.
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M o d el 5
m 5 1 0 15 2 0 25
IP (M  =  m} 0 .1 0 .2 0.4 0 .2 0 .1
nT = 40 /C =  {2,3, . . .  , 8 } M  = {5,10, . . . ,60}
Model 5 is similar to model 2 , but with a lower value of the observation threshold 
tit- Models 1 to 4 all have tit > n/ix? ensuring tha t the number of observations taken 
would be sufficient to carry out the equivalent fixed-sample test. Model 5, however, has 
n r  < n fix and thus includes the possibility of being forced to terminate the trial when 
the number of observations taken would be insufficient to carry out a fixed sample test 
with the desired error rates. This enables us to consider the effects of under-powered 
sample size sequences on out optimal tests and the error spending method. In trials 
where the design calls accumulation of data until a fixed level of information has been 
reached, this can occur due to non-clinical reasons, such as lack of funding.
6.2 C on d ition a l p rop erties o f  th e  in form ation  th resh o ld  
te s ts
The main motivation for our optimal threshold group sequential tests is to assess the 
performance of the error spending tests with respect to their expected sample sizes, but 
first we wish to consider the properties of the optimal tests in their own right. As with 
the random group sequential tests of chapter 5, our threshold group sequential tests 
can be considered as a set of fixed group sequential tests, of the type found in chapters 
3 and 4. Each element of the set corresponds to a fixed group sequential boundary for 
a specific sequence of group sizes m  =  (rn{j\ ) , . . . ,  where we note tha t while
we still use K  to denote the maximum number of analyses, it is no longer fixed as
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has been the case in previous chapters. The number of observations seen by analysis i 
determines the upper and lower bounds of the continuation region which we have found 
by the backwards induction algorithm discussed in §6.1.3.
In this section, we consider the properties of the fixed group sequential tests which 
comprise the optimal threshold group sequential test. Any specific group size sequence 
m  uniquely determines a sample size sequence n  and we shall discuss the properties of 
the tests conditional upon the sample size sequence following the discussions in chapter 
5. In §6.2.1, we discuss the achieved conditional error probabilities, in §6.2.2 we discuss 
the conditional and average objective function values achieved by the threshold group 
sequential test, and in §6.2.3 we discuss the risks of the decision rules corresponding to 
our optimal tests.
6 .2 .1  A ch iev ed  error p ro b a b ilit ie s
Our optimal threshold group sequential tests can be viewed as a collection of fixed 
group sequential tests, one for each sample size sequence which may occur during the 
course of the clinical trial. We define 5(n) to be the achieved type I error probability 
of the fixed group sequential test obtained by applying the threshold group sequential 
test to sample size sequence n, with an analogous definition for the achieved type II 
error probability j3{n). Due to the symmetric nature of the examples discussed in 
this chapter, with overall error probabilities a  =  (3 = 0.05, for any given group size 
model and sample size sequence n  an optimal threshold group sequential test will have
5 (n ) =  P(n )-
Figure 6-1 shows the values of 5(n) achieved by the threshold group sequential test 
optimised for objective function F\ and following models 1 and 5. These results show 
a range of values of 5(n), from 0.041 to 0.057 for model 1 and from 0.033 to 0.061 for 















Figure 6 -1 : Achieved type I  error probability conditional upon sample size 
sequences for two optimal threshold group sequential tests. The group sizes 
follow models 1 and 5 and the tests are optimised for F\. Overall type I  and 
type II error probabilities are 0.05.
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the random group sequential tests is that the values of 5(n) no longer fall into discrete 
clusters, depending upon the final sample size tik- The scatter plot shows tha t there is 
still a clear link between the maximum sample size and the achieved error probability, 
however the link is no longer as strong as in the random group sequential tests we 
studied in chapter 5.
There are two factors which make the effect of the maximum sample size on achieved 
error probability less striking for threshold group sequential tests than for the random 
group sequential tests we considered in chapter 5. Firstly, for any specific value tik 
of N k  there axe more possibilities for the sample size sequence with that tik- In 
most cases, there will be sequences with different numbers of analyses leading to the 
same tik■ This increases the range of different values of 5(n) to be seen for any given 
maximum sample size. Secondly, it was noted in chapter 5 (page 95) that the clusters of 
5(n) values became less distinct as the maximum sample size increased. For model 1, 
all the maximum sample sizes axe greater than the fixed sample size ny*x, while for 
the random group sequential tests there were sample size sequences with tik < n/{x. 
Achieved values of 5(n) for the threshold group sequential test following model 5 and 
optimised for F\ are shown in the lower portion of figure 6-1. Model 5 has tit < rifix , 
and the clustering of a(n)  values observed in chapter 5 is more noticeable here than in 
the results for the threshold group sequential test following model 1 .
Figure 6-2 shows the range of 5(n) value achieved by the threshold tests optimised for 
F\ following group size models 2 and 3. In a sense, both these models axe generalisations 
of model 1 with a greater degree of uncertainty as to the possible group sizes. Model 2  
has a greater range of possible group size, but still concentrates probability mass on 
each group having 15 observations. In contrast, model 3 has the same three possible 
group sizes as model 1, but places equal probability mass upon each. Model 2 has many 
more possible sample size sequences than model 1 , and this results in the histogram 
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Figure 6 -2 : Achieved type I  error probability conditional upon sample size 
sequences for two optimal threshold group sequential tests. The group sizes 
follow models 2 and 3 and the tests are optimised for F \. Overall type I  and 




F, F21 F31 Fa
1 0.041 -  0.057 0.039 -  0.059 0.035 -  0.063 0.039 -  0.059
2 0.039 -  0.063 0.036 -  0.066 0.029 -  0.077 0.036 -  0.066
3 0.042 -  0.057 0.039 -  0.059 0.035 -  0.063 0.039 -  0.059
4 0.043 -  0.058 0.040 -  0.061 0.035 -  0.066 0.040 -  0.061
5 0.033 -  0.061 0.032 -  0.062 0.030 -  0.065 0.033 -  0.062
Table 6.1: Ranges of achieved conditional error probabilities for optimal 
threshold group sequential tests. Values are for tests following group size 
models 1 to 6 , and minimising objective functions F\, F2 1 , F 31 and F4 . A ll 
tests had average type I  and type II  error probabilities a  = (3 = 0.05.
link between the maximum sample size and achieved 5(n), but the link is now relatively 
weak compared to the variation in 5(n) for any fixed nx-  The overall range of 5(n) 
values is also slightly larger for model 4 than for model 1, while the range of conditional 
error rates for model 3 is almost exactly the same as for model 1.
Similar patterns were seen in threshold group sequential tests optimised for F 2 1 , F 3 1 , 
and F4  and for other group size models. Ranges of 5(n) values are shown in table 6 .1  
for tests following all the group size models we defined in §6.1.4 and optimised for all 
of the objective functions under consideration. For each of these models, the narrowest 
range of 5(n) values is for the tests minimising F i, while the tests minimising F 31 
have the widest ranges of conditional error probabilities. From the differences between 
these results for models 1 and 2  we can see that increasing the range of possible group 
sizes increases the range of values of 5(n) observed. However, comparing the results 
for models 1 and 3 show that altering the probabilities of the different group sizes 
occurring has little effect upon the ranges of conditional error probabilities. From the 
results for model 4, we can see that allowing each possible group size between 10 and 20 
observations has altered the range of conditional error rates very little when compared 
with model 1, which has the same range of group sizes but only allows 10, 15, or 20 











Figure 6-3: Achieved type I  error probability conditional upon sample size
sequences for an optimal threshold group sequential test. The group sizes 
follow model 1 and the test is optimised for F$\. Overall type I  and type 
II error probabilities are 0.05. Each group size sequence had the number of 
analyses indicated by the plotting character.
model 5 we can see that lowering the information threshold has had a small effect on 
the conditional error rates, and that the changes have mostly been to make the error 
rates more conservative.
Within the range of 5(n) values for any specific value of N k , the number of analyses 
carried out strongly affects the achieved 5(n). Figure 6-3 shows the achieved 5(n) 
values for the test following model 1 optimised for objective function F3 1 , plotted 
against the achieved maximum sample size. The plotting characters are the value of K  
for each sample size sequence n. For example, if the trial is forced to terminate after 
a total of 55 observations have been taken, there could have been three, four, or five 
analyses. The figure shows that achieved value of 5(n) will be larger if there have been 
four analyses than if three analyses have been carried out, and larger still if there have 
been five analyses for any particular value of N k - This is similar to the well-known 
property of error inflation caused by increasing the number of analyses which has been 
discussed by several authors, including Armitage, McPherson & Rowe (1969).
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Figure 6-4: Plotted values are ratios of objective function values conditional 
upon the sample size sequence n to the values optimal for that n and 5(n). 
All tests follow group size model 1 and objective functions F\, F2 1 , F 3 1 , and 
F4 are minimised. Average error rates are a  = (3 = 0.05.
6.2.2 Achieved objective function values
We define Fr (n) to be the value of objective function Fr achieved by the threshold group 
sequential test when the observed sample size sequence is n. We also define F f  (n, 5(n)) 
to be the optimal value of objective function Fr among all fixed group sequential 
tests which have sample size sequence n and type I and type II error probabilities 
equal to 5(n), the error probability of the optimal threshold group sequential test 
conditional upon n. The averages of these values are denoted by Fr and F f  respectively. 
Figure 6-4 shows histograms of the ratios Fr(n )/F f  (n, 5(n)) for optimal threshold 
group sequential tests following group size model 1 and minimising F \ ,F 2 1 ,-F3 1 , and 
F4 . These results show that the achieved conditional objective function values are close
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Model r Fr Fr° F r/'O 'fix
1 35.81 35.80 0.827
1 21 28.20 28.19 0.65131 19.13 19.12 0.442
4 28.10 28.08 0.649
1 36.04 36.02 0.833
0 21 28.55 28.51 0.659z 31 19.66 19.64 0.454
4 28.49 28.46 0.657
1 35.81 35.80 0.827
0 21 28.21 28.18 0.6520 31 19.19 19.17 0.443
4 28.13 28.11 0.650
Model r Fr Fr° Fr /  T lfix
1 35.50 35.49 0.820
A 21 27.71 27.70 0.640
31 18.74 18.73 0.433
4 27.69 27.68 0.640
1 37.88 37.86 0.875
21 31.00 30.96 0.7160 31 21.59 21.56 0.500
4 30.57 30.54 0.706
Table 6.2: Minimum values of objective functions Fi, F2 1 , F3 1 , and F4  for  
threshold group sequential tests following models 1 to 5. Values are averaged 
over the sample size model chosen, and all tests have error probabilities 
a  = (3 = 0.05.
to the minimum possible for matching group sizes and error rates in each case. For 
model 1, all the ratios Fr (n) /  Fr° (n, a(n )) were less than 1.006, indicating tha t the 
objective function values for all the possible sample size sequences were close to being 
conditionally optimal. The ratios for model 3 were similar, while those for model 2 were 
larger, up to approximately 1.03. Maximum values of the ratio Fr (n) /  F° (n, a (n )) 
for model 5 were very close to those for model 2.
Overall objective function values averaged by the group size model are given in table 
6.2 for both the optimal threshold group sequential tests and the tests optimised 
conditionally on n  and a(n ). In all cases, the value of Fr is only slightly larger than tha t 
of F ° , indicating tha t knowledge of the sample size sequence n does not significantly 
alter the optimal objective function vale which can be achieved.
Comparing the results for the different models, we can see that the results are fairly 
robust to alterations in the group size models. Keeping the same possible group sizes 
but altering the probability of each occurring makes only a very small difference as
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shown by the differences between the results for models 1 and 3. By comparing the
results for models 1 and 2, we can see that increasing the range of possible group sizes
has a larger effect, as does lowering the observation threshold tit, but these differences 
are still small. By keeping the range of group sizes the same but allowing more values 
within tha t range, as we do when going from model 1 to model 4, we see a small 
improvement in the optimum objective function values.
6 .2 .3  B a y es risk  o f  th e  th resh o ld  grou p  seq u en tia l te s t s
We have considered the performance of our optimal threshold group sequential tests 
in §6.2.1 and §6.2.2 with respect to the frequentist properties of error probability and 
expected sample size. We now consider the efficiency of the corresponding Bayesian 
decision rules by examining the expected cost of these rules.
In §6.1.2 we defined our decision problem, which is to choose between Do: 1/jl = O’ and 
D$: with a prior 7r(/i) on /z. The costs of incorrectly deciding D$ and Dq axe
do and d$ respectively. We write d  =  (do, d$) for the decision cost vector, and let d opt 
be the value of d  which gives the Bayes rule corresponding to our optimal threshold 
group sequential test. That is, d opt is the decision cost vector which gives a Bayes rule 
with the probabilities of incorrectly deciding Ds and D q to be a  and (3 respectively. 
We then write 7 1 ^ (6 .opt) for the Bayes risk of the decision rule which corresponds to 
our optimal random group sequential test optimising objective function Fr . The risk 
of a decision rule is simply the expected cost of the rule, and our problem has been 
constructed to have
opt) =  k\F r -I- k2 (di7r(<5)P«{i?o} +  doir(0)Fo{ds}^ , (6.2)
as discussed in §6.1.2, where Fr is the objective function that the Bayes rule has been 
designed to minimise; the values of the constants k\ and k 2 depend upon which objective
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function we wish to minimise and are listed on page 78. We also define the risk of this 
rule, conditional upon an observed sample size sequence n  to be
7liT\ n , d opt) = kiF r(n) +  k2 (d*7r(<5)]Pj{.Do|n} +  do7r(0)Po{d*|n}) . (6.3)
If we knew in advance what sample size sequence was to occur in the trial, the same 
decision cost vector would give a different Bayes rule to that obtained as a special 
case of the random groups Bayes rule. We can easily calculate this rule using the 
backward induction algorithm from §6.1.3, optimising the objective function of our 
choice. Equation (6.3) can then be used to evaluate the risk of this Bayes rule, which 
we denote 7?i-F^(n, d opt)-
Figure 6-5 shows the values of 'R^r \ n , d opt)/T liF\ n , d opt) for the Bayes rule following 
group size model 1 and optimising each of -Fi,F2 i 5^ 3 i> and F4 . Unlike the values in 
figure 6-4, which were ratios of expected sample sizes for tests which had been forced to 
have matching error rates, the results in figure 6-5 are risk ratios between decision rules 
which do not have matching error rates but have the same costs for wrong decisions. 
The risks take both expected sample sizes and the error probabilities into account. 
We are comparing the expected costs of the overall Bayes procedure conditional upon 
a particular sample size sequence n  to the optimal Bayes rule for that n  given the 
same decision cost vector d opt. From figure 6-5, it is clear that the conditional risks
(rp\
7Zr (n, d opt) are very close to the lowest possible risks for the same decision cost vector 
d opt and sample size sequence n. This indicates that the Bayes rule defined by the 
decision cost vector d opt is very close to optimal for each possible sample size sequence 
individually, as well as having the minimum risk when averaged over the sample size 
model. Similar patterns were observed for the other sample size models studied.
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Figure 6-5: Efficiency of the Bayes rules minimising objective functions 
F \,F 2 \ ,-^3 1 , and F4 . Displayed values are ^ ^ ( n , d opt) /  1zlF\n ,d o p t). All 
risks are calculated using the decision cost vector d opt, which gives a Bayes 
rule corresponding to the optimal threshold group sequential test with error 
rates a  = (3 = 0.05 and following group size model 1.
6.2.4 Conclusions
We have considered the behaviour of the optimal threshold group sequential tests when 
applied to a range of group size models. Many other models would be possible and 
in particular it must be noted that some of the group size models we have considered 
have possible maximum sample sizes considerably larger than the fixed sample size 
rifix, however it would be straightforward to construct models which avoided this. For 
example, we could define models which had different possible group sizes if we were near 
the fixed sample size; in practice this would correspond to a trial protocol specifying 
that under these conditions the next analysis would be carried out sooner than had
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been the case during the earlier stages of the trial.
Our main motivation in developing the optimal threshold group sequential tests was 
to provide a tool to assess the performance of the error spending tests, which we shall 
do in the following section. However, the optimal threshold group sequential tests are 
useful designs in their own right, provided that a sensible group size model can be 
formulated. Comparing the results for models 1 and 2 has shown that increasing the 
range of possible group sizes at each analysis increases the range of values of 5(n) which 
may be observed and slightly decreases the achieved efficiency. Thus, by controlling 
the range of possible group sizes we can restrict the variation in conditional error 
probabilities to a tolerable range. Comparisons between models 1 and 3 have shown 
tha t altering the probabilities of the possible group sizes has little effect upon the 
properties of the test. Models 1 and 4 have the same range of possible group sizes but 
model 4 permits many more values of Mi in that range. Comparing the results for 
these models has shown a very light increase in the range of 5(n) values and a slight 
increase in the efficiency of the tests. Hence, it seems it would be possible to construct 
models which perm itted near-continuous monitoring of the data and to design very 
flexible trials by using these models.
From the results discussed in §6.2.1 — §6.2.3 and those from other models we have 
used, it seems tha t the achieved values of 5(n) and Fr (n) are somewhat less variable 
for the threshold group sequential than for the random group sequential designs of 
chapter 5. This can partly be attributed to the fact tha t the group size models used 
in the threshold designs have less variable maximum sample sizes than the sample size 
models introduced in §5.1.5.^ Another reason is that few of the maximum sample sizes 
in the optimal threshold group sequential tests are less than while in the random 
group sequential tests we studied models with many values of N k  which were below 
the sample size required for the equivalent non-sequential design.
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6 .3  P erform an ce o f th e  error sp en d in g  m eth o d
We now consider the performance of the error spending tests defined by the 7 -family 
and p-family error spending functions when applied to the group size models introduced 
in §6.1.4. The properties of the error spending tests are compared to those of the 
threshold group sequential tests, firstly with regard to deviations from the nominal 
error probabilities in §6.3.1, then with respect to the efficiency of the tests in §6.3.2. 
We do not consider the A-family tests as a fixed maximum number of analyses is 
integral to the definition of the A-family tests, and thus applying these tests to the 
group size models we consider in this chapter would be impractical.
6 .3 .1  D e v ia t io n s  from  th e  n o m in a l error ra tes
The error spending tests preserve type I error at exactly the nominal level, but the type 
II error varies with deviations from the planned group size sequence. Error spending 
tests were designed for testing H^'.p < 0 against H \\p  > 0  with equal type I and type 
II error probabilities 0.05 at p, =  0 and p  =  0.25. For each of the group size models 
we defined in 6.1.4 the most likely schedule of analyses is for there to be three groups 
of 15 observations each, each observation being independent and identically N (p , 1.0) 
distributed. Param eter values 7  =  —3.24 and p =  2.71 result in tests meeting these 
design criteria. The achieved type II error probabilities of the 7 -family tests conditional 
upon the achieved sample size sequence are shown in figure 6 - 6  for group size models 
1, 2, and 5. For each example we have seen, the type II errors achieved by the 7 - and 
p-family error spending tests has been very similar for each sample size sequence n, 
although those for the p-family tests have been slightly larger on average.
It is immediately noticeable that almost the majority of the deviation from the nominal 
error is downward; that is (3(n) <  (3 for most sample size sequences. This is because 
the error spending test have been designed for a sample size sequence with maximum
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M o d e l  1 Model 2 M odel 5
i l
0.020  0.025 0.030 0.035 0.040  0.045 0.050





0.02  0 .03 0.04 0 ,05  0.06 0.07
i3(n)
Figure 6 -6 : Achieved type II error probability conditional upon sample size
sequences for  7 -family tests following group size models 1, 2, and 5. A.U tests 
were designed for three groups of 15 observations, with equal type I  and type 
II error probabilities a = (3 = 0.05.
sample size equal to the value of n r  in the group size models, which exceeds the sample 
size for the equivalent non-sequential design in most cases. Model 5 is the exception to 
this generalisation, as in this model n r  = 40, while n jix = 43.30. The error spending 
tests for model 5 have still been designed for a total of 45 observations in three equal 
groups, and thus in this case there are some sample size sequences where the error 
spending test is forced to terminate before the planned sample size has been reached. 
W ith as few as 5 observations less than planned, the error spending tests see type II 
error probability as large as 0.075, 50% greater than the intended error probability. 
For models 1 and 2 there is a small amount of upwards deviation in type II error 
conditional upon the observed sample size sequence. This error inflation occurs when 
we reach the target information threshold exactly, but take more than the planned 
number of analyses during the trial. For example, in model 2 we can take as many 
as nine analyses to reach our planned maximum sample size of 45 observations. The 
achieved values of /3(n) are mostly clearly divided into clusters, depending upon the 
achieved value of n ^ , although when the group sizes follow model 2  there is some 
overlapping of the clusters for the larger values of N k -
To examine the overall variability in error probabilities, incorporating both type I and 
type II error, we define the total deviation from the nominal error rates conditional
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M od el  1
OTGST 7-FAMILY p-FAMILY
I I I 1
0.0 0.005 0.010 0.01S 0.020 0.025 0.030 0.0 0.005 0.010 0.015 0.020 0.025 0.030 0.0 0.005 0.010 0.015 0.020 0.025 0.030
T ( n )  T ( n )  T ( n )
M o d e l  2
OTGST
0.01 0.02 
T ( n )
7-FAMILY
l l
0.0 0.01 0.02 0.03
T (  n )
p-FAMILY
0.0 0.01 0.02 0.03
T ( n )
Figure 6-7: Deviation from the nominal error rates conditional upon sample size
sequences for error spending tests following models 1 and 2. Values for the optimal 
threshold group sequential tests (marked OTGSTJ are shown for comparison. The 
error spending tests were designed for three groups of 15 observations, with equal 
type I  and type II  error probabilities a  = P = 0.05. The optimal tests have average 
error probabilities a  = f3 = 0.05.
upon sample size sequence n to be T(n) =  |5(n) — a\ -I- |/3(n) — f3\. Figure 6-7 shows 
the deviations from the nominal error rates for the optimal threshold group sequential 
test and both families of error spending tests when applied to group size models 1 
and 2 . The threshold group sequential tests have been optimised for objective function 
F\. It is clear that the deviations for the error spending tests are, for some sample 
size sequences, much larger than the deviations for the threshold group sequential test. 
This has been true for other examples not shown here when the optimal tests have been 
designed to minimise objective functions F \ , F2 1 , or F4 . Tests designed to minimise F31 





















K 21 101.2 101.6
31 102.6 104.2
4 101.1 101.7
Table 6.3: Tabulated values are average risks of threshold group sequential 
tests based on the j-fam ily and p-family designs, given as percentages of the 
risk of the relevant optimal threshold group sequential test. All risks are 
evaluated using the cost of a wrong decision from the appropriate optimal 
threshold group sequential test.
the nominal error rates a  and (3 for the tests optimising F31 was almost as large as tha t 
of the error spending tests.
6 .3 .2  E ffic ien cy  o f  th e  error sp en d in g  m e th o d
Since the optimal threshold group sequential tests and error spending tests have 
different conditional error probabilities for any given sample size sequence n, we do 
not use expected sample size as an efficiency criterion. Instead we use the risk or 
expected cost of the threshold group sequential tests and the error spending tests to 
compare the efficiencies of these designs. Recall from §6.1.2 tha t we define Dq and D$ 
are the decisions ‘/i =  01 and = S \ and d$ and do are the costs of incorrectly making 
these decisions. We refer to d =  (d0,dj) as a decision cost vector and for any given 
particular combination of group size model and objective function of interest there is 
a value d opt of d  which gives the Bayes rule corresponding to our optimal threshold
147
group sequential test. Using an equivalent equation to (6.3), we define the risk of the 
7 -family error spending test conditional upon sample size sequence n  to be
'R p \ n ,d opt) = kiF r +  k2  (doPo{As|n} +  di^P^-D olii}) .
The risk of the 7 -family test averaged of our group size model is denoted 'R ^ \ d npt) 
and we make equivalent definitions for the p-family tests.
Table 6.3 shows results for the error spending method. Values in this table are the 
average risk for the 7 - and p-family tests given as percentages of the average risk of 
the corresponding optimal threshold group sequential test. All the error spending tests 
have been designed for three groups of 15 observations and have equal type I and type 
II error in these circumstances, while the optimal tests have these error probabilities 
averaged over the group size model. The performance of the error spending tests is 
fair in most cases, although the results for the optimisation of F31 indicate tha t the 
error spending tests are noticeably sub-optimal in this case. In all cases, and in other 
examples we have not reported here, the 7 -family tests are slightly superior to the 
p-family tests.
To examine how much of the inefficiency shown in table 6.3 is due to the non-optimality 
of the error spending tests in the fixed groups setting and how much is due to the 
unanticipated group sizes, we consider the risk of the error spending tests in the fixed 
groups setting. To do this, we found the fixed groups designs for the sample size 
sequence n  =  15, 30,45) with equal type I and type II error probabilities a  = (3 = 0.05 
which minimise each of Ti,.F2 1 , .£3 1 , and F4 . Table 6.4 shows the risks of the error 
spending tests given as percentages of the risks of the optimal fixed group procedures; all 
risks were calculated using the decision cost vector from the relevant optimal threshold 
group sequential design. In all cases, a large proportion of the inefficiency of the error 
























Table 6.4: Tabulated values are risks of fixed group sequential tests from the 
7 -, and p-families, designed for the most likely sample size sequence in each 
model, given as percentages of the risk of the relevant optimal fixed group 
sequential test. A ll risks are evaluated using the cost of a wrong decision 
from the appropriate optimal threshold group sequential test.
Figure 6 - 8  compares the risks of the optimal threshold group sequential tests and 7 - 
family tests conditional upon the observed sample size sequence n. The optimal tests 
are all designed to minimise objective function F i, the expected sample size when 
fj, = <5/2, and have average error probabilities a  — (3 = 0.05. The error spending tests 
have these error probabilities when the sample sizes follow the planned sequence n  =  
(15, 30, 45). All risks are calculated using the decision cost vector d opt which gives the 
Bayes rule corresponding to the relevant optimal threshold group sequential test; these 
costs were used in the calculation of tables 6.3 and 6.4. The plotted values are the 
conditional risks given as percentages of the average risk for the relevant Bayes rule.
The plots in figure 6 - 8  show a small number of sample size sequences for models 2 
and 5 where the conditional risk of the error spending test is slightly lower than for the 
optimal test. This is because the optimal test minimises the risk over the entire sample 
size model, and not necessarily for each n. The general pattern in the plots in figure 6 - 
8  is tha t the points where the conditional risk of the error spending test is closest to
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Figure 6-8: Conditional risks of the optimal threshold group sequential tests 
and ^-family error spending tests following sample size models 1, 2, 3, and 5. 
Optimal tests minimise objective function F \, with average error probabilities 
a  =  /3 =  0.05. Error spending tests have these error probabilities under the 
most likely sample size sequence, n =  (15, 30, J^ 5). All risks are given 
as percentages of the average risk of the relevant optimal threshold group 
sequential test, and are calculated using the decision costs of this optimal 
test.
that of the optimal test represent sample size sequences with smaller maximum sample 
sizes. When the maximum sample size is considerable larger than the value of N k  
for which the error spending test was defined then the conditional risk of the error 
spending method is further from the conditional risk of the optimal procedure. This 
indicates that the error spending test does not make efficient use of the observations 
gathered by overshooting the planned maximum sample size. The plot of conditional 
risks for tests following model 5 shows a somewhat different pattern. The cluster of 
points which have the largest conditional risks represent sample size sequences where
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riK = 40, tha t is where we have not seen the number of observations tha t the error 
spending test was designed for.
From table 6.3 and figure 6-8, and from similar plots for the other objective functions, 
we can see that where the average risk for the error spending function is, say, 3% 
greater then the average risk of the optimal test, then the conditional risks of the error 
spending test range up to about 6% greater than the corresponding risks of the optimal 
tests. The cases where the conditional risk of the error spending test is furthest from 
the conditional risk of the optimal threshold test are when there is a large overshoot 
of observations and tik is significantly larger than the planned maximum sample size. 
Thus, even if the average risk of an error spending procedure is close enough to the 
risk of the corresponding optimal threshold group sequential test, there may be sample 
size sequences for which the error spending test performs particularly poorly.
6 .4  D iscu ssio n
Our optimal threshold group sequential tests provide an alternative means of measuring 
the performance of the error spending tests to the optimal random group designs we 
used in chapter 5. The threshold designs provide a more accurate comparison to the 
circumstances in which an error spending design is often used; when we continue to 
observe accumulating data until a fixed information level is reached.
The comparisons in §6.3 show that the error spending method can be highly efficient for 
sample size sequences close to those for which it was designed. However when there is 
a large overshoot of data, resulting in a maximum sample size considerably larger than  
tha t which was planned, the error spending method can be significantly inefficient in 
the sense of having a much larger expected cost conditional upon the observed sample 
size than the conditional risk of our optimal threshold group sequential designs. In such 
circumstances, the error spending method can make little use of the extra information
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provided by the large final group of observations as the majority of the type I error has 
already been spent by this point.
Throughout the results presented in §6.2, we saw that the properties of the optimal 
threshold group sequential designs were closely linked to the range of sample sizes which 
could be observed at each analysis. When the range was kept constant, altering the 
probabilities of given sample size occurring or allowing a greater number of possible 
sample sizes did little to increase the range of error probabilities conditional upon 
observed sample size sequences, 5(n). Thus, we could design group size models which 
would allow frequent monitoring of the data and which could approach fully sequential 
monitoring. So long as the maximum group size of such a model was small, we would 
maintain an acceptable range of values of 5(n) and would gain the reduction of expected 




We have developed group sequential tests which minimise expected sample size for a 
number of situations and looked at the performance of existing methods relative to  the 
optimal designs. We now wish to summarise the conclusions from each chapter and 
make some comments on these results in §7.1, before outlining some avenues of further 
work which remain to be investigated in §7.2. Firstly, we will restate our original 
problem for convenience; we first defined and discussed this problem in §1.2.1.
We assume a new treatm ent is being compared to a control, which could be either 
a placebo or an established treatm ent and that the difference between the treatm ent 
on trial and the control can be measured in some numerical fashion. We denote the 
treatm ent difference by //, with positive values of ji implying superiority of the new 
treatm ent. The available data consist of observations X i, X 2 , . . . ,  where each X i is 
independently N (fi , a2) distributed with a 2 known. We wish to test the null hypothesis 
H 0:fi <  0 against the one-sided alternative H\:fi > 0 with some chosen size a  at ^  = 0 
and with power 1 — (3 fixed at fi = 5. In the trial design stage, 6  would be chosen to 
be some clinically significant and plausible treatm ent effect.
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7.1 D iscu ss io n  and recom m end ations
7 .1 .1  A n  o v erv iew  o f  our resu lts
We have found optimal group sequential tests in several setting and used these tests 
to gauge the expected sample size properties of the A-family and error spending tests. 
In chapters 3 and 4, we looked at fixed group sequential tests where the sequence of 
group sizes was known in advance. We considered symmetric designs with equal type 
I and type II error rates in chapter 3 and designs where the type I and type II error 
probabilities were not equal in chapter 4. There was very little difference between the 
results in the symmetric and asymmetric settings. For both sets of fixed groups results 
we saw tha t the A-family of tests were the least efficient method and tha t the two 
families of error spending functions had similar properties, although the 7 -family tests 
were generally slightly more efficient than the p-family designs. This pattern continued 
throughout chapter 5 and while the A-family was excluded from chapter 6  the 7 -family 
error spending designs were still slightly superior to the p-family tests here. We thus 
recommend the error spending tests using the 7 -family of error spending functions for 
general use, although care must be exercised in selecting a value of the param eter 7 .
7 .1 .2  C h o ice  o f  o b je c t iv e  fu n ctio n s
We set out to optimise group sequential tests with respect to the expected sample 
size of the design for various values of p. These expectations are called objective 
functions, and we have considered a total of nine objective functions in our discussions. 
Initially we optimised five objective functions defined by Jennison (1987) and Eales &; 
Jennison (1992).
F\ =  Etf/2 {./V}
F2 =  Eo{iV} =  IEtf {./V}
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•^3 — ^ 3 5 /25 / 2 { N }
1
These objective functions are all symmetric in nature and in chapter 4 we defined six 
new objective functions to replace F2  and F3.
Of these, F2 1  and F 31 are symmetric and designed to specifically replace F2 and F3  
respectively. Objective functions F2 2 , F2 3 , F 32 and .F33 are asymmetric and in §4.3.2, 
we discussed these objective functions. We recommended tha t in general use, F2 1  and
certain situations where their asymmetry is beneficial, such as testing a new treatm ent 
which is known to have superior secondary characteristics to the control.
Throughout chapter 3, results for the minimisation of T2 , -F4 , and F$ were similar. In 
chapter 4 we replaced F2  by F21  and here the minimum values for F2 1 , F 4 , and F$ 
were very close. Moreover, the results presented in figures 3-1 and 4-2 showed tha t a 
test optimised for one of these objective functions was close to optimal for the other 
two objective functions from this trio. The results presented in chapters 5 and 6  did 
not include the optimising of F5 , but the results for objective functions F2 1  and F4  
were very similar. While we have not presented results in chapters 5 and 6  for the 
performance of these tests with respect to the objective functions for which they were 
not optimised, they were similar to those observed in chapters 3 and 4. It seems tha t 
in most cases examining results for all of F2 1 , F4 , and F 5 will not be necessary and tha t 
it will be sufficient to consider one of these objective functions.
F2i = - ( ^ { N } + E s { N } )  F2 2  = Eo {N } F2 3  = E s{N }
F 3I — ~  +E3<S/2{^}) -^ 22 =  -^ 23 =  -^35/2 { ^ }
Fsi are to be preferred and that the asymmetric objective functions be reserved for
155
We note tha t in each chapter the results for F 3 (or F 3 1 ) have been significantly different 
from those for the other objective functions considered. Figures 3-1 and 4-2 have shown 
tha t tests optimised for F 31 perform poorly with respect to other objective functions. 
This is because F31 represents very extreme values of //, and in this situation our 
optimal action is to encourage very early stopping. Tests optimised for other objective 
functions axe more conservative at early analyses. We also note tha t of all the tests not 
optimised for F3 1 , those which minimised F2 1  and F4  were very nearly equal in their 
achieved values of F 3 1 , and superior to tests optimised for F\ and F 5 .
Based on the results in chapters 3 to 6 , we recommend that the efficiency of any group 
sequential design should be assessed in its performance for F\ and F2 1 . The objective 
function F 31 is a special case and, like the asymmetric objective functions, should be 
considered only in certain examples. As we noted above, a test which is near-optimal for 
F2 1  will also have good properties for F4  and F5 . The computation for tests minimising 
F2 1  are slightly less intensive than those for F4  and F5 . Moreover, the monotonicity 
we desire in finding the optimal Bayes rules (discussed on page 29) can be proven for 
rules minimising F\ and F21 (Lai, 1973; Brown, Cohen & Strawderman, 1979).
7 .1 .3  S o m e c o m m e n ts  on  th e  error sp en d in g  r e su lts
The results we have seen in chapters 3 and 4 showed the error spending tests can be 
highly efficient for equally spaced analyses if the value of 7  or p is chosen with care. 
However, they also showed that certain values of the parameters 7  and p produce tests 
which are further from optimality or have unacceptably large maximum sample sizes. 
A prime motivation in our development of the optimal tests in chapters 5 and 6  was to 
assess the performance of the error spending tests when unanticipated group sizes are 
observed, the situation for which this method was developed. We have seen tha t if the 
number of observations seen is less than that planned, the type II error probability of 
an error spending design can be significantly inflated over the nominal level. On the
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other hand, if more observations become available than was anticipated in the design 
of the trial then the error spending method can only make use of this to lower the type 
II error probability, not to improve the type I error rate. In the Bayes setting, this 
means tha t the error spending method is further from the optimal expected cost when 
we see more or less observations than was anticipated.
7 .1 .4  P r a c t ic a lity  o f  o p tim a l te s ts  w ith  ran d om  grou p  s izes
Our optimal random group sequential tests of chapter 5 and optimal threshold group 
sequential tests of chapter 6 depend upon the specification of a model for the possible 
sample size sequences which may occur during the conduct of the trial. The comparisons 
of the results for different group size models in chapter 6 shows th a t the optimal tests 
are robust to small changes in the model and hence precise accuracy in the model 
specification will not be crucial.
In some situations, the specification of a model for the possible sample size sequences 
will not be possible and in these cases the methods we have developed will not be 
practical. However, our optimal tests can still play an im portant role here by assessing 
the performance of error spending tests or of other flexible designs such as W hitehead’s 
triangular test (Whitehead, 1992, chapter 4).
7.2 F urther work
7 .2 .1  A sse ss in g  o th er  te s t  d esig n s
We have used our optimal designs to assess the performance of the A-family and error 
spending methods. These methods were chosen as they are currently widely used and 
each family incorporates a wide range of tests. However, other group sequential designs 
exist and it would be interesting to compare their expected sample size properties to
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both our optimal tests and the A-family and error spending methods. In particular, 
W hitehead’s triangular test (Whitehead, 1992, chapter 4) has been widely used and 
a software package is available to implement it. We have not considered this method 
in our discussions as we wish to avoid designs where the maximum sample size is 
significantly larger than the sample size required by the equivalent non-sequential 
design; W hitehead’s triangular test has a maximum sample size approximately 1.6 
times tha t of the fixed sample test.
It would also be interesting to extend our optimal designs to two-sided tests. Eales h  
Jennison (1995) and Chang (1996) have used the approach of finding a Bayes decision 
problem with a solution corresponding to the desired optimal group sequential test in 
the two-sided setting. Jennison & Turnbull (2000, chapter 2) find two-sided A-family 
tests to be closer to optimality than we have found in the one-sided case, so there are 
differences in behaviour between these two settings to be investigated.
7 .2 .2  S a m p lin g  sch em es
In chapters 5 and 6 we investigated our optimal random groups and threshold designs 
by considering their properties for a number of models of sample size sequences. These 
models were chosen to explore the behaviour of our optimal designs and the error 
spending method, but for the optimal tests to be directly useful models which axe closer 
to the actual accrual of information in a clinical trial would need to be investigated. 
The independent and identically distributed information increments of chapter 6 would 
be a suitable place to start, and could lead to very flexible designs.
7 .2 .3  V a riab le  grou p  s ize  d esig n s
Group sequential designs have been proposed which allow the trial organisers to carry 
out more frequent analyses if the trial is close to termination at some stage (Lan &;
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DeMets, 1989). Lan &; DeMets found some reduction in expected sample size could be 
achieved by this method, but that the error rates of the test were perturbed as altering 
the schedule of analyses in a data dependent fashion violated the sequential design. By 
building the option of carrying out more frequent analyses into the overall designs of 
our optimal tests, this perturbation of error rates could be avoided.
This possibility is also attractive from an alternative point of view. We could think 
in terms of carrying out analyses less frequently if there was little chance of the trial 
term inating at the next analysis. This would result in a small increase in expected 
sample size, but would avoid unnecessary meetings of a data monitoring committee 
and hence ease the logistical burden of carrying out a group sequential clinical trial.
7 .2 .4  A d a p tiv e  a llo c a tio n
We noted in §1.2.3 tha t a large amount of research has been done on sequential 
allocation rules, where new patients are not necessarily evenly divided between the new 
and control treatm ents but are allocated in some fashion which is based on the data 
observed to date. Coad & Rosenberger (1999) have found that combining sequential 
allocation rules with a fully sequential early stopping rule has potential benefits. In 
their setting, the response variable was binary with each patient being recorded as a 
treatm ent success or failure. By combining a sequential allocation rule with an early 
stopping rule, the number of treatment failures was reduced. Jennison & Turnbull 
(2000, chapter 17) have looked at adaptive allocation rules in the group sequential 
setting, using A-family tests, and found that it is possible to significantly reduce the 
number of patients randomised to the inferior treatment. It would be interesting to 
investigate the effects of combining a sequential allocation rule with an optimal group 
sequential design.
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7 .2 .5  A sy m p to t ic  n o rm a lity  o f  te s t  s ta t is t ic s
Throughout this thesis, we have studied the simple problem of independent and 
identically distributed response data. In §1.2.1 we outlined some of the work tha t 
has been done to show that many more sophisticated models have this structure 
asymptotically. However, it is not clear how well this asymptotic approximation holds 
in small samples, such as during the early stages of a sequential clinical trial. We have 
seen tha t existing group sequential designs can be close to optimal with respect to 
expected sample size, and it is possible that the inaccuracy induced by the asymptotic 
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